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Background: People with COPD engage in lower levels of physical activity (PA) compared 
to healthy people. PA interventions (PAI) for people with COPD are not offered in the current 
healthcare system. Aim: To assess the feasibility of conducting a trial to explore the 
effectiveness a PAI versus pulmonary rehabilitation (PR) in improving physical activity in 
patients with COPD (the LIVELY COPD project); and to assess the treatment fidelity of the 
LIVELY PAI.   
Methods: A mixed methods randomised controlled feasibility trial was undertaken and the 
treatment fidelity of the PAI was assessed. COPD patients referred to PR in two health and 
social care trusts were screened; n=50 were recruited and randomised. The PAI consisted of 
a 12 week pedometer driven walking intervention, participants had weekly contact with a 
physiotherapist/nurse and set step goals. Outcome measures were collected at baseline, post 
intervention and follow up. Qualitative interviews were conducted at post intervention. Based 
on a review of the literature, the Borrelli 2011 checklist was used to assess the fidelity of the 
PAI.  
Results: N=50 participants were recruited (PAI n=23, PR n=27). There were less dropouts 
in the PAI (26%) compared to PR (52%). Participants in the PAI increased their average daily 
step count in line with the minimal clinically important difference for step count in COPD, 
this was not observed in PR.  The results of the qualitative component demonstrated that the 
participants experienced a range of health benefits. Participants in both groups encountered 
barriers to participation; the PAI had a stronger emphasis on facilitators.  The LIVELY PAI 
was delivered with good fidelity and the use of the Borrelli 2011 checklists provide a feasible 
platform for assessming fidelity of a PAI.  
Conclusion: These findings support the feasibility of the LIVELY COPD project and there 
was important learning which could help ensure the success of a future trial. Testing the 
feasibility of a trial with a mixed methods design was a valuable process and the qualitative 
data enriched our results. Assessing the fidelity of the LIVELY PAI increased our 
understanding of the intervention. Future research is needed to test the intervention in a fully 
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Chapter 1 - Introduction 
 1.1 Introduction 
This chapter will provide background information about the prevalence, presentation and 
treatment of chronic obstructive pulmonary disease (COPD). It will present evidence 
regarding the importance of physical activity (PA) for people with COPD and describe 
the levels of PA in the COPD population (Table 1.1 PA levels for different cohorts of 
people with COPD and healthy people). This chapter will also outline the importance of 
conducting and reporting on feasibility trials; the inclusion of a mixed methods research 
design within a feasibility trial, in addition to the relevance of assessing and monitoring 
treatment fidelity in the context of a feasibility trial. The aims and organisation of this 
thesis will also be outlined. 
 
 1.2 Chronic Obstructive Pulmonary Disease  
COPD is a chronic and debilitating disease of the airways, characterised by irreversible 
airflow obstruction (GOLD 2017). This chronic airflow limitation is caused by changes 
in both the small airways and parenchymal destruction (emphysema) (GOLD 2017). 
These changes are caused by significant exposure to noxious gases, mainly smoking. 
Globally COPD is a highly prevalent cause of mortality and morbidity; it is currently the 
fourth leading cause of death worldwide; by 2020 it is estimated to be the third leading 
cause of death (Lozano et al. 2012). The increasing prevalence is due to the continued 
exposure to noxious gases and the ageing population in more developed countries 
(Mathers and Loncar 2006). The prevalence of COPD in the United Kingdom (UK) is 
estimated to be 2% (Snell et al. 2016). In Northern Ireland (NI) it is estimated that 1.8% 
of the population are living with COPD (DHSSPSNI 2013). However the actual 
prevalence of COPD is likely to be higher given that COPD is under diagnosed, 
particularly in the earlier stages of the disease (Soriano et al. 2009). 
 
COPD is primarily a disease of the airways with some significant systemic 
(extrapulmonary) effects (GOLD 2017).  These include renal and hormonal 
abnormalities, skeletal muscle dysfunction and anaemia and are due to the abnormal 
reaction in the systemic circulation (Palange 1998, GOLD 2017, John et al. 2005).  




the presence of other conditions can contribute to the increased severity of the disease 
(Vestbo et al. 2013).  Some of the other comorbidities frequently reported in COPD 
patients include cardiovascular diseases, anxiety and/or depression and lung cancer 
(Hillas et al. 2015). The main symptoms of COPD include progressive breathlessness and 
chronic cough (GOLD 2017). These symptoms can be are managed through 
pharmacological and non-pharmacological treatment. Pharmacological treatment 
includes bronchodilators, corticosteroids and combination therapies, mucolytics and 
theophylline and in some cases oxygen therapy (NICE 2010). Non-pharmacological 
therapies include smoking cessation, non-invasive ventilation, surgery, nutrition and 
pulmonary rehabilitation (PR) (NICE 2010). PR can be defined as an interdisciplinary 
programme of care for patients with chronic respiratory impairment that is individually 
tailored and designed to optimise each patient’s physical and social performance as well 
as their autonomy; programmes comprise of individualised exercise programmes and 
education (Bolton et al. 2013). PR has been shown to increase exercise capacity and 
quality of life in people with COPD (McCarthy et al. 2015). Exercise training and 
education are the key components of the treatment of PR. Individuals with COPD tend to 
avoid activities that induce breathlessness (Katajisto et al. 2012, Todt et al. 2015); these 
can be simple activities of daily living for example washing and dressing. Lower levels 
of activity have been observed in the early stages of the disease process (Watz et al. 2009) 
which decreases further with increasing disease severity (Troosters et al. 2010a). PR is 
currently the only form of exercise training available within the health service for people 
with COPD. 
 
The British Thoracic Society (BTS) guidelines recommend that PR programmes are 
delivered for a minimum of 6 weeks (6-12 weeks) with two weekly supervised exercise 
sessions and a third session unsupervised (Bolton et al. 2013). It is recommended that a 
combination of progressive muscle resistance and aerobic training should be delivered 
for the exercise training and there are 20 recommended educational topics in the BTS 
guidelines (Bolton et al. 2013). Qualitative research with COPD patients and health 
professionals has identified six key topics that they perceived as important for inclusion 
in the education component of PR (Wilson et al. 2007). PR is part of the standard 
treatment of COPD and there is a strong evidence base to support this; PR has been shown 
to not only improve exercise capacity and quality of life (McCarthy et al. 2015), it has 




as length of stay (Griffiths et al. 2001). Despite this evidence, a recent audit in PR for 
England and Wales has demonstrated that PR does not seem to suit all patients with 
COPD; not all patients referred to PR attend for assessment and not all patients who are 
assessed enroll in the programme (Steiner et al. 2016).  Furthermore dropout rates for PR 
for those patients who enroll in PR have been reported to be as high as 50% (Chaplin et 
al. 2017); data from a recent audit of PR in England and Wales reported a dropout rate of 
29% (Steiner et al. 2016).    Finally PR does not always result in increased PA (Spruit et 
al. 2013, Bolton et al. 2013). 
 
 1.3 Physical Activity and COPD 
PA is defined as any bodily movement produced by skeletal muscles that results in energy 
expenditure (Casperson et al. 1985, WHO 2017).  Exercise is a subset of PA that is 
planned, structured, and repetitive and has as a final or an intermediate objective the 
improvement or maintenance of physical fitness (Casperson et al. 1985). Regular PA is 
associated with improved health outcomes in relation to the prevention of several chronic 
disease and premature death (Warburton et al. 2006). The British Association of Sport 
and Exercise Science (BASES 2011) have devised PA guidelines to clarify the minimum 
amount of PA that people should engage in to maintain good health.  These guidelines 
recommend that adults should engage in three core activities; aerobic activity, strength 
training and reduce time spent sitting/lying. The guidelines state that healthy individuals 
should be active on every day of the week; this activity should add up to 150 minutes of 
moderate activity or 30 minutes on at least 5 days of the week with at least two days of 
muscle strength training. With regards to aerobic activity, comparable benefits can be 
achieved through 75 minutes of vigorous activity spread across the week: or in 
combinations of moderate and vigorous activity. Aerobic activity should be completed in 
bouts of ten minutes; during moderate activity individuals should feel their heart beat 
faster and still be able to maintain a conversation whilst in vigorous activity their heart 
would beat more rapidly, therefore making it difficult to carry out a conversation.   Daily 
PA can also be completed in terms of step count. Current guidelines recommend 10000 
steps per day for healthy adults (Tudor –Locke and Bassett 2004); walking at 






People with COPD engage in lower levels of PA than healthy individuals (Pitta et al. 
2005). The COPD population included in this study engaged in a mean (standard 
deviation (SD)) of 44(26) minutes of walking per day compared to 81(26) minutes 
completed by healthy people.  Tudor-Locke et al. (2011) have recommended that 
individuals living with a disability and/or chronic illness, including people with COPD, 
complete 7000-8000 steps per day. The PA levels of patients with COPD can vary 
depending on country (Table 1.1). The studies contained in Table 1.1 contain small 
numbers which prevent any firm conclusions regarding the daily PA levels of people with 
COPD in these countries, but however do give us some representation of the varying 
levels of daily PA in people with COPD and how they compare with healthy adults. A 
recent meta-analysis demonstrated that individuals with COPD complete on average 
4,579 steps per day and their PA levels are mainly influenced by disease severity 
(Saunders et al. 2016). As observed in healthy populations, PA plays an important role in 
the maintenance of health in people with COPD (Min Lee and Skerret 2001); Higher 
levels of PA are associated with better COPD outcomes in terms of reduced 
exacerbations, hospitalisations and mortality (Garcia-Aymerich et al. 2006, Moy et al. 
2013, Gimeno-Santos et al. 2014).  Given the research indicating the importance of PA 
in people with COPD, there has been a focus on interventions to increase PA in this 
population. PR is currently the only form of exercise training offered to people with 
COPD within the health service and it does not always result in increased PA (Spruit et 
al. 2013). 
 
Wascheki et al. (2011) have reported that objectively measured PA is the strongest 
predictor of all-cause mortality in people with COPD.  PA can be objectively measured 
in COPD using a number of different devices. A recent review by Byron and Rowe (2016) 
identified the five most commonly used devices to measure PA in the COPD literature: 
(i) The SenseWear Armband device (ii) The DynaPort Activity Monitor, (iii) The 
ActiGraph 7164, GT1Mand GT3X+devices (iv)The RT3 Tracker and (v) the Yamax 
Digiwalker. All of these devices are accelerometers except for the Yamax Digiwalker 
which is a pedometer. In an exploration of the validity of activity monitors in people with 
COPD; the ActiGraph GT3x. DynaPort and SenseWear armband have been identified as 





There is some existing literature exploring different platforms for delivering PR and PA 
training to people with COPD. For PR, researchers have compared unsupervised home 
based PR with traditional PR (Holland et al. 2016), web based PR programme with 
traditional PR (Chaplin et al. 2017) and once weekly supervised versus twice weekly 
supervised PR (O’Neill et al. 2007). In general results of these different programmes still 
showed short to medium term benefit comparable with traditional PR. In terms of PA 
training, interventions have varied in terms of the type of PA, frequency, duration and 
components included (Wilson et al. 2014). For example Behnke et al. 2005 compared a 
10 day hospital based walking programme, consisting of five, 15 minute walking sessions 
per day  with a control group (did not received any training).  Elsewhere Pomidoiri et al. 
2012, compared a low intensity calisthenics and breathing programme with a high 
intensity whole body endurance and strength programme, both programmes consisted of 
one hour training, three times per week for 12 weeks. These interventions showed 
favourable effects. However, no previous research has compared a PAI to PR in people 
with COPD. The effectiveness of a PAI, compared to PR at increasing PA in people with 
COPD is unknown. 
 
The review by by Wilson et al. 2014 was available at the outset of this Thesis and as such 
was used to inform the rationale for the PA intervention. In Wilson et al. (2014) eight of 
the twenty articles included were solely walking based interventions (Behnke et al. 2005, 
Wewel et al. 2008, Hospes et al. 2009, Breyer et al. 2010, Moy et al. 2010, Pomidori et 
al. 2012, Moy et al. 2012, Pleguezuelos et al. 2013).   More recent publications have also 
explored the effectiveness of PAIs in people with COPD (Moy et al., 2015, Altenburg et 
al. 2015, Demeyer et al. 2017). Although these publications were not available at the 
outset of this thesis it is reassuring that they too have included many of the suggestions 
from Wilson et al. 2014; they also focused on walking. For example the study by Demeyer 
et al. 2017compared a 12 week semiautomated 12 week telecoaching programme with 
usual care (no intervention). The intervention group received a step counter and exercise 
booklet, weekly step goals were automatically generated based on local weather reports 
and each patients current PA levels. Participants in this intervention demonstrated 
improvements in PA and exercise capacity. 
 
Step count is a simple and understandable metric of PA and walking represents a form of 




undertaken in an individual’s own time and environment (Tully et al. 2007) and is 
necessary for activities of daily living. More recently the use of a pedometer for self-
monitoring has been identified as a successful strategy for promoting adherence and 
increasing PA in PAIs for people with COPD (Mantaoni et al. 2016, Leidy et al. 2014) 
 
1.4 Feasibility trials  
In recent years the role of feasibility studies has gained increased attention (Lancaster 
2015).  Feasibility studies are pieces of research conducted before a main study in order 
to answer the question ‘Can this study be done?’ (NIHR 2012).  The main reasons for 
conducting a feasibility study can be grouped into four main classifications: (i) process; 
this refers to recruitment and retention rates, (ii) resource; deals with time and any budget 
problems, (iii) management; this explores personnel and data management issues and (iv) 
scientific; assesses treatment safety, determination of dose levels and response and 
estimation of treatment effect and its variance (Thabane et al. 2010). Despite the 
importance of conducting a feasibility trial there is an inconsistency in the literature 
regarding the reporting of feasibility trials. The National Institute for Health Research 
(NIHR 2012) has published criteria to determine the success of conducting a feasibility 
trial and these can be used to guide the reporting of such studies. More recently, Thabane 
et al. (2016) have published a proposed extension to the Consolidated Standards of 
Reporting Trials (CONSORT) statement for the reporting of feasibility and pilot studies. 
According to Thabane et al. (2010) the most frequent mistake made in the conduct of 
feasibility trials is that researchers place an emphasis on effectiveness as an outcome.    
 
The use of both quantitative (descriptive) and qualitative analysis has been recommended 
in feasibility trials (Tickle-Degnen 2012, O’Cathain 2015, Craig et al. 2006).  Obtaining 
participants’ views within a feasibility trial can help determine the acceptability of 
different aspects of the trial including for example the intervention itself and outcome 
measures. Acceptability of the intervention is a key criterion of feasibility. Furthermore 
conducting mixed methods research has been advocated within physiotherapy research 
(Shaw et al. 2010). Physiotherapy as a profession aligns both subjective and objective 
assessments to help determine treatment and diagnosis; mixed methods research is 
therefore well placed within physiotherapy research. Rauscher and Greenfield (2009) 
proposed three different designs for mixed methods research: (i) the quantitative research 




(ii) the qualitative research is conducted first to help inform how the intervention or 
quantitative data will be collected and (iii) the quantitative and qualitative research are 
conducted simultaneously throughout the research process, both the quantitative and 
qualitative research are addressing the same research question; the third method is the 
most applicable for a feasibility trial, as the quantitative and qualitative data are 
addressing the same research question.  
 
Another key purpose of conducting feasibility trials is to reduce threats to the validity of 
the study’s outcomes (Tickler-Degnan 2012). Validity can be defined as both internal and 
external. Internal validity ensures that the results of the intervention are attributable to the 
intervention and no extra treatment factors (Moncher and Prinz 1991). External validity 
enhances the replicabliltiy of the intervention, for example, if the intervention was to be 
repeated in a full RTC then the same - if not similar - results would be expected (Moncher 
and Prinz 1991). Treatment fidelity, although a concept that is often neglected in the 
literature (Borrelli et al. 2005), has been identified as important in maintaining the validity 
of a trial.  Treatment fidelity can be defined as the methodological strategies used to 
monitor and enhance the reliability and validity of behavioural interventions. It also refers 
to the methodological practices used to ensure that a research study reliably and validly 
tests a clinical intervention (Bellg et al. 2004). In short; treatment fidelity ensures that the 
intervention is delivered as intended (Bellg et al. 2004).  
 
 1.5 Summary 
COPD is a preventable and treatable yet incurable disease. PA levels are low among the 
COPD population (Troosters et al. 2010a). Despite the established benefits of PA in 
people with COPD there are no interventions specifically targeted at increasing PA in this 
population offered within the health service. However, research has demonstrated that 
PAIs can increase PA in people with COPD, and walking interventions are frequently 
used in this population (Wilson et al. 2014). A pedometer driven walking intervention 
may have the capacity to increase PA in people with COPD compared to PR. It could also 
offer an alternative to PR allowing for increased choice for patients with COPD. 
 
Recent publications have highlighted the need to conduct and report on feasibility trials 
(Thabane et al. 2016). Before investigating a PAI and comparing a PAI to PR in a full 




the trial. Testing the feasibility of a trial in a mixed methods design will provide important 
information regarding the acceptability of the trial (Cooper al. 2014). Finally the 
assessment and monitoring of treatment fidelity has the potential to reduce any threats to 
the validity of a proposed trial, it is therefore an important element to include (Bellg et al. 
2004).  
 
 1.6 Aims and organisation of this thesis 
 1.6.1 Aims and organisation of thesis 
There were two key aims of this thesis. Firstly, to assess the feasibility of conducting a 
trial to explore the effectiveness of a pedometer driven clinician facilitated PAI versus 
PR in improving PA in COPD patients referred to PR (the LIVELY COPD project); and 
secondly, to assess the treatment fidelity of the LIVELY PAI. In order to achieve these 
aims, a mixed methods randomised controlled feasibility trial was undertaken and the 
treatment fidelity of the PAI was assessed. These aims have informed the chapters within 
this PhD, each chapter has its own unique objectives. 
 
 1.6.2 Organisation of thesis 
Chapter 2 details the methods used for the LIVELY COPD project. This includes a 
description of the procedures used for screening, recruitment, randomisation and the 
assessment tools used (for example: questionnaires, activity monitors, the incremental 
shuttle walk test) and also details the elements included in the PAI and PR. 
Chapter 3 describes the quantitative component of the LIVELY COPD project which 
examined the feasibility of exploring the effectiveness of PAI versus PR in improving PA 
in COPD patients referred to PR. This chapter utilises the NIHR (2012) criteria for 
success of a feasibility study to assess the feasibility of the trial as a whole as well as 
guidance from other current literature to assess the feasibility of the PAI, specifically 
(Paxton et al. 2017). 
Chapter 4 describes the qualitative component of the LIVELY COPD project, the 
methods employed and the results of the qualitative component of the LIVELY COPD 
project are reported.  
Chapter 5 details a scoping review conducted to identify how treatment fidelity is defined 
and to explore the extent to which the reported fidelity is assessed/monitored in the 




and exercise therapy and how the methods employed in this literature map to the five 
domains of treatment fidelity as set out by the National Institute for Health, Behaviour 
Change Consortium (NIH BCC) (Bellg et al. 2004). 
Chapter 6 describes the development of a framework to assess the treatment fidelity of 
the LIVELY COPD project using the Borrelli (2011) checklist. This chapter also includes 
the results of the assessment of treatment fidelity of the LIVELY PAI. 
Chapter 7 summarises the main research findings and outputs from the research 
conducted in the current thesis. The implications and recommendations for future 
research and practice are also discussed. 
 
 1.6.3 Roles of research team and financial support 
This PhD was funded by the Department of Employment and Learning (DEL) and fully 
embedded in the LIVELY COPD project which was funded by Northern Ireland Chest 
Heart and Stroke (NICHS). The protocol for the LIVELY COPD project was developed 
by Dr Brenda O’Neill (BO’N) (Chief Investigator), Professor Judy Bradley (JB), 
Professor Suzanne McDonough (SMcD), Dr Lorcan McGarvey (LMcG) (local Principal 
Investigator (PI), Belfast Health and Social Care Trust (BHSCT)), Dr Terence McManus 
(TMcM) (local PI, Western Health and Social Care Trust (WHSCT)),  Professor Thierry 
Troosters (TT), Professor Madelynne Arden (MA), Dr Ian Bradbury (IB), Dr Tim 
McDonnell (TMcD), Dr Denise Cosgrove (DC). The LIVELY COPD project was 
supported by the Northern Ireland Clinical Research Network (NICRN), respiratory 
health and the PAI was delivered by network coordinators (DC, CH and AMcD). My 
primary role within the LIVELY COPD project was (i) data collection; assessing patients 
with the outcome measures at each time point (methods are outlined in Chapter 2); This 
involved liaising with the network staff delivering the PAI and those delivering PR, (ii) 
data input and analysis; all outcome measure data collected was inputted into Statistical 
Package for Social Sciences (SPSS) version 22.0 (SPSS Inc., Chicago, IL) for analysis, 
(iii) conducting and analysing the qualitative component and (iv) the development and 
implementation of the protocol for the assessment of fidelity  of the PAI. 
 
For each of the chapters/studies different members of the research team were involved or 
had more prominent roles and Chapter 5 was conducted in collaboration with a master’s 
student (RMcC). The researchers involved and the roles of each of the members of the 
research team are outlined at the beginning of each chapter. 
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Table 1-1Physical Activity levels for different groups of people with COPD and healthy people 
Study Population N= Device used Results 
Wilson 2014** Northern Ireland 
(healthy adults)  
N=30  ActiGraph 
GT3X 
Light PA (mins/day) MVPA (mins/day) Daily steps 
236 (59) 35 (20) 7,802 (2,574)* 
 
 







Mild (mins/day) Moderate (mins/day) Daily steps 
93(15) 27(7) 6383 (643) 
Belgium 
(healthy adults) 




65 (70) 9372 (3574) 
 





USA (COPD) N=21 SenseWear Pro 
Armbands 
62(15) 21(7) 5115 (675) 
 








Egan et al. 2012 Republic of 
Ireland ( COPD) 
N=46 SenseWear Pro 
Armbands 
Daily Physical activity duration in minutes  Daily steps 
48.0 (66.8) 3611 (2863) 
 







   
 
Chapter 2 - Methods 
 2.0 Chapter overview 
The LIVELY COPD project (Chapter 3) was designed to assess the feasibility of 
conducting a trial to investigate the effectiveness of a PAI (physical activity consultation 
and a pedometer-based walking programme) versus PR in improving PA in COPD. This 
general methods chapter will detail the LIVELY PAI, outline the procedures followed for 
the outcome measure assessment for the LIVELY COPD project, data collection and will 
describe the development of the study materials for the LIVELY COPD project.  The role 
of each of the members in the study team is outlined in Table 2.1.  
 
Table 2-1 Role of members of study team  
Personnel Role  
Orlagh O’Shea -Preparation and updating of study materials  
-Conducting and scheduling outcome measures 
assessments 
-Data entry, data checking and data cleaning                                                                   
-Analysis of results 
-Write up of methods 
Dr. Brenda O’Neill -Development of the LIVELY PAI  
-Preparation and updating of study materials  
- Selection of outcome measures 
-Development of clinical research record forms 
-Training of staff for outcome measure assessment 
-Training of providers to deliver the PAI 
-Conducting outcome measure assessment (back up for 
annual leave) 
-Analysis of results 
-Intellectual contribution to and write up of chapter 
Prof. Judy Bradley -Development of the LIVELY PAI  
- Selection of outcome measures 
-Development of clinical research record forms 
-Training and mentoring of providers to deliver the PAI 
-Analysis of results 
-Intellectual contribution to and write up of chapter 
Prof. Suzanne 
McDonough 
-Development of the LIVELY PAI 
-Selection of outcome measures 
-Development of clinical research record forms 
-Training and mentoring of providers to deliver the PAI 
-Analysis of results 
-Intellectual contribution to and write up of chapter 
Dr. Adele Boyd -Preparation and updating of study materials  
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-Conducting and scheduling outcome measures assessment           
-Data entry 
Dr Denise Cosgrove -Screening of patients for the LIVELY COPD project 
-Participation in training to deliver the PAI 
-Delivery of the LIVELY PAI 
Dr Catherine Hanratty -Screening of patients for the LIVELY COPD project 
-Participation in training to deliver the PAI 
-Delivery of the LIVELY PAI 
-Data entry 
Adrian McDonald -Screening of patients for the LIVELY COPD project 
-Participation in training to deliver the PAI 
-Delivery of the LIVELY PAI 
Dr Terence McManus -PI for the WHSCT 
Dr Lorcan McGarvey  -PI for the BHSCT 
Prof Madeline Arden -Development of the LIVELY PAI 
Prof Thierry Troosters -Development of the LIVELY PAI 
Dr Tim McDonnell -Development of the LIVELY PAI 
Dr Jason  Wilson  -ActiGraph data analysis training 
-Objective PA data checking and cleaning 
  
 2.1 Introduction 
Complete reporting of RCTs is important to allow for accurate assessment and 
replicability of the methodology and findings of the trial (Schulz et al. 2010, Hoffman et 
al. 2014). Therefore the aim of this chapter is to outline the general methods of the 
administration and analysis of the assessment tools and to assess the outcome of the 
intervention (PAI) and the comparative condition (PR). The assessment tools are 
described with reference to the published guidance and recommendations in addition to 
the evidence of reliability and validity for each tool where available. This chapter also 
aims to describe the PAI and PR and the study materials for the LIVELY COPD project.   
 2.2 Study Design and Study procedures  
A randomised controlled mixed methods design was used in this trial. Participants were 
randomised to ensure that the allocation of patients in this trial was not biased by baseline 
status. A feasibility RCT was conduted to help inform a future trial. Patients attended four 
study visits for outcome assessment. The baseline assessment was conducted over two 
appointments 7 days apart (Visit 1 and 2). Participants were randomised to either group 
(PAI or PR) following baseline assessment. The summary the outcome measures used is 
available in Table 2.2. The LIVELY COPD project was testing the feasibility of a PAI 
versus PR in improving PA in people with COPD, therefore PA was a key outcome 
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measure of the current study. The selection of measures for the assessment of PA were 
based on recent research on PA monitors in COPD and the respiratory population (Van 
Remoortel et al. 2012, Bradley et al. 2015) PR has been proven to increase exercise 
capacity and quality of life, therefore exercise capacity and quality of life measures were 
included (McCarthy et al 2015); the CAT and ISWT are routinely used in PR to assess 
these variables (Steiner et al. 2015). Participants were assessed again post-intervention 
(Visit 3) and at 3 months following the end of the intervention (Visit 4). All data collected 
in this study was inputted and analysed in Statistical Package for the Social Sciences 
(SPSS) version 22.0.0 for Windows (SPSS Inc Chicago IL. USA), unless otherwise 
detailed.  Data was inputted into SPSS by AB, OO’S and CH. All data inputted into SPSS 
was checked by BO’N and JB, unless otherwise described in the methods. 
 
 2.2.1 Baseline demographics 
All patients who had been screened and expressed an interest in participating in the study 
were approached at the PR assessment clinic, where informed consent was obtained 
(Appendix 1, LIVELY Clinical Research Form (CRF) Instructions, Screening and 
Recruitment Process page 5, 6 on CD-ROM). Once informed consent had been obtained 
a range of demographic information was obtained from the participant, including age, 
date of birth, smoking history, whether they were on long term oxygen therapy, their 
resting SpO2, living arrangements, work status/history, previous attendance at PR, 
medical history, comorbidities and medications (respiratory and non-respiratory).  
Further information was obtained from the PR assessment team notes; including 
spirometry, height and weight which was used to calculate their body mass index (BMI). 
This information was recorded in the case report form (Appendix 2, LIVELY CRF, page 
5, 6 and 8, on CD ROM) 
  
 2.2.2 Outcome measure data collection 
 2.2.2.1 Medical Research Council (MRC) Breathlessness Scale 
The MRC breathlessness scale (Appendix 2, LIVELY CRF, page 7, on CD-ROM) is a 
subjective measure of disability as result of shortness of breath in respiratory populations 
(Fletcher et al. 1959). The MRC breathlessness scale was conducted at baseline only. 
Patients chose a rating of their breathlessness on a five point scale (Grade 1 to Grade 5). 
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Grade 1 represents the least amount of disability as a result of shortness of breath (“not 
troubled by breathlessness except on strenuous exercise”) and grade 5 the most severe 
disability (“too breathless to leave the house or breathless when dressing or undressing”). 
The MRC breathlessness scale is self-completed and takes about one minute to 
administer. The MRC has been validated for use in patients with COPD (Bestall et al. 
1999). The guidelines for PR recommend that respiratory patients with an MRC score of 
2-5 should be referred to PR (Bolton et al. 2013). 
 
 2.2.2.2 Exercise Capacity 
The incremental shuttle walk test (ISWT) was used to measure exercise capacity in this 
study (Appendix 2, LIVELY CRF, page 9, on CD-ROM).  The ISWT is a popular test of 
exercise capacity for people with COPD and is increasingly being used in research 
because it is externally paced (Palange et al. 2000). This test was conducted at each time 
point. The ISWT was conducted in line with standard procedures for conducting the 
ISWT (Holland et al. 2015). At baseline participants performed two ISWTs to ensure that 
any change occurring post intervention/follow up was not due to a learning effect 
(Holland et al. 2014).  Two assessors were required to be present for this test; this was 
usually a combination of a physiotherapist, nurse or a research assistant. Singh et al. 1994 
demonstrated the ISWT to be a valid test of exercise capacity in patients with chronic 
airflow limitation.  The ISWT is a recommended test for determining exercise capacity 
for PR (Bolton et al. 2013). The ISWT ranges from 0-1020m and a higher score indicates 
a higher exercise capacity. 
 
 2.2.2.3 Physical Activity measures 
PA was measured at three time points; baseline, post intervention and at follow up using 
three different measures. Two objective measures and one subjective measure were used 
to measure PA. An accelerometer (ActiGraph GT3X+) and a sealed pedometer (Yamax 
DigiWalker CW-700) were the objective measures employed.  These devices were worn 
on the same elastic belt (activity monitor belt) and were worn over seven days. The 
International Physical Activity Questionnaire (IPAQ) was the subjective measure of PA 
used in the LIVELY COPD project. Details on how to prepare the ActiGraph and 
pedometer as well as instructions for how to explain these devices to the participant are 
included in Appendix 1, (LIVELY CRF instructions, page 8-11 and 18-20, on CD ROM). 
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 2.2.2.3.1 ActiGraph GT3X+  
The ActiGraph GT3X+ is tri-axial accelerometer (19 grams; 4.6 cm x 3.3cm x 1.5 cm) 
which is worn around the waist. The total cost for one ActiGraph GT3X+ (£153.78), one 
“large” elastic belt (£9.26), one ActiGraph USB cable (£4.94) and one single ActiLife 6 
software license (£923.31) was £1091.29 (prices as of January 2014). The ActiGraph 
measures the time spent in PA at different intensities, step counts and sedentary 
behaviour.  The ActiGraph is factory calibrated so did not require any manual calibration 
by the research team.  Before giving the ActiGraph to participants, the device was fully 
charged and initialised using the Actilife software (version 6.8.0) and set to record for 
that participant. The ActiGraph was set to record at 1 second epochs but reintegrated to 
15 second epochs for analysis (Byron and Rowe 2016). The ActiGraph was worn around 
the waist on an elastic belt and positioned on the dominant hip, in line with the anterior 
superior iliac spine. The elastic belt was fitted onto the participant by the researcher to 
give a visual demonstration on correct positioning. The ActiGraph was only worn during 
waking hours. Participants were given both written and verbal instruction on where and 
when to wear the ActiGraph. The written instruction booklet also contained a diary for 
participants to record the daily wear time of the ActiGraph (Appendix 3, Activity monitor 
instruction booklet).  
 
After the seven day wear time, the ActiGraph was returned to the research team by the 
patient and the data was downloaded using the ActiLife (Version 6.11.9). The number of 
valid days of wear time were confirmed using the “Wear-time validation” tab. Choi et al. 
(2011) wear time validation algorithm was applied. Choi et al. (2011) checked for non-
wear time using two windows (window 1 and window 2); Non-wear time is calculated 
using consecutive zero counts >/ 90 minutes (window 1), if non zero counts lasting up to 
2 minutes  were detected during both 30-minute periods of upstream and downstream 
checking (window 2) from a specific time interval.    All data including >/5 days with 
>/10 hours of daily wear-time were then scored in ActiLife and exported to Microsoft 
Excel for data analysis.  Each participant’s daily levels of; light-lifestyle activity (101-
1951 counts per minute (cpm)); total moderate-vigorous physical activity (MVPA) 
(>/1952 cpm); MVPA accumulated in 10 minute bouts; number of bouts of MVPA 
accumulated in 10 minutes; sedentary time (<100 cpm); and step counts were calculated 
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using the Freedson Combination 1998 formula (manufacturer’s algorithm).  Data was 
cleaned in Microsoft Excel; ensuring that all days met the wear time criteria and removing 
any data that was not required for analysis for example Epoch or average step counts. 
 
There is some level of debate regarding the amount of wear time required for a PA data 
set to be considered valid; there is a variety of hours and days reported in the literature, 
however there are also a number of studies that do not report this wear time (Byron and 
Rowe 2016).  A minimum of 10 hours of wear time is the most commonly reported wear 
time in the COPD population and a minimum of 5 valid days across the 7 day period is 
recommended for a data set to be valid (Byron and Rowe 2016). However given the 
ambiguity and lack of gold standard guidelines for the number of hours and days for a 
data set to be valid we explored our data to determine what combination of hours and 
days would optimise our data (Appendix 4, Data checking and wear time combinations 
for ActiGraph), yet maintain best practice.  Based on the findings, our exploration and 
guidance from the literature, only data including 5 valid days of ten hours wear time per 
day were included for analysis. ActiGraph data was checked by OO’S and JW. This was 
done systematically throughout the downloading and scoring process (Appendix 4, Data 
checking and wear time combinations for ActiGraph and pedometer pre analysis). 
 
The ActiGraph GT3X+ is a valid instrument to measure PA in people with COPD 
(Rabinovich et al. 2013).  Furthermore Byron and Rowe (2016) conducted a review to 
understand how activity monitors have been used in COPD research to date. They 
recommend the use of a tri-axial accelerometer which provides access to raw data; the 
ActiGraph GT3X+ meets these criteria.   
 
 2.2.2.3.2 Yamax DigiWalker CW-700 pedometer 
The DigiWalker CW-700 is a pedometer (21 grams; 5cm x 3.8cm x 2.1cm) worn on the 
waist. The total cost for one DigiWalker CW-700 pedometer was £19.95 (price as of 
January 2014). The DigiWalker pedometer measures step counts and walking time.  The 
pedometer is factory calibrated so did not require any manual calibration by the 
researcher. Before the pedometers were distributed, the time on the pedometer was 
checked and adjusted if necessary. The pedometer was worn alongside the ActiGraph on 
the belt; the pedometer was worn medially to the ActiGraph. A 20-step test was conducted 
to confirm the pedometer was working and positioned correctly. The 20-step test needed 
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to record between 19-21 steps before the pedometer could be sealed with tape.  The 
pedometer was sealed with tape so that participants’ could not view their step counts and 
therefore their PA could not be influenced over the seven day wear time period. The 
pedometer was fitted onto participants to give a visual demonstration on correct 
positioning. The pedometer was only worn during waking hours. Participants were also 
given written information on where and when to wear the pedometer. The written 
instruction also contained a diary for participants to record their daily wear time of the 
pedometer (Appendix 3, Activity monitor instructions booklet).   
 
After the monitoring period (at baseline, post intervention and follow up), data recorded 
on the pedometer on daily step counts were manually recorded into the participant’s CRF. 
A valid day of pedometer data required steps to be recorded between 100 and 50,000 steps 
(Matthiesson et al. 2015). After removal of invalid days, datasets with >/5 valid days were 
analysed, data was checked systematically with JW (Appendix 4, Data checking and wear 
time combinations for ActiGraph and pedometer pre analysis).  
 
The Yamax DigiWalker pedometer is accurate and reliable for counting steps (Crouter et 
al. 2003, Schneider et al. 2004). The Yamax DigiWalker pedometer has previously been 
used to measure PA in the COPD population (Hospes et. al 2009, Tabak et al.2014) 
 
 2.2.2.3.3 International Physical Activity Questionnaire  
PA was assessed subjectively with the IPAQ long form at each time point (Appendix 2, 
LIVELY CRF, page 19-23, on CD-ROM) The IPAQ contained 25 questions which 
include four different PA domains: work outside the home (7 questions), transport (6 
questions), work inside the home (6 questions) and leisure time (6 questions).  The 
IPAQ’s scoring protocol (Guidelines for Data Processing and Analysis of the 
International Physical Activity Questionnaire (IPAQ) – Short and Long Forms November 
2005) was used to summarise the results. The data from these questions can then be used 
to calculate an individual’s total MET-minutes spent in walking, moderate and vigorous 
PA. There are two questions on sitting time; one question on average sitting time on a 
week day and one question on average sitting time on a weekend day. The IPAQ is self-
completed and takes about 15 minutes to administer. The IPAQ is a validated measure of 
metabolic equivalent minutes (MET-minutes) spent in different physical activities and 
sedentary behaviour (sitting time) over the previous seven days (Craig et al. 2003). The 
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IPAQ has been validated for use in healthy individuals (Craig et al. 2003) and previously 
used to measure PA in the COPD population (Liao et al. 2014).  
  
 2.2.2.4 HRQoL questionnaires 
 2.2.2.4.1 EQ-5D-5L Health Questionnaire 
The EQ-5D-5L, English version for the UK (Appendix 2, LIVELY CRF, page 24-26, on 
CD-ROM) was used in the LIVELY COPD project to measure health status. The EQ-5D-
5L was completed at all-time points, it is self-completed and takes about three minutes to 
administer.  The EQ-5D-5L consists of two parts; the descriptive system and the visual 
analogue scale (VAS) (0-100) rating of health. The descriptive system contains five 
dimensions; mobility, self-care, usual activities, pain/discomfort and anxiety/depression 
which are rated on 5-point Likert scale.  Higher scores on these five questions indicate 
increased problems in these five dimensions. Response patterns for the numbered values 
of the five questions are reported from optimal health status (11111) to severe problems 
in all dimensions (55555). Using the response patterns an index value is calculated using 
the EQ-5D-5L Index Value Calculator Version 1. A lower score indicates a worse 
perceived health status. A separate score is recorded from the VAS scale, with a lower 
number indicating worse perceived health. Nolan et al. (2016) found the EQ-5D-5L to be 
valid and responsive measure of health status in people with COPD. The EQ5D5L has 
previously been used in the COPD population (Gillespie et al. 2013, Briggs et al. 2010, 
Cross et al. 2010. 
 
 2.2.2.4.2 COPD Assessment Test (CAT)  
The CAT aims to quantify the impact of COPD on the patients’ health or health related 
quality of life (Appendix 2, LIVELY CRF, page 27, on CD-ROM). This is a self-
administered outcome measure and takes about three minutes to administer. The CAT 
was completed at all-time points in the LIVELY COPD project.   It consists of eight 
questions which are scored on 6-point Likert scale. The eight questions relate to common 
symptoms of COPD and quality of life including cough, phlegm, chest tightness, 
dyspnoea, usual activities, and confidence in leaving their home, sleep and energy levels. 
A higher score on the Likert scale indicates reduced symptoms or impact on quality of 
life. For example in relation to cough a “0” indicates “I never cough” and “5” indicates 
“I cough all the time”.  The scores for each question are then added up to give a total 
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score between 0-40. A higher score indicates a more severe impact of COPD on the 
patient’s life. The CAT can be expressed as an absolute value or the values can be 
categorised according to the level of impact of COPD on the patients’ health: >30 very 
high, >20 high, 10-20 medium and <10 indicates a low impact. The CAT was developed 
specifically for the COPD population and is validated in this population (Jones et al. 
2009).  
 
 2.2.2.5 Transtheoretical model (TTM) 
The TTM has previously been used to assess individuals’ health behaviours including PA 
(Hutchinson et al. 2009). The TTM comprises of stages of change (SOC), self-efficacy 
and decisional balance.  
 
 2.2.2.5.1 Stages of change Questionnaire (SOC) 
The SOC Questionnaire (Appendix 2, LIVELY CRF, page 28, on CD-ROM) is used to 
identify what stage of change an individual is at in relation to their PA behaviour 
(Marshall and Biddle 2001). The stages within this questionnaire range from pre-
contemplation (not thinking about taking part in PA over the past 6 months) to 
maintenance (taking part in regular PA activity over the past 6 months), including five 
different stages. PA was defined in this questionnaire and examples of what regular PA 
were given to allow participants to make an informed decision of which stage best 
reflected their current status.  The questionnaire is adapted from Stages of Exercise 
Behaviour Change Questionnaire by Marcus et al. (1992a). This questionnaire is self-
completed and takes about three minutes to administer; it consists of five statements and 
the participant chooses the one which best describes their current stage. This 
questionnaire has previously been applied to the people with bronchiectasis (Wilson et al. 
2016, Bradley et al. 2015). This questionnaire has been validated in healthy populations 
(Cardinal 1997). 
 
 2.2.2.5.2 Marcus’s Self Efficacy 
Marcus’s Self Efficacy Questionnaire (Appendix 2, LIVELY CRF, page 29, on CD-
ROM) provides information on participants’ confidence to be physically active in certain 
situations (Marcus and Forsyth 2009). Self-efficacy has been identified as one of the 
clearest correlates of PA in adults (Bauman et al. 2002). This questionnaire is self-
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completed and takes about three minutes to administer; it was administered at each time 
point. It contains five questions and an additional disease specific question (“When I have 
respiratory symptoms”) was included, this question has been included in previous work 
by the research team in bronchiectasis (Bradley et al 2015).  The items are based on 5-
point Likert scale with a higher score indicating a greater self-efficacy to engage in PA. 
This questionnaire has been used in patients with bronchiectasis (Wilson et al. 2016, 
Bradley et al. 2015). This questionnaire has been validated in healthy individuals (Marcus 
et al. 1992a). 
 
 2.2.2.5.3 Decisional balance 
The decisional balance was conducted at baseline only (Appendix 2, LIVELY CRF, 
page 29-30, on CD-ROM). Participants were asked, “In your opinion what are the 
benefits of taking part in physical activity?” and, “In your opinion what are the 
downsides of taking part in physical activity?” These questions were adapted from 
Marcus and Forsyth (2009).  These anticipated barriers and benefits were then used by 
the provider of the intervention to shape the PAI.  
 
 2.2.2.6 Global Rating of Change (GROC) 
The GROC scale in the current study was adopted from Perry (2007). This scale is used 
to assess if a patient has improved, deteriorated or experienced no change over a period 
of time, usually with respect to an intervention (Appendix 2, LIVELY CRF, page 48, on 
CD-ROM). This instrument is self-completed and takes two minutes to administer.  In 
LIVELY, COPD project participants were asked to recall their ability to be physically 
active at baseline compared to either post intervention or follow up; in terms of “better,” 
“worse,” or “no change”. If there had been a change participants were asked to rate the 
magnitude of this change across a seven point scale from “a tiny bit-almost the same,” 
along the spectrum to “a very great deal.” Participants were then asked to rate the 
importance of this change or lack of change to them across the same seven point scale. 
The GROC scale has been previously used in COPD research as an anchor method to 
calculate the minimal clinically important difference (MCID) for the ISWT (Singh et al. 





   
 2.2.2.7 VAS for achieving outcome goal 
Participants in both PR and the PAI were to set an outcome goal; something functional 
they would like to achieve by the end of their respective programme, for example being 
able to walk to the local post office.   This instrument is self-completed and takes two 
minutes to administer (Appendix 2, LIVELY CRF, page 50, on CD ROM). Post-
intervention; all participants were asked to rate on a 10-point VAS whether they had 
achieved this goal: 0 representing “not met at all” and 10 indicating that the goal was 
“fully met.”  
 
 2.2.3 Qualitative Assessment 
Semi-structured interviews were conducted post-intervention to explore participants’ 
experience views of the programme. Full details of the qualitative component are reported 
in the Chapter 4. 
 2.3.4 Development of the LIVELY COPD project clinical research form 
(CRF) 
A CRF was developed to record all baseline demographics and outcome measure data at 
each point (Appendix 2, LIVELY CRF, on CD-ROM). A CRF instruction manual was 
also developed with all relevant information on how to conduct each study visit and 
outcome measure in a standardised manner (Appendix 1, LIVELY CRF instructions, on 
CD-ROM).  It also contained a task log indicating the primary person responsible for each 
task. The instruction manual contained information on how to plan for study visits, 
administer outcome measures in standardised fashion and details on how to initialise 
position and download data from the activity monitors. All versions of the CRF and 
associated instruction manual were developed in accordance with the LIVELY study 
protocol; feedback was provided on all draft versions by members of the LIVELY COPD 
project team.  Pilot testing sessions with the research team were conducted to ensure the 
order of the outcome measures and clarity of instructions. The LIVELY COPD project 
was conducted in both the BHSCT and the WHSCT; separate site specific versions of the 
CRF and instruction manuals were created for each trust to contain the correct phone 
numbers for emergencies and contact details for the staff in each trust and to enable use 
of each specific trust logo.  
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 2.3 The Physical Activity Intervention 
 2.3.1 Training of providers 
Three healthcare professionals (HCPs) (2 physiotherapists and 1 respiratory nurse) were 
trained to deliver this intervention. These three individuals were recruited from within the 
NICRN. The intervention providers attended five training sessions in total, two were 
conducted prior to the recruitment of the first patients to the LIVELY COPD project and 
three throughout the course of the intervention (Appendix 5, PAI file, section 9, Training, 
on CD-ROM). The intervention providers were mentored throughout the delivery of the 
intervention by two experienced members of the research team (JB and SMcD). The 
mentors had contact with the providers before and after the delivery of each consultation 
in the intervention to each participant.   The providers were also given materials for 
delivering the intervention (Appendix 5, PAI file, section 1-7, on CD-ROM). 
 
 2.3.2 The physical activity intervention 
Participants recruited to the LIVELY study were either randomised to PR or to the PAI, 
following their baseline outcome measure assessment. The PAI was a clinician facilitated 
pedometer driven, 12 week walking intervention. The pedometers were unsealed for the 
intervention to allow them to be checked by participants therefore be used as a 
motivational tool. The PAI considered the, 'capability', 'opportunity', 'motivation' and 
'behaviour,' (COM-B) model of behaviour change and included 20 behaviour change 
strategies (BCS) (Appendix 6, List of Behaviour Change Strategies for the LIVELY PAI 
(amended)) (Michie et al. 2014, Michie et al. 2013). The current guidelines for PA and 
influences from the stages of changes were also considered in the development of the 
intervention (BASES 2011, Marcus and Forsyth 2009). Participants had seven face to face 
consultations (consultation 1-6 and consultation 12) with an intervention provider; five 
consultations were conducted over the phone (consultations 7-11).  Face to face 
consultations were expected to last up to one hour and were conducted in an outpatient 
hospital department and telephone consultations were expected to last about 15-20 
minutes. However there was some flexibility permitted, participants could transition to 
telephone contact earlier if they felt they were ready. The first week (familiarisation 
week), the participants were given their unsealed pedometer (Yamax Digiwalker CW700) 
and step diary. The intervention provider demonstrated how to access the seven day recall 
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on the pedometer and the correct position of the pedometer. Participants also completed 
a 20 step test to ensure the pedometer was correctly recording step counts. Participants 
then used this first week; the “familiarisation week,” to become familiar with using the 
pedometer and documenting their steps in the diary.  
 
When participants returned the following week (week 2), an outcome goal relating to an 
activity or function was set, for example “To be able to walk to the centre of town on my 
own without fear.”  This was revisted during the intervention, and reviewed at the end to 
determine if it had been achieved. At week 2 the intervention provider also reviewed the 
step diary and the pedometer from the familiarisation week to ensure they matched. A ten 
minute self-efficacy walk was also conducted to determine how many steps the 
participant could achieve in ten minutes. The result of this ten minute self-efficacy walk 
and the participants’ baseline daily step count was used to set a goal for the subsequent 
week (Table 2.3 Examples of how weekly step goal was set). Participants also set an 
action and coping plan each week to set out how they planned to achieve their goal and 
how they would overcome any unexpected situations or anticipated barriers. The 
providers explored with the participants any prompts or reminders to do walking. This 
goal setting and action and coping planning were conducted each week, from week 2-11. 
Additional strategies could be employed by the provider to encourage the participant to 
be more physically active based on the participants’ stage of change, (Appendix 5, PAI 
file, section 7, Toolkit, on CD-ROM). Participants also received disease specific 
education at consultations 1 and 5: management of breathlessness and positions of ease 
(consultation 1) and inhaler technique (consultation 5). At the final consultation (12), the 
intervention provider revisited the barriers encountered by that participant and the 
successful strategies used to overcome these. They also explored the benefits the 
participant experienced from the programme and discussed plans for maintenance as well 
as relapse prevention. The protocol facilitated the intervention to be extended by one 
week if the provider felt that the participant needed an additional week (13 week 





   
 Intervention materials (LIVELY manual, pedometer, Living Well with 
COPD (LWWCOPD) Booklet) 
All participants in the LIVELY PAI were given a pedometer, a LIVELY manual and a 
LWWCOPD booklet. The LIVELY manual contained an action and coping plan for each 
week where they documented their step goal. It also contained a step diary for participants 
to record their daily step count.  This manual was developed specifically for the LIVELY 
intervention by members of the research team and is included in the appendices 
(Appendix 7, LIVELY PAI Patient Manual, on CD-ROM). The LWWCOPD booklet is 
an educational booklet specifically developed for people with COPD which was designed 
to be used in PR (Cosgrove et al. 2013).  
 
 2.3. 3 Pulmonary rehabilitation 
PR was delivered by clinicians as per usual practice. Ten PR sites across two trusts were 
included in the LIVELY COPD project.  The key staff delivering the PR programme 
included respiratory physiotherapists and nurses with experience in management of 
COPD and in delivering PR. The PR programmes consisted of a 6-week supervised group 
based face to face outpatient (community or hospital location) programme and was 
delivered according to well established guidelines (Bolton et al. 2013).  The exercise 
component usually lasted for one hour and was delivered twice weekly. It generally 
consisted of cardiovascular exercises and upper and lower body strengthening exercises. 
A diary was used during PR to record the exercises undertaken and the level of 
breathlessness measured on the BORG scale was also noted by each participant.  
Education sessions (30-60 minutes) were delivered at least once weekly.  Patients were 
provided with a booklet of exercises and encouraged to perform these independently on 
a third occasion. Patients in the PR groups also received the LWWCOPD booklet 
(Cosgrove et al. 2013).  
 
 2.4 Conclusion  
This chapter describes the procedures for data collection in the LIVELY COPD project 
(Chapter 3), including the collection of anthropometric and demographic data and 




   
Tables 
Table 2-2 Summary table of outcome measures 
Outcome measure Purpose 
Medical Research Council 
Breathlessness Scale 
Breathlessness 
Incremental Shuttle Walk Test  Exercise capacity 
ActiGraph GT3x Physical Activity (objective) 
Pedometer Physical Activity (objective) 
International Physical Activity 
Questionnaire 
Physical Activity (subjective) 
EQ-5D-5L Health related quality of life 
COPD Assessment Test Health related quality of life 
Stages of change questionnaire Transtheoretical model 
Marcus self-efficacy  Transtheoretical model 
Decisional balance Transtheoretical model 
Global rating of change Subjectively assess degree of change/ lack of 
change 
Visual analogue scale  Subjectively assess degree of achievement of 






















Total weekly step count for 7days from previous week 19,747 
 
Average daily steps from previous week 
2,821 
 
Self-efficacy walk result  
1,027 
 
Agreed step goal  
4,300 on 7/7 days 
Example 2 
Total weekly step count for 7days from previous week 
39,935 
 
Average daily steps from previous week 
5,705 
 
Self-efficacy walk result  
992 
 
Agreed step goal  
8,000 on 5/7 days 
The step target for each subsequent week was individually tailored agreed between 
the physiotherapist/nurse and the participant by referring to 1) current walking 
behaviour identified from the mean daily step count for the previous week calculated 
from the pedometer steps/walking diary, and 2) the number of steps accumulated 
during the 10-minute ‘self-efficacy walk’.  The consultations included discussion of 
current physical activity behaviour, the identification of barriers and facilitators to 
change, strategies to enable patients to meet walking goals and address barriers, and 
strategies to enhance confidence/self-efficacy around achieving goals (self-efficacy, 
goal setting), action and coping plans, problem solving, social support, information 
on the consequences of behaviour from credible sources, and maintenance and 
preventing relapse.  




   
Chapter 3 - Clinician facilitated physical activity 
intervention versus pulmonary rehabilitation in improving 
physical activity in COPD: A feasibility study 
 3.0 Chapter overview 
The LIVELY COPD project was a randomised controlled feasibility study which aimed 
explore to the effectiveness of a PAI (clinician facilitated pedometer driven walking 
intervention) versus PR in improving PA in COPD. This chapter will summarise the 
methods used in this trial, the results of the assessment of feasibility of the LIVELY 
COPD project according to the NIHR criteria for feasibility, the results of the assessment 
of feasibility of the LIVELY PAI and discuss the results.  The role of each the members 
on the study is summarised in Table 3.1. 
 
Table 3-1 Role of members on the study team 
Personnel Role  
Orlagh O’Shea -Conducting and scheduling outcome measures 
assessments          
-Data management                                                          
-Analysis of results 
-Write up of methods 
Dr Brenda O’Neill -Development of LIVELY PAI 
- Selection of outcome measures 
-Development of clinical research records 
-Conducting outcome measure assessment (back up for 
annual leave) 
-Analysis of results 
-Intellectual contribution to and write up of chapter 
Prof. Judy Bradley -Development of LIVELY PAI 
- Selection of outcome measures 
-Development of clinical research records 
-Analysis of results 
-Intellectual contribution to and write up of chapter 
Prof. Suzanne 
McDonough 
-Development of LIVELY PAI  
-Selection of outcome measures 
-Development of clinical research records 
-Analysis of results 
-Intellectual contribution to and write up of chapter 
Dr Adele Boyd -Conducting outcome measures assessment           
Dr Denise Cosgrove -Screening of patients for the LIVELY COPD project 
-Delivery of the LIVELY PAI 
Dr Catherine Hanratty -Screening of patients for the LIVELY COPD project 
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-Delivery of the LIVELY PAI 
Adrian McDonald -Screening of patients for the LIVELY COPD project 
-Delivery of the  LIVELY PAI 
Dr Terence McManus -PI for the WHSCT 
Dr Lorcan McGarvey  -PI for the BHSCT 
Prof. Madelynne 
Arden 
-Development of the LIVELY PAI 
Prof. Thierry Troosters -Development of the LIVELY PAI 
Dr Tim McDonnell -Development of the LIVELY PAI 
 
 3.1 Introduction 
Globally, PR is established as a core component in the management of COPD and has 
been shown to enhance health related quality of life, reduce dyspnoea and improve 
exercise capacity (McCarthy et al. 2015). The majority of PR programmes are supervised 
outpatient-based, and delivered in a group format (Bolton et al. 2013). Dropouts and non-
adherence rates from PR are high, emphasising that PR may not suit all patients with 
COPD (Jones et al. 2014 Steiner et al 2016). The current availability of PR programmes 
is unable to reach all those with COPD who would potentially benefit from PR (Steiner 
et al 2016, Rochester et al. 2015).  Furthermore while Spruit et al. (2013) report that the 
components of PR which are aimed at increasing exercise tolerance and improving self-
efficacy could be considered a good platform to improve daily PA levesl, there is limited 
evidence to indicate whether the improved exercise capacity following PR translates into 
improved PA levels in COPD (Troosters et al. 2010b, Watz et al. 2014).  There is 
therefore a need to explore alternative platforms to delivering exercise/PA training 
traditionally delivered in the context of PR.  
 
PA is fundamental for the prevention of chronic disease and premature mortality (Min-
Lee and Skerritt 2001). Walking represents a form of PA that has been shown to be 
effective in increasing PA in clinical populations and is necessary for activities of daily 
living (McDonough et al. 2013). Although studies in COPD have demonstrated the 
effectiveness of individualised walking programmes, these alternative programmes do 
not seem to be offered within current models of healthcare provision for COPD (Wilson 
et al. 2014). A home-based pedometer-driven walking intervention may offer an 
innovative and alternative method of delivering PA training that could be provided to 
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large numbers of patients with COPD on an individual basis. Walking could provide for 
flexibility around life commitments and promote a change in activity levels.  
 
The importance of conducting a feasibility study prior to a full RCT has been emphasised 
by key funders such as the MRC and the NIHR, as well as recent publications (NIHR 
2012, Craig et al. 2006, Thabane et al. 2010, Lancaster 2015).  
 
 3.1.1 Aim  
The aim of this study was to assess the feasibility of conducting a trial to investigate the 
effectiveness of a clinician facilitated PAI (PA consultation and a pedometer-based 
walking programme) versus PR in improving PA in COPD patients referred to PR. 
 
 3.1.2 Objectives  
I. To use the NIHR criteria (Table 3.2) to assess the feasibility of conducting a trial 
to compare the effectiveness of PAI versus PR in patients with COPD referred to 
PR. 
II. To assess the feasibility of delivering a PAI to patients with COPD 
 
 3.2 Methods 
The reporting of this trial adheres to the Template for Intervention Description and 
Replication (TIDieR) (Hoffman et al. 2014), (Appendix 8, TIDieR checklist results for 
the clinician facilitated physical activity intervention versus pulmonary rehabilitation in 
improving physical activity in COPD: A feasibility study). See Chapter 2 for full details 
on the LIVELY PAI, the procedures followed for the outcome measure assessment, data 
collection and the study materials for the LIVELY COPD project.   
 
 3.2.1 Design 
The study design was a multicentre mixed methods randomised, parallel-group, 
feasibility study. The full study protocol for LIVELY is available at 
https://clinicaltrials.gov/.  Ethical approval was obtained from the NI Research Ethics 
Committee 13/NI/0014 and site governance approval was obtained from the BHSCT and 
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the WHSCT (Appendix 9 Ethical approval from the Northern Ireland research ethics 
committee, Appendix 10 Study approval from the BHSCT governance, Appendix 11 
Study approval from the WHSCT governance). 
 
 3.2.2 Population  
Patients with COPD (n=50) referred for PR to any of the ten sites that provide PR within 
the BHSCT and the WHST were included. All PR sites reported that they were adhering 
to the BTS guidelines for PR prior to the commencement of and midway through the 
study (Bolton et al. 2013). Patients with a primary diagnosis of COPD (NICE 2010), a 
good understanding of written English (as reported by the individual patient) and in a 
stable phase (no change in symptoms or medication in previous 4 weeks) at the time of 
assessment were included. Exclusion criteria were inability to safely take part in a 
walking programme or PR (e.g. unstable angina, neurological, spinal or skeletal 
dysfunction affecting ability to exercise) as decided by the PR team or inability to 
comprehend or follow instructions (e.g. dementia), (Appendix 1, LIVELY CRF 
instructions, The screening and recruitment process page 5-6, on CD-ROM).  
 
 3.2.3 Recruitment and randomisation 
Patients were randomly assigned to two groups using computer-generated block random 
numbers by a member of the team not involved in any other aspect of the study in order 
to ensure allocation concealment: Group 1-PAI or Group 2- PR. The allocation was 
retained in sealed opaque envelopes which were opened to reveal group allocation only 
after consent and after completion of baseline assessment. Patients were stratified 
according to HSC Trust to help ensure that equal numbers of patients within each Trust 
were randomised to each group.  
 
As this was a feasibility study, no formal sample size calculation was used. Based 
on previous publications a sample size of 50 was deemed appropriate to achieve the 
aims/objectives of this study (Sim and Lewis, 2012). This sample size also reflected a 
realistic target for the intervention period and one which was anticipated would provide 




   
 3.2.4 Interventions:  
Participants were randomised to either the PAI or PR.  
 
The PAI intervention was a 12 week clinician facilitated pedometer driven walking 
programme. All participants were provided with a Yamax Digiwalker CW700 and 
manual with weekly step diary and action and coping plans.  Participants had weekly 
contact with the interventionist (specifically trained physiotherapist or nurse). Each week 
participants set a step goal based on their previous weeks step count and their self efficacy 
walk.  (Full details of the intervention can be found in Chapter 2). 
 
Participants in the PR group attended the supervised exercise class twice a week for 6 
weeks and were also given a booklet with exercises to perform independently on a third 
occasion. (Full details of PR can be found in Chapter 2) 
  
 3.2.5 Data collection  
All screening, recruitment, adherence (number of sessions attended) and drop outs as well 
as the occurrence of adverse events were recorded. Demographics (gender, age, height, 
and weight), medical and social details and spirometry results were obtained at baseline 
assessment. Patients attended four study visits for outcome assessment: baseline 
assessment was conducted over two appointments, 7 days apart (Visit 1 and 2). 
Participants were assessed again post-intervention (Visit 3) and at 3 months following the 
end of the intervention (Visit 4). All data was collected by a trained independent assessor, 
either a physiotherapist and/or a research assistant, not involved in the delivery of 
intervention.   
 
The following outcome measures were collected: PA with the ActiGraph GT3X+ 
accelerometer (Rabinovich et al. 2013) and a sealed Yamax Digiwalker CW700 
(Schneider et al. 2004) pedometer which were worn around the waist for seven days 
during all waking hours, as well as the long form of the IPAQ (Craig et al. 2003); exercise 
capacity with the ISWT (Singh et al. 1994); health status with the CAT (Jones et al. 2009) 
and EQ5D5L (Briggs et al. 2010); and a modified GROC scale (Perry 2007).  Participant 
stage of change was also assessed and decisional balance was assessed at baseline only 
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(Marcus and Forsyth 2009). Full details on data collection methods can be found in 
Chapter 2. 
 
 3.2.6 Feasibility of the PAI  
Each week participants set a step goal. The step goal and the actual step count achieved 
by the participant were recorded and analysed to assess whether participants were 
reaching their goal each week, and the degree of improvement. Additionally, an outcome 
goal was set at baseline, and at the post intervention assessment (visit 3) participants were 
asked to report the extent to which they met this goal on a visual analogue scale (0-10) 
with ten being “fully met”. The PAI was considered to be feasible based on whether 
individuals’ could achieve their weekly step goal, achieve their overall outcome goal, and 
increase their step count across the intervention. 
 
 3.2.7 Data analysis  
All participant screening and outcome measure data was entered into SPSS version 22.0 
(SPSS Inc., Chicago, IL). Data entry was independently assessed for accuracy and 
analysed per protocol. All continuous variables were checked for normal distribution 
using the Shapiro-Wilk Test, which confirmed that most of the data were normally 
distributed; BMI, FEV1% and FVC were not normally distributed. Descriptive statistics 
were used to summarise the screening, recruitment, adherence and population 
demographics. Only ActiGraph data that contained a minimum of five days of ten hours 
wear time were used for analysis; and only sealed pedometer data that had a minimum of 
five days of 100-50,000 steps were used for analysis (Byron and Rowe 2016, Matthiessen 
et al. 2015). As this was a feasibility study, we were not focused on statistical significance 
and therefore mean difference (standard deviation (SD)), with 95% confidence interval 
(CI) was estimated at each follow-up time point for all outcome measures using paired t 
tests. Data is presented mean ([95% CI] or (SD)), and nominal data is presented as 
percentages.  
 
All pedometer data relating to weekly step goals and steps achieved were recorded in 
Microsoft Excel 2010. Mean weekly step goals and mean weekly steps achieved were 
calculated and plotted graphically to demonstrate how these numbers tracked each other 
over time during the PAI. The mean difference between participants first and last recorded 
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mean daily pedometer step count was also calculated.  Finally participants VAS scores 
for whether they felt they had achieved their outcome goal were also recorded and a mean 
score calculated.  
 
 3.3 Results 
 3.3.1 Participants  
Participant flow through the study is summarised in Figure 3.1. Six hundred and fifty one 
participants were screened between 4th April 2014 and 27th July 2015. Of those eligible 
11% (n=50) were recruited (see Table 3.3 for full screening data). Patients with a mean 
(SD) age of 64.1(8.6), 24M and FEV1 1.4 (0.6) L/min were recruited over the 16 month 
period.   Patients were assessed and randomised to PAI (n=24) or PR (n=26) One 
participant who was randomised to the PAI attended PR instead; PR (n=27) and PAI 
(n=23). 
 
Patient characteristics are available in Table 3.4. This group had complex needs; n=30 
had more than 2 self-reported comorbidities and were prescribed multiple medications 
(mean 7.82 (3.84) which includes their specific respiratory medications).  Additional 
patient characteristics are available in the Appendices, Appendix 12.  
 
 3.3.2 Intervention adherence 
There were 26% (6/23) drop outs in the PAI group.  Reasons for not starting and drop 
outs are detailed in Figure 3.1. The PAI was adhered to (attended at least 75% sessions) 
by all 17/17 (100%) of those who did not drop out (Williams et al. 2011). The time taken 
to compete the intervention was 12.4 weeks, ranging from 10.7 to 16.3 weeks and 
participants on average completed a mean 11.8 (0.6) of the 12 planned consultations.  
 
There were 52% (14/27) drop outs in the PR group. Reasons for not starting and drop outs 
are detailed in Figure 3.1. PR was adhered to (attended at least 75% sessions) by 9/13 
(70%) of those who did not drop out (Williams et al. 2011). Participants who adhered to 




   
Figure 3.1 also details the retention rates for participants providing post intervention (visit 
3) and follow-up (visit 4) outcome measures: post intervention n=18 (PAI) and n=19 (PR) 
and at follow up n= 15 (PAI) and n= 18 (PR). These numbers relate to participants 
providing at least one outcome measure. Some participants did not adhere to their 
intervention but returned for outcome measure assessment.  
 
 3.3.3 Outcome measures  
A range of outcome measures were included in this study. The mean (SD) time taken in 
minutes to administer the study outcome measures at baseline was visit 1 80.2(20.0), and 
46.9(21.1) at visit 2; the average time taken to administer the study outcome measures at 
post intervention was 62.9(12.6) and at 3 month follow-up was 49.6(15.6).   
 
The available outcome measure data for the ActiGraph and pedometer were generally less 
than the paper based and ISWT outcome measures as we used the recommended wear 
time criteria on this data; only data with five days of ten hours of wear time was included 
(Byron and Rowe 2016) and only pedometer data with five valid days of between 100-
50,000 steps were included for analysis (Matthiessen et al. 2015).  A few patients who 
could not attend follow up appointments completed the outcome measures by post.  
Specific details and reasons for all missing data are included in Table 3.5. 
 
 3.3.3.1 Post intervention (visit 3) 
The mean (SD) daily step count as recorded by the ActiGraph for the PAI group at 
baseline was 3305.6 (1960.2) steps for n=17 participants, and at post intervention was 
4768.2 (2992.2) steps for n=14 participants; the mean difference (SD) [CI] was 972.0 
(3230.3) [-1080.3 to 3024.4], n=12. The mean (SD) daily step count as recorded by the 
ActiGraph for the PR group at baseline was 3946.3 (2263.1) steps for n=27 participants 
and at post intervention was 3476.6 (2307.9) steps for n=12 participants; the mean 
difference (SD) [CI] was 4.3 (662.7) [-440.9 to 449.5], n=11.  
Moderate-vigorous PA measured by the ActiGraph increased for the PAI group and 
decreased for the PR group. Post intervention the pedometer step count (sealed 
pedometer) increased in both groups, the increase observed in the PAI group was in line 
with the MCID (Demeyer et al. 2016). PA levels assessed by the IPAQ demonstrated 
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improvements in both groups from baseline to post intervention.  The ISWT scores 
improved for both groups. The CAT score improved for both groups from baseline to post 
intervention. The EQ5D5L index score was unchanged for the PAI group and there was 
an improvement of 0.1 in the PR group from baseline to post intervention. There were 
improvements in both groups in the EQ5D5L VAS scores post intervention. Table 3.6 
details the mean difference (SD) [CI] for ActiGraph, pedometer and IPAQ data from 
baseline to post intervention. Table 3.7 details the mean difference (SD) [CI] for ISWT, 
CAT and EQ5D5L data from baseline to post intervention. 
 
 3.3.3.2 Minimal clinical important difference 
For those who adhered to the PAI (n=17); ActiGraph step counts were available for n=11 
at baseline and post intervention, 36% (n=4) met the MCID for step count (change of 
600-1100 (Demeyer et al. 2016), CAT scores were available for n=16 at baseline and post 
intervention, 37.5% (n=6) of these met the MCID (change of 2 (Kon et al. 2014)). ISWT 
scores were available for n=15 at baseline and post intervention, 33.3% (n=5) of these 
met the MCID (change of 47.5m (Singh et al. 2008)). 
 
For those who adhered to the PR (n=9); ActiGraph step counts were available for n=5 at 
baseline and post intervention; none of these met the MCID for step count (Demeyer et 
al. 2016). ISWT scores were available for n=5 at baseline and post intervention, 20% 
(n=1) of these met the MCID (Singh et al. 2008) and 44.9% (n=4/9) met the MCID for 
CAT (Kon et al. 2014).  
 
 3.3.3.3 Follow-up (visit 4)  
Figure 3.2 represents the mean daily ActiGraph step counts at baseline (visit 1 and 2), 
post intervention (visit 3), and at follow-up (visit 4) for both groups. There appears to be 
a general trend towards increasing step counts across the three time points in the PAI 
group, and in the PR group there was a decline in step count from baseline to post 
intervention, and then an increase at follow up.  The mean (SD) and frequency data follow 





   
 3.3.4 Adverse events (AEs) 
There were 4 related and unexpected AEs (PAI: (n=3) i.e. blister on the right heel and big 
toe, flare up of a knee swelling, reaction to nickel on pedometer due to a nickel allergy); 
and PR (n =1) i.e. dizziness when leaving out patient department after an appointment for 
assessment had been completed.  These AEs were managed by providing advice to the 
patients for resolution, and no-one withdrew based on these AEs.   
 
 3.3.5 Feasibility of the PAI  
In relation to the achievement of weekly step goal, participants appeared to overachieve 
their step goals in the first week of the PAI, but as the intervention progressed the step 
goal and step count achieved aligned more closely (Figure 3.3). For those who provided 
step counts at two time points, most patients (17/20) demonstrated an increase in their 
step count following the PAI; step count recorded by the pedometer improved by a mean 
(SD) 2087(252) steps between week 1 and the last step count recorded (Figure 3.4). 
Following the PAI, participants rated whether they had met their outcome goal set out at 
the start of the intervention using the VAS scale (0=not met at all, 10 = fully met). VAS 
scores were available for n=16/18.; n=1 was unwell and did not travel for outcome 
measure assessment and n=1 could not remember his goal. Overall participants reported 
achieving their goal; mean 8.8 (SD) (2.9). 
 
 3.4 Discussion 
This feasibility study demonstrates key considerations for conducting a future trial of a 
PAI versus PR in COPD. The applicable NIHR criteria for the success of a feasibility trial 
were met and based on the results of this study, including the qualitative data, a future 
trial is feasible. Before proceeding to a larger trial, strategies for reducing dropouts, 
improving adherence and for optimising efficiency of data collection would need to be 
considered. The PAI was effective for increasing step count and feasible to deliver. 
 
Recruitment to this study was generally feasible; we planned to recruit over a period of 
14 months and achieved target at 16 months. Our recruitment process for this feasibility 
study was uniquely influenced by opportunities for ease of access to programmes; we 
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confined the study to two HSC Trusts. Recruitment rates can vary across the COPD 
literature. For example, recruitment rates of 3.9% (103/2646) in a recent study exploring 
the feasibility of conventional PR versus a web based PR (Chaplin et al. 2017) and 63.3% 
57/90 in a cohort study on PR in COPD (Cosgrove et al. 2013) have been reported. In 
research on PAIs in COPD, 18.1% (140/775) were recruited in a study exploring the 
effects of a short-term (3 months) and a long-term (18 months) exercise program on self-
reported disability and physical function in COPD (Varga et al. 2007) and 89.8% (71/79) 
in a study exploring the effects of supervised high intensity continuous or interval training 
with unsupervised self-paced training (Berry et al. 2003). A large number of patients 
attending the PR clinics were not suitable for this study for example due to 
musculoskeletal problems, vascular problems, cardiac issues (198/601, 33%); our criteria 
helped us to identify these patients and triage their care to an appropriate service, test or 
procedure prior to further assessment for PR. Not all patients referred for PR were 
interested in taking part (n=131/601, 22%), and a small number (44/601, 7%) had COPD 
but this was not the primary respiratory diagnosis and they were therefore excluded.    This 
study provides data to estimate the number of sites that would be needed for a larger trial, 
the estimated sample size for full scale trial is 150 (75 per group) to allow us to detect a 
1500 between group step difference with 80% power, taking into account the current 
MCID for this population (Demeyer et al. 2016). Broader inclusion criteria to include 
these patients, as well as more PR sites, could improve the recruitment rates. To achieve 
this recruitment target for a larger trial we would need to explore the capacity for 
recruitment at each PR site. 
 
The dropout for the PAI (26%) was lower than the dropout in PR (52%). A number of 
participants in the current study dropped out of PR for health reasons, patients with COPD 
can experience frequent exacerbations and often present with a number of comorbidities 
(Steiner et al. 2016). There were other barriers to participation in the PR group that had 
the potential to be overcome in the PAI; the individualised and flexible nature as well the 
opportunity for phone contact could have facilitated participation for participants who did 
not enjoy the group setting, had transport difficulties or were restricted in their flexibility 
due to other commitments. The qualitative component further explored barriers to 
adherence; the results of this are reported in Chapter 4. Furthermore the dropout rate for 
PR (52%) was higher than that reported (29%) in a recent PR audit conducted in England 
and Wales (Steiner et al. 2016). Reasons for this higher rate of dropout are unclear, and 
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previous studies in PR in the Northern Ireland COPD population have reported dropout 
rates which are more consistent with the rest of the UK (between about 10%- 28%) 
(Cosgrove et al. 2013, O’Neill et al. 2008). Therefore prior to embarking on a future trial 
strategies could be explored to reduce drop out rates from PR. For example, dropout rates 
from PR could possibly be reduced through the implementation of quality assurance 
measures and audit to ensure PR programmes are fully embedded as guidelines 
recommend (Steiner et al. 2016). Additionally, identifying the characteristics of patients 
that are less likely to drop out as well as phenotypes of patients who are at risk of dropping 
out (for example patients with a lower socioeconomic status) (Steiner et al. 2017) might 
help reduce dropouts of patients in a future trial and enhance the feasibility. 
 
A high number of participants did not meet the wear time criteria for the ActiGraph 
(Byron and Rowe 2016). A future trial could consider less stringent wear time rules to 
optimise data or consider utilising a different monitor. Although the ActiGraph GT3X is 
considered one of the most valid activity monitors for measuring PA in people with 
COPD (van Remoortel et al. 2012), a future trial should explore with patients where they 
are most likely to wear an activity monitor e.g. wrist, thigh, ankle, or waist. Popular 
activity monitors such as the Fitbit have been validated in people with COPD and could 
be considered in a future trial to maximise PA data (Voojis et al. 2014). Additionally, 
some data was lost due to error in researcher download (Table 3-5), a standard operating 
procedure has been developed to prevent this happening in the future (Appendix 14). 
Finally step count was also assessed with a pedometer which was sealed (to hide the step 
count data) at baseline and again post intervention. Current evidence indicates that these 
two devices are not interchangeable, and the ActiGraph is a more precise measure of PA 
and so it may be more suitable for data collection as an outcome measure for research 
(O’Neill et al. 2017a). The pedometer (unsealed) however did appear to be a feasible tool 
for setting and monitoring step counts during the PAI and it provided good motivation to 
participants. 
 
The PAI appears to be safe to deliver; with few minor adverse events. Recording the 
achievement of weekly step goals as an indication of feasibility has been reported in other 
studies (Paxton et al. 2017). Throughout the intervention the step goals and actual steps 
achieved were closely matched with most patients achieving their goal each week similar 
to other studies in clinical populations (McDonough et al. 2013). The greatest 
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improvement was observed in the first week with smaller, more gradual improvements 
over time; perhaps just wearing the monitor in the first week provided an initial 
motivation. The pedometer data obtained from participants during the PAI, demonstrated 
(for those who recorded step counts at two time points) the mean increase (2087) was 
almost double that of the upper end of the MCID for step count in the COPD population 
(600-1100) (Demeyer et al. 2016), demonstrating the potential efficacy of this 
intervention and potential for use in a future trial.  Patient selection for such interventions 
may be important. A recent multicentre randomised controlled study reported that patients 
more likely to respond to PA coaching interventions were those patients with better 
preserved functional capacity (Demeyer et al. 2017). Some of our patient population were 
perhaps too frail to benefit maximally from the proposed PAI.   
 
PR aims to increase quality of life and exercise capacity (Bolton et al 2013). Both the 
CAT and ISWT are routinely used, and have demonstrated increases in line with their 
reported MCID (Dood et al 2011, Bolton et al. 2013).  However in the current study, of 
those who adhered to the PR intervention only 44.9% met the MCID for CAT and 20% 
for ISWT.  A recent PR audit in England and Wales reported 61% of patients reached the 
MCID of CAT and 57% for ISWT (Steiner et al. 2015). All our sites subjectively reported 
adhering to core components of the BTS guidelines but the fidelity of the PR was not 
assessed, as PR was viewed as usual care and therefore the control condition (Bellg et al. 
2004). The NIH BCC guidelines for fidelity do not recommend assessing and monitoring 
the fidelity of the control condition (Bellg et al. 2004). A future trial will need to ensure 
that PR programmes are optimised before the trial commences, although it is understood 
that not all patients will respond to treatment; improving the quality of the service 
provided can impact on the benefits experienced by patients (Steiner et al. 2016).  
 
The estimated time to deliver the PAI to eight patients individually across 12 weeks is 
60.8 (34.4) hours. The estimated time to deliver a PR programme to eight patients in a 
group over 6 weeks is 24 hours. The LIVELY PAI takes approximately double the amount 
of time to deliver to eight patients compared to the PR, which would result in increased 
costs. However, there is a large SD in the predicted length of time to deliver the PAI to 
eight patients, and the PAI had a higher rate of adherence which has potential for cost 
saving implications in the longer term. Finally, we are comparing two different modes of 
treatment for people with COPD and there are opportunities to modify the PAI to reduce costs 
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and bring them more in line with PR.  For example, using an online platform linked to the 
activity monitor whereby the step counts are automatically uploaded, so that the 
interventionist can review these before the consultation, would reduce costs. The number 
of face to face consultations could also be decreased; qualitative data from the current 
trial demonstrated that some participants felt they could have transitioned to this earlier 
(Chapter 4). It has been suggested that much of the coaching could be done using a 
telemedicine approach (Demeyer et al. 2017, Moy et al 2015), although not all trials were 
equally successful (Vorrink et al. 2016).  Furthermore delivery in a group setting while 
retaining individual setting of step goals could decrease the time taken to deliver the PAI. 
In addition the phenotype of patients preferably referred to conventional PR or to PAI 
may be different 
 
The feasibility nature of this study limits our ability to draw conclusions about the 
effectiveness of this PAI in comparison to PR. The PR delivery was conducted as part of 
usual care, with no monitoring from the research team; a future trial should consider ensuring 
all PR sites included in the study are optimised prior to study implementation through to study 
completion. Strengths include the assessment of the fidelity of the PAI (Chapter 6) and all 
data recorded and analysed in this paper was assessed for accuracy.  
  
 3.4 Conclusion 
All applicable NIHR criteria for the success of a feasibility study were met with important 
learning and information regarding recruitment, eligibility, outcome measures and the sample 
size for a future study identified. The mixed methods design has enriched the data and 
exploring patients’ views and satisfaction has helped complement and verify the quantitative 
findings.  The LIVELY PAI appears to be effective in improving step counts in people with 
COPD, feasible to deliver and had good fidelity. This study provides key information to 






































Assessed for eligibility (n=651) 
Excluded (n=601)  
Not meeting criteria (n=198) 
Declined to participate (n=215) 
Other (n=186) 
Not reporterted (n=2) 
Enrolment 
Randomised (n=50) 
Allocated to PR (n=26) Allocated to PAI (n=24) 
Allocation 
Baseline assessment (n=26) Baseline assessment (n=24) 
Received allocation n=27 
Did not receive allocation n=0 
PR n=27 
Received allocation n=23 





-Did not start n=1 (other 
commitments 
-Drop out n=5 (n=2 health 
issues, n=1 other 
commitments, n=1 felt it 




-Adhered to intervention** 
n=9 
-Attended <9 classes n=4 
-Did not start n=6 (n=2 
health issues, n=2 LTF***, 
n=1 family issues, n=1 
perceived there to be too 
many woment in the waiting 
area) 
-Drop out n=8 (n=1 work, 
n=4 health issues, n=2 lack 
of enjoyment, n= 1 transport 
issues) 
 
Post intervention (visit 3) 
Retained n=19 
Withdrawl n=3 
LTF n=5  













Figure 3-1 Flow of participants through the study and adherence to the PAI and 
PR *participant attended PR instead of PAI by mistake, **Adherence set at 
75%, ***LTF= Lost to Follow-up 
42 
 
   
 
Figure 3-3 ActiGraph step count at baseline (visit 1 and 2), post intervention (visit 3) 
and at follow up (visit 4) 
 
 
Figure 3-4 Mean daily step count goal compared to the step count achieved across the 
12 weeks of the PAI [numbers of participants providing step count data at each time 
point varies due to attendance and withdrawals; familiarisation week1=21; week2 n=18; 
week3 n=19; week4 n=18; week 5 n=17; week6 n=18; week7 n=18; week8 n=17; 












Baseline (visit 1 and 2)       Post intervention (visit 3)       Follow up (visit 4)
Actigraph steps baseline-post intervention-follow up in the 



























   
 
Figure 3-5 Difference between the mean daily step count for the familiarisation week 
and last mean daily step count available step count recorded with unsealed pedometer 
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Tables 
 
Table 3-2  National Institute for Health Research Success Criteria for a feasibility trial* 
Criteria Present Comment 
Number of eligible patients.         See Table 3.3 
Willingness of participants to be randomised.  Yes all patients 





Willingness of clinicians to recruit participants.  See Table 3.3. 
Characteristics of the proposed outcome measure.          This has been 
reported. 
Time needed to collect and analyse data.  
 
This has been 
reported in the main 
paper. 
Follow-up rates, response rates to questionnaires, 
adherence/compliance rates. 
 Figure 3-1and Table 
3-5 details these. 
Standard deviation of the outcome measure, which 




















   
Table 3-3 Screening data, reasons for exclusion from the LIVELY study in COPD 
Exclusion criteria Number of participants (n=601) 
Not meeting criteria 
                   COPD not primary Diagnosis 












Unable to comprehend/follow instruction 
Unable understand English 
198 
47 
120 [e.g. black outs, musculoskeletal 
problems, gait pattern means pedometer may 
not work, torn Achilles, fibromyalgia and 2 
sticks for walking, chronic back pain, severe 
depression, cardiac issues/angina, epilepsy, 
intermittent claudication , wheel chair, long 
term oxygen therapy and use of a rollator],  
19 [e.g. pulmonary exacerbation or any 
change in symptoms or medication in the last 
four weeks resulting in the patient being 
deemed clinically unstable by the clinical 
pulmonary rehabilitation team] 
8 
4 
 Declined to participate 
wanted PR as planned 
not interested in PR 
other health issues perceived by patient 
time commitments 
unknown 
unwilling to take part in research 
family/carer/social reasons 
unwilling due to additional assessments  














did not attend PR information session 
unable to contact 





referred to incorrect PR site 
Did not attend outcomes assessment 







27 [e.g. awaiting lung surgery, wrong HSC 





Non reported 2 










   
Table 3-4 Baseline demographics and characteristics of participants  
Mean (±SD), unless otherwise indicated 
BMI- Body Mass Index 
FEV1- Forced Expiratory Volume in 1 second 












Age (years)  64.14 (8.6) 61.09 (8.5) 66.741 (7.9) 
Gender (m:f) 24:26 13:10 11:16 












































































































































   
Outcome Measure 
and reasons for 







PR Post intervention 
N=19 
PAI  Follow up 
N=15 
PR Follow up 
N=18 
ActiGraph Available N=17 Available N=24 Available N=14 Available  N=12 Available N=12 Available N=14 
Not meeting wear 
time criteria (5 
days of ten hours) 




N=1       
Researcher error 
in download 
N=2   N=1  N=3    
Paper base 
outcomes only 
  N=1  N=1  N=1   
ActiGraph error    N=1    
Pedometer Available N=22 Available N=21 Available N=16 Available N=13 Available N=10 Available N=13 
Not meeting wear 
time criteria ( 5 
days of 100-
50,000 steps) 




N=1       
Paper based 
outcomes only 
  N=1  N=1  N=1   
IPAQ Available N=23 Available N=27 Available N=18 Available  N=18 Available N=15 Available N=17 
Unable/unwilling 
to complete 
   N=1   N=1  
Table 3-5  Continued. Available outcome measures at each time point and reasons for any missing data 
 
 





































                  IPAQ- International Physical Activity Questionnaire; GROC- Global Rating of Change; CAT- COPD Assessment Test; ISWT- Incremental Shuttle Walk Test
Outcome Measure 
and reasons for 







PR Post intervention 
N=19 
PAI  Follow up 
N=15 
PR Follow up 
N=18 
GROC   Available N=13 Available N=13 Available N=11 Available N=9 
Outcome measure 
added to CRF after 
visit was completed 
  N=4  N=5   N=4  N=8  
Unable/unwilling to 
complete 
  N=1  N=1   N=1  
CAT Available N=23 Available N=27 Available N=27 Available N=19 Available N=15 Available N=18 
Not available in CRF   N=1     
EQ5D5L Available N=23 Available N=27 Available N=18 Available N=19 Available N=15 Available N=17 
Unable/unwilling to 
complete 
     N=1  




  N=1  N=1 N=1   
Unable/unwilling to 
complete 
  N=1  N=1   N=1  







Available N=17 Available N=18 Available N=14 Available N=17 
Unable/unwilling 
to complete 







   
Table 3-6 Results of participant outcome measures (ActiGraph, Sealed pedometer, IPAQ) for 



















































































































































active & above 
N=1 N=2 N=2 
 

































































10 2 7   




10 11 7   
 IPAQ category 
- High 
2 7 5 4   
IPAQ International Physical Activity Questionnaire; MVPA Moderate Vigorous Physical Activity. *Not 
meeting criteria. Ʃ patient non-compliant with wearing device ® researcher download error.π: paper 
based outcomes only completed. β ActiGraph error, α: unable/unwilling to comple 
Table 3-7 Results of participant outcome measures (GROC, ISWT, CAT, EQ5D5L) for the PAI 
group and PR group at baseline and post intervention. (Mean (SD) [CI]) 
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3.3 to 4.6]  
N=19 
-0.4 (6.4) [-


























































[-0.1 to 0.1] 
N=19 
0.1 (0.2) [-





















14.9 to 20.1] 
N=19 
13.3 [-0.9 to 
27.4] 
GROC Global Rating of Change; CAT COPD Assessment Test. π: paper based outcomes only 
completed.  α: unable/unwilling to complete, # outcome measure added to CRF post visit Ω 









   
Chapter 4 - Patients perceptions of a PAI and of PR in the 
LIVELY COPD project 
 4.0 Chapter Overview 
This chapter reports the methods and results of the qualitative component of the LIVELY 
COPD project (Chapter 3) which used a mixed methods approach. Five researchers were 
involved in conducting this qualitative research and each member had a specific role as 
outlined in the Table 4.1. 
 
Table 4-1 Role of members on the study team 
Personnel Role 
Orlagh O’Shea -Development of protocol for analysis of 
qualitative component                                                                           
-Development of semi structured interview 
script                                                               
-Conducted semi structured interviews                                      
-Carried out qualitative analysis                                                 
- Drafted results                                                                                  
- Completed write up of chapter 
Prof. Judy Bradley  -Development of protocol for analysis of 
qualitative component                                                                          
-Development of semi structured interview 
script.                                                          -
Carried out qualitative analysis                                                                    
- Drafted results                                                                          
-Contributed to the intellectual interpretation 
of results and write up of chapter 
Dr Brenda O’Neill  -Development of protocol for analysis of 
qualitative component                                                                           
- Development of semi structured interview 
script                   -Conducted semi structured 
interviews                                       - 
Contributed to the intellectual interpretation 
of results and write up of chapter 
Dr Adele Boyd -Conducted semi structured interviews 
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4.1 Introduction 
Qualitative research is increasingly conducted within feasibility studies (O’Cathain et al. 
2015).   Obtaining patient perspectives through qualitative research can help to fully 
explore the workings of each treatment arm and address any uncertainties or limitations 
within the design prior to commencing a future randomised controlled trial.  Therefore a 
qualitative research component was included as part of the LIVELY COPD feasibility 
project (Chapter 3). The importance of mixed methods research has been emphasised in 
the MRC guidelines, as it allows greater understanding of patients’ perceptions, for 
example barriers to participation (Craig et al. 2006), which in the context of a feasibility 
study can help understand problems with adherence and retention before progressing to a 
future trial.  Additionally, in some instances the qualitative data can demonstrate a 
favourable effect on health outcomes where quantitative methods have failed (Moffat et 
al. 2006). Conversely, patients’ views and perspectives are important, for example, even 
if the quantitative outcomes showed a favourable effect, if the intervention was 
unacceptable to the participants then there would be little support for moving forward to 
a future trial. 
 
There is a small body of available research investigating patients’ views about PR (de 
Sousa Pinto et al. 2013).  In 2013 de Sousa Pinto et al. published a review of qualitative 
literature exploring patients’ views of the impact of PR on their lives. Eight articles were 
included in this review and five main themes were identified: (i) support during PR, (ii) 
learning process through education, (iii) opportunity through health transition, (iv) 
barriers, difficulties and negative points, and (v) the benefits of PR. This review found 
that there are a number of beneficial aspects of PR; patients appeared to welcome the 
support from peers and health professionals in the programme as well as the educational 
aspect of PR. Patients also recognised PR as an opportunity for change and which enabled 
them be more optimistic about the future. The difficulties and negative aspects of PR 
themed in this review included transport difficulties, lack of support during the 
programme and lack of clarity in the information leaflets given. Some participants 
perceived the lack of support once the programme had finished as an obstacle to 
maintenance.  Gaining an insight into patients’ lived experiences like this has been 
recognised as an important step in optimising healthcare (Department of Health 2000). 
Qualitative research in PR has been used to help inform the current BTS PR Guidelines 
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(Arnold et al. 2006, Fishcer et al. 2007, Harris et al. 2008, Bulley et al. 2009, Bolton et 
al. 2013). 
 
It is evident that PA is fundamental for the prevention of chronic disease and premature 
mortality (Min-Lee and Skerrett 2001). As such, there is a large body of literature 
exploring PAIs in various populations, including, for example, older adults, colorectal 
cancer patients, people with multiple sclerosis, mental health problems and COPD 
patients (King et al. 1998, Pilutti et al. 2014, Hubbard et al. 2016 Williams et al. 2016, 
Wilson et al. 2014). Researchers have explored participants’ perspectives of participating 
in PAIs in these populations (Franco et al. 2014, Hubbard et al. 2016, Learmonth and 
Motl 2016, Mason and Hotl 2012). However, to date there is no qualitative research 
exploring COPD patients’ views and experience of a PAI.  
 
 4.1.1 Aim  
The aim of this study was to explore the participants’ views and experience relating to 
their satisfaction and the benefits of a PAI and of PR.  
 
 4.1.2 Objectives 
(i) To conduct semi structured interviews with all participants in the LIVELY COPD 
project in both the PAI and PR following the completion each intervention;  
(ii) To transcribe and analyse the interviews from both groups separately using Kings 
Template Analysis as a framework (King 1998) and  
(iii) To report on the results of the analysis, comparing the PAI and PR where 
applicable. 
 
 4.2 Methods 
This qualitative study recruited patients from the LIVELY COPD project (Chapter 3); a 
randomised controlled mixed methods feasibility study. All patients who were recruited 
to the LIVELY COPD project were invited to complete individual face to face interviews 
at their post intervention assessment (visit 3) facilitated by a semi structured interview 
guide (Table 4.2). Interviews were conducted in a quiet clinical room at the study site.  
Ethical approval was obtained from the Office of Research Ethics in NI, Rec reference: 
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13/NI/0014, IRAS project ID: 107423 (Appendix 9, Ethical Approval from the Northern 
Ireland Research ethics committee). Written informed consent was obtained from each 
patient as part of the LIVELY COPD project and again verbally prior to each interview.  
The write up adheres to the consolidated criteria for reporting qualitative studies 
(COREQ) guidelines (Tong et al. 2007)         
 4.2.1 Data collection  
A schedule for the semi structured interviews was developed by the project team in line 
with the main aims of the study, focusing specifically on exploring the participants’ 
views and experience relating to their satisfaction and the benefits of a PAI and of PR. 
The semi structured interview schedule was developed during the design phase of the 
LIVELY trial.  The current research regarding the COPD population, PR and PA were 
used to inform the focus of the semi structured interview. The health psychologist 
(MA), involved in supporting the intervention was also consulted during the 
development of the semi structured interview schedule. As the transcripts were being 
analysed minor amendments were made to the prompts associated with the interview 
schedule to better capture the aims of the study. Table 4.2 provides an outline of the 
interview schedule. The full semi structured interview schedule is available in the 
appendices; (Appendix 15, Semi Structured Interview Script on CD ROM). Interviews 
were conducted by independent outcome measure assessors (OO’S, BO’N and AB) who 
were not involved in the delivery of either the PAI/PR, to limit bias (Appendix 16, 
Qualitative analysis research team: credentials, training and/or experience).   
 4.2.2 Data analysis  
Interviews were audio recorded and transcribed verbatim by OO’S and an administrator. 
Interviews were analysed using Template Analysis as described by King 1998. Previous 
publications in healthcare that have used this approach were referenced for guidance 
(McCluskey et al. 2011, King et al. 2002). Firstly, members of the team (OO’S, JB and 
BO’N) agreed to a priori themes; these themes were drawn from the questions in the semi 
structured interview schedule and at all times the aim of the qualitative research was kept 
in mind (Appendix 17, A priori themes for qualitative component of the LIVELY COPD 
project). At commencement of analysis, OO’S and JB analysed 25% of the transcripts 
from each group independently. All relevant text was attached to a code, if there was no 
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relevant theme or subtheme, a subtheme was added to an existing theme. Following the 
analysis of these transcripts, the initial template was developed (Appendix 18, Initial 
template for qualitative component of the LIVELY COPD project). OO’S then analysed 
the remaining transcripts with this template assigning all relevant text to the appropriate 
theme and amending the template as required throughout (Appendix 19, Amended of 
initial template for qualitative component of the LIVELY COPD project). During the 
analysis, the relevant text from each transcript was tabulated under the appropriate theme; 
a table was produced for each individual transcript. When all transcripts had been 
analysed, the tables were printed and the hard copies divided so as each theme and 
corresponding quote was separate. The themes with the associated relevant text were then 
pasted into a folder so that each theme and the relevant quotes from each individual 
transcript were held together. A separate folder was produced for the PAI transcripts and 
for the PR transcripts.   
 4.2.2.1 Quality checks 
King 1998 advocates that quality and reflexivity checks are carried out during analysis of 
the transcripts. In this study, once all the transcripts had been analysed, the transcripts 
from each group were then re-read, (by OOS or JB) with the amended initial template to 
ensure that all aspects of the interviews were included. When all the transcripts had been 
re-read OO’S and JB met and discussed their findings and no further changes were made 
to the template.  
In a further effort to enhance the validity and quality of our work, two colleagues (AR 
and NG), not involved in the project but with knowledge in this subject area, were each 
given 3 transcripts; (AR 3 PR transcripts and NG 3 PAI transcripts) and were invited to 
generate themes independently. This was completed without any advance exposure to the 
template (Appendix 16, Qualitative analysis research team: credentials, training and/or 
experience). No new additional themes were created and there was largely agreement 
between the researchers. There were some minor agreed changes to the template, for 




   
A flow diagram of the methods is available in Figure 4.1. The final template and 
corresponding quotes were used to write up results (Appendix 20, Final template for the 
qualitative component of the LIVELY COPD project). 
 4.3 Results 
Fifty participants were recruited to the LIVELY COPD project (Chapter 3). Thirty two 
participants were available to complete interviews; n=16 PAI and n=16 PR (Table 4.3). 
A flow diagram of participants available for semi structured interviews is available in 
Figure 4.2.  The mean (SD) length of time for each interview was 17 (7) minutes. Five 
core themes were identified (Perceived benefit and impact of PAI/PR,  views of and 
satisfaction with PAI/PR, adherence to the PAI/PR, views about outcome measures, 
views about continuing exercise/PA) with a number of subthemes relating to each theme 
which are available in Table 4.4 Themes and subthemes.  
 4.3.1 Perceived benefit and impact of PAI/PR  
The semi structured interview explored what benefits the participants in each group 
experienced. There were five common subthemes within the theme perceived benefits 
and impact of PAI/PR; physical health, mental health, social activity and social support 
and enjoyment. 
 4.3.1.1 Physical health 
Participants in both groups experienced improvements in their physical health, expressing 
improvements in their respiratory health and increased functional ability. Respiratory 
health benefits were mainly in relation to breathlessness. Perceived improvements in 
physical health manifested in being able to complete activities of daily living such as 
cleaning or gardening with more ease and confidence.  
“My breathing is better, I am able to control my breathlessness better, so yes I feel 
that it has done some good.” (M79 PAI) 
“I think it does because I can do, you know, this shortness of breath is not with me 
as often or as much.” (F74 PR) 
“Well at the start I wouldn’t have even attempted hovering or dusting or anything.  
Now I am doing them all.” (M55 PAI) 
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 “I can go out leisurely walking with my daughter and I found that where I would 
be going behind them and they were waiting on me always and saying come on and 
that, I felt that I could keep up a lot longer, not all the time though.” (F74 PR) 
 
 4.3.1.2 Mental health 
The prevalence of mental health disorders in people with COPD including anxiety and 
depression has been documented in the literature (Maurer et al. 2008). PR has been shown 
to be effective in improving the symptoms of these comorbidities (Bolton et al. 2013). 
Participants in both groups reported improvements in their mental health.  
“I think definitely because you’re physically, you feel physically stronger and able 
to cope and then, obviously then it makes you feel much better within yourself” 
(M58 PR) 
“You know I could go out of here now and just cry and just say I need to get home, 
I need to get home as fast as I can. I reckon the programme has helped me. Because 
I had something to do, a goal to reach” (F58 PAI) 
 4.3.1.3 Social activity and social support 
Participants in both groups experienced social benefits from taking part in their respective 
programme, both in terms of improved social support from family and friends and their 
increased ability to go out and be more socially active. Support from family and friends 
was evident through family and friends noticing and commenting on improvements in 
their appearance or activity. 
 
“Yeah my sister has, she says I am more…..getting out of the house more whereas 
before I wouldn’t of bothered.” (F56 PAI) 
 
“Yes, yes I have been out a couple of times where I wouldn’t have been before.” 
(F77 PR) 
 
“They said I was looking much better, you see it is weight wise too for I was only 6 
stone when I came out of hospital so there is a whole other factors.” (F63 PR) 
  
 4.3.1.4 Enjoyment  
Enjoyment in taking part in the programme was a perceived benefit for participants in 
both groups. Being able to achieve specific goals also seemed to make the PAI more 




   
 “Once I started to see that I was achieving my goals it became more enjoyable 
right.” (M63 PAI) 
 
“Yes, I enjoyed it, it taught me a lot about things you weren’t doing and things you 
should be doing.” (M61 PR)  
 
 4.3.2 Views of and satisfaction with PAI/PR 
The semi structured interview schedule explored participants’ views and satisfaction of 
their respective programmes. Overall, participants in both groups appeared satisfied with 
their respective programmes, however, there were components of both the PAI and PR 
that participants were more satisfied with than others. Sub themes within this theme 
include tailoring of content, frequency, duration and mode of contact, education and 
educational materials and suggestions for improvement. 
 4.3.2.1 Tailoring of the content of the PAI/PR to the individual 
PR is delivered in a group setting and is traditionally less individualised in comparison to 
the LIVELY PAI which was delivered on a one to one basis. The PAI was designed to be 
personalised to the individual, driven by their baseline step count and personal goals. 
Participants in the PR group felt they had some degree of input into the class, for example, 
they could stop when they were tired and the exercises were progressed over the course 
of the programme. In contrast participants in the PAI felt they were fully involved in 
shaping the intervention for themselves. 
 
“I mean you were able to say, if you felt it too much you could stop.” (F67 PR) 
 
“I didn’t really have any input into it, it was just laid out to do warm up exercises 
first and then to do all the usual……The only difference was once you had been 
there two or three weeks the ups from half a second, or half a minute to a minute 
then a minute and a half then two minutes.” (M76 PR) 
 
“I would have to say 100%...…. because I always, although [provider’s name] 
always, this is face to face, although I set a goal per day steps, be it 10,000 or 




   
 4.3.2.2 Frequency, duration and mode of contact with provider or    PR 
staff 
Participants in the PAI group had once weekly contact with the provider for 12 weeks; 
the first 6 weeks were delivered face to face, followed by 5 weeks of telephone contact 
and participants then returned for a face to face consultation at week 12. Participants in 
PR had twice weekly contact for 6 weeks. Participants in both groups were generally 
satisfied with the duration of the frequency of contact; however there were a small number 
in each group who would have been willing to have increased frequency of contact and 
to continue the PAI/PR for longer. In the PAI there was also a general feeling that there 
was good balance between face to face and telephone contact; most participants felt that 
these first 6 weeks of face to face were needed to establish a relationship with the 
provider. Some participants had a preference for the face to face contact while others felt 
they could have transitioned to the telephone contact earlier.  There were also a small 
number of participants in the PR group who felt that twice a week was too much and 
would have preferred increased flexibility in the timing of the class.  
 
“I think 12 weeks probably right partly“(M67 PAI) 
 
“Six weeks, I think was just perfect.” (F74 PR) 
 
“I could have come down a bit more often do you see but then he had other 
people to see to like you know.” (C212 M61 PAI) 
 
 “…I think it was just right because then it takes you a while to get to know 
somebody and know there, and then [provider’s name] she needs to know what I 
can do and what I can’t do and you sort of work it out between the two of yous and 
how you are going to do this and in the end, I think it takes, it really does take about 
six weeks to get there in the end. (F57 PAI)  
 
 “Could have been done earlier.” (M67 PAI) 
 
“But  I would have liked to have kept going.” (M76 PR) 
 
“I did think twice a week a bit much now….It was a lot for me…….Maybe once a 
week.   I would think now that’s only for me……I find it….everybody mightn’t be 
the same as me but I am very busy two days a week and I go to another wee class 




   
 4.3.2.3 Education and educational materials 
Participants in both groups received disease specific education in line with the BTS 
guidelines (Bolton et al. 2013) and participants also received an information booklet 
(LWWCOPD) (Cosgrove et al. 2013). In the PAI, the education component was delivered 
one to one. In PR, education was delivered in a structured format to the group.  The 
education was generally viewed positively in each group. Many participants appeared to 
find the education surrounding management of breathlessness and inhaler technique 
helpful. Most patients perceived the material in the LWWCOPD for PR booklet to be 
useful as reference point. However some participants were ambivalent towards the 
booklet and only read it in parts.  A small number of patients in PR did not perceive the 
education to be relevant to them.  
 
“I thought the inhaler technique was a bit of a revelation, ok compared to what I 
thought I knew and what he actually taught me was very, very good. “ (M63 PAI) 
 
 “All the reading material, everything was absolutely brilliant and anything you 
are not sure of you just go back to the book and just refresh yourself…..”(F67 PAI) 
 
 “I did aye, I felt they helped as well. Just coping with your breathing and difficulty 
breathing and stuff like that and proper use of inhalers which I wasn’t aware I 
wasn’t using it properly cos I was using them how I was shown to use them ya 
know.” (M58 PR) 
 
 “I don’t use oxygen, they talked about oxygen I don’t use oxygen and other 
medications that, you know didn’t apply to me but at the same time they talked about 
a lot…..” (F77 PR) 
  
 4.3.2.4 Suggestions for improvement  
Suggestions for improvement of each programme were identified by some participants.  
For the PAI, suggestions for improvement included: wanting more educational content 
and another individual felt the programme should account for other forms of PA. 
Participants also suggested holding the PAI in the summer and some follow up contact 
with the interventionist.  Some suggestions for improvement in the PR group related to 
increasing the intensity or difficulty of the exercises and one participant felt that walking 
could have been included as part of the programme. 
 
“….but there are other ways of using energy other than walking.  Well it seems to 
not to have been taking into consideration…..Yeah I just perhaps feel that if 
somebody is doing something else on top of the walking that is perhaps not 
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acknowledged or understood and that means that, it gives you a bit of a false idea 
of what somebody is doing.” (F63 PAI) 
 
“Well I, I feel that I probably could have done a bit more than what they were 
offering but obviously, it’s obviously a, it’s mixed levels of ability there. There’s 
people that were a lot worse than myself, you know what I mean?” (M58 PR) 
 
 4.3.3 Adherence to the PAI/PR 
Low levels of PA and low levels of adherence to PR have been reported in the literature 
in the COPD population (Watz et al. 2009, Steiner et al. 2016). Therefore this qualitative 
work aimed to explore what enabled the patients to adhere to their programme 
(facilitators) and any reasons for non-adherence (barriers). 
 
 4.3.3.1 Facilitators for adherence to the PAI/PR 
A number of facilitators were identified in each group that enabled adherence and also 
enhanced performance in the respective groups. Common facilitators included intrinsic 
motivation, the staff/interventionists and social support. PAI specific facilitators included 
the pedometer, as well as the action and coping plans, a number of participants in the PAI 
group also developed their own specific strategies to facilitate adherence. The group 
setting was a facilitator specific to the PR group.  
 
 4.3.3.1.1 Intrinsic motivation  
Patients’ participation in the PAI and PR was intrinsically facilitated through their own 
motivation; some participants felt they were naturally quite motivated individuals.   
 
 “…………..you know so I would drive myself.  I would be a naturally driven person 
so if I agreed in the programme that I was going to do whatever I was going to do.” 
(M65 PAI)  
 
“Pushed me hard and that’s what I said to them, push me hard and I want to feel it 
that I come out of here, that I am a wee bit sore that I know that I done me job..” 
(M79 PR)  
 
 4.3.3.1.2 Social support 
Social support from family and friends was a common facilitator in enabling 
participants in both groups to take part in the programme. For example in the PAI 
group, one participants’ friends stopped offering them lifts as they were aware they 
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were taking part in the programme and in the PR group another participant was 
supported through their church group.   
 
“Ah none of them will give me a lift now because I have told them all not to stop to 
give me a lift.  So I have to walk everywhere now.” (M47 PAI) 
 
 “Well I have done quite a bit because we have another church group on a Tuesday 
night and it’s called fit for life and the people that can’t walk, the idea is you walk 
and pray or you walk and talk and if you can’t you stay in the building.  They had 
a video but it was too fast for me so I was doing some of these and I was introducing 
them to some of my exercises which was good, you know the wall press ups the sits 
and the mini squats you know.” (F73 PR) 
 
 4.3.3.1.3 Staff/providers 
The staff delivering each intervention was a common facilitator for each group; 
encouraging participants and the relationship that developed across the intervention 
helped participants to fully engage in their respective programme. 
 
 “In the initial stages and the fact that you were going to meet [provider’s name] 
and the fact that he was taking this with the due diligence which was required and 
you felt it was important to do the same thing, therefore it was important in the 
initial stages.” (M63 PAI) 
 
 “And these people that done this, everyone is encouraging, they’ve got personality, 
they have got everything and they made you feel as if you were alive and you hadn’t 
got what you have.” (M79 PR) 
 
 4.3.3.1.4 Pedometer and action and coping planning (PAI specific) 
Most participants in the PAI felt the pedometer facilitated their PA. Being able to monitor 
their PA with direct feedback was a key facilitator. Setting an action and coping plan with 
a specific goal each week and achieving this goal also helped facilitate participants to 
engage in the programme and increase their PA levels. The action and coping plan was 
specific to each individual and allowed for flexibility in their PA. This facilitated 
participants’ engagement in the PAI. 
 
 “……I found the pedometer particularly useful to drive me to the goals that I set 
myself.” (M65 PAI) 
 
 “………….I would go out of my way to make sure I achieved that or else I would 
have to have a very good reason that I could square with my own conscience…..…… 




   
“Well, being a diary……………..you have to fill it in at appropriate 
times…………….….and there is no excuse for missing a time you know.  It does 
drive you to do it and you get some satisfaction out of doing it like anyone who does 
keep a diary.” (M79 PAI) 
 
 4.3.3.1.5 Individual strategies to increase PA (PAI specific) 
During the PAI participants developed their own specific strategies to facilitate their 
adherence to the intervention and achieving their goals.  For a small number of 
participants in the PAI group, the sense of achievement they experienced when they 
reached their goals facilitated their participation. Participants were also encouraged to 
reward themselves if they achieved their goal.  
 
 “It’s what….when, [provider’s name] said to me about you should give yourself a 
treat if you do your walking, you give yourself a treat………..so I got my nails done 
which led to me getting my hair done which led to people saying how better I looked 
which I was so totally delighted about people thought I had actually went and got 
makeup and all done but it is just that, I think it improves the way you feel about 
yourself.”(F57 PAI)   
  
 “…………um today I parked in the farthest away car park and walked from level 
H down the stairs, I didn’t take the lift, you know so my confidence ………….it’s 
just a confidence thing.”  (M65 PAI) 
 
 4.3.3.1.6 Group setting (PR specific) 
The group setting of PR was a facilitator for some individuals who found themselves 
competing with and comparing themselves to others in the group, and this encouraged 
them to work harder, and further facilitated their engagement in the programme. 
 
“Well you have to push yourself you don’t get the same…….You’re not sort of, not 
intentionally but when you are up there you’re sort of competing against the other 
people.” (M76 PR) 
 
 4.3.3.2 Barriers 
Participants in each group reported a number of barriers to participation in their respective 
programmes. Barriers included physical and mental health, the weather/environmental 
factors, lack of social support, time/other commitments and for the PR group specific 




   
 4.3.3.2.1 Physical health 
Participants in both groups often perceived their overall health as a barrier. In terms of 
respiratory symptoms, breathlessness appeared to inhibit their ability to be physically 
active. Often periods of ill health independent of their respiratory symptoms prevented 
participants in both groups from full participation. 
“Even now as I was these last few days I wasn’t well but I was still doing breathing 
and doing walking round the……because I couldn’t put no speed on… Because I 
had an infection in my chest like.  You know and I couldn’t get out to do any 
walk….” (M73 PAI) 
 “No, no if I didn’t want to do it I wouldn’t have done it.  I just, you know.  There 
was one day there, I got out of bed for a couple of minutes, I wasn’t too well and I 
just got back into bed so I didn’t use the pedometer at all that day, so.” (M47 PAI) 
“Um sometimes the breathlessness would have put me off going out walking.  So I 
hope to be able to go back to walking now after this.” (F77 PR) 
 
“I missed one. No no. The one day I didn’t come I just took violently sick.  I had ate 
something obviously disagreed with me …” (F62 PR) 
 
 4.3.3.2.2 Mental health (PAI specific) 
Mental health problems have been reported as a barrier to adherence to exercise 
programmes in the COPD population (Heerema-Poelman et al. 2012). In the current 
study, mental health presented as a barrier to participation for a small number of 
participants in the PAI group only.  
“I don’t know.  That sorted like….my mental state at the time to be honest.  But if it 
is it will be really one or two days like it wouldn’t disrupt the programme 
completely.  It would just be that I am feeling down and I just have to go down and 
come up out of it.” (F63 PAI) 
 “Do you know what I mean.  like I could get two days of cleaning the house and 
different things and then two days of just not moving, barely even feeding myself. I 
had a few wee spells of that. My moods go up and down, they are like waves up and 
down.” (F58 PAI) 
 4.3.3.2.3 Weather/environmental factors 
The weather was a common barrier for both groups. The wind and rain or any adverse 
conditions often prevented a number of participants from being physically active, but did 
not specifically hinder adherence to the PR programme. 
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“No there always is a situation when walking into the wind and things like that 
would have been a bit of an issue.” (M63 PAI) 
“Yeah I hate the rain, I hate being out…… the wind would stop me walking as much. 
It catches the breath….” (F62 PR) 
 
 4.3.3.2.4 Lack of social support 
Lack of social support was a common barrier to both groups.  Some participants identified 
not having friends/family around to support their PA/exercise as a barrier.  
“No you see I live on my own which probably doesn’t help matters.   So no.”  (F63 
PAI) 
 “I think if I could go out and walk, it would mean a lot more to me, because I don’t 
get to walk much and …………they are lonely places and I don’t like walking on 
my own.” (F74 PR)   
 
 4.3.3.2.5 Time/other commitments 
Time and/or other commitments were a barrier in both the groups. For example, 
Christmas time was a particularly busy work period for one participant in the PAI group. 
In the PR group, barriers included other commitments such as work or general life; for 
example taking the car to the mechanic prevented one patient from participating fully in 
the programme; spouses taking ill or bereavements also presented as barriers to 
participation in PR. 
“I think, well I just felt it was done at the wrong time of year.  I mean not just 
because of me and my craft shows at Christmas but because of the fact for anybody 
Christmas is a funny time you are out racing around one minute then you are lying 
about and then you get the bad weather.” (F63 PAI) 
“…….and I do have a part-time job and if it didn’t suit me on Tuesdays and 
Thursdays and I wouldn’t come, so maybe more flexibility.  You know.   I am free 
on a Thursday so that doesn’t matter but on a Tuesday I do children pick up at 3.00 
pm so I always have to leave early on a Tuesday.” (F60 PR)  
 
 4.3.3.2.6 Group setting (PR specific) 
Although a number of participants found the group setting to be very beneficial, others 
did not enjoy this aspect of PR and it served as a very strong barrier to participation for 
those individuals. For example this was the reason for withdrawal for a few patients who 




   
“I only went for one session because I found that I didn’t feel as bad as what some 
of the other people actually looked.  They were wearing oxygen tanks and you know 
I just didn’t feel that I was that bad to warrant pulmonary rehabilitation.” (F58 PR) 
 
“Well it wasn’t, oh dear.  It wasn’t the programme I found that the people on the 
course were in my opinion very self-obsessed with their own conditions and it drove 
me………………. I just couldn’t hack it. …………….which is naughty but that’s 
really why, nothing to do with the physios or the exercises.” (M72 PR) 
 
 4.3.3.2.7 Motivation to do the programme independently (PR specific) 
Some participants in the PR group expressed a lack of motivation to do the home exercise 
programme as a barrier. Participants found it difficult to motivate themselves outside of 
the class structure. 
 
“It’s kinda easier coming to a class cos you know when you’re coming to a class 
you just kind of have to do it. Whereas it’s more difficult to sometimes to motivate 
yourself to do it, I mean I’ll do it tomorrow…..it’s easier to put it off. “(M58 PR) 
 
“….. you need somebody to drive you.  You know you need somebody with a big 
stick to keep you at it.”  (F74 PR) 
 
 4.3.4 Views about outcome measures 
A range of outcome measures were completed by participants at different time points. 
Participants wore activity monitors (containing an ActiGraph and a sealed pedometer) on 
a belt for 7 days, completed an exercise test (ISWT) and completed paper based 
questionnaires. Participants expressed their views about each of these outcome measures, 
as well as recommending how the outcome measure process could potentially be 
improved upon.  
 4.3.4.1 Activity monitors (worn on belt) 
Participants’ comments regarding the activity monitor belt (ActiGraph and sealed 
pedometer) were mixed. Some appreciated the objective nature of the measurement. 
Others participants found this cumbersome and did not enjoy wearing it and others did 
not mind wearing it.  
 
 “…..you are able to see what I’ve been doing. You are not taking my word for it.  
Plus it is all sellotaped up and there is nothing you can do to…….you can’t lie about 




   
“I thought they were very awkward……..They were very awkward when you were 
going to the toilet.” (M68 PR) 
 





 4.3.4.2 Incremental shuttle walk test  
The ISWT is an externally paced test of exercise capacity (Singh et al. 2008). Participants 
found it useful as a measure of their physical fitness and they could tell that they had 
improved.  A few participants did not enjoy this test because it made them breathless or 
aggravated other comorbidities such as leg pain.  
“I think that from the start until now I think, well I know I’ve improved I don’t have to 
think that I know I’m 100% better than I was when you first did that walk……..because I 
didn’t feel the pressure as much when I first started walking when we did it the first time 
I was shattered after half a dozen steps you know half a dozen after that you know where 
I felt this time I had progressed a lot better.” (F67 PAI) 
 
“As I say I have difficulties in my legs so sometimes I found it difficult to walk, but I just 
sort of past through it and just got on with it.” (M47 PAI) 
 
“You know that walking I think it is a good test of how you can move and your breathing 
and all you know.”  (F73 PR) 
 
 4.3.4.3 Questionnaires 
Some participants did not mind the questionnaires where others had a negative view, 
finding them complicated or difficult to understand, or felt they were vague or perhaps 
lacked repeatability.  
“Um I think they were good,” (F63 PAI) 
“…..all those questionnaires and all, they are a bit complicated.  I thought they 
were all really, some of them weren’t as complicated as others but…..” (F57 PAI) 









   
 4.3.4.4 Recommendations for the best method to test the effectiveness of 
the PAI/PR 
Participants in both groups provided various recommendations on what they thought was 
the best way to measure the effect the PAI/PR had on their health. There was no common 
view on what was the best method to test the effectiveness of the PAI/PR. In the PAI 
group, one participant suggested conducting spirometry and another felt reviewing the 
providers’ notes would be the best method to measure the effectiveness of PAI, while 
some felt that simply seeing how much they could walk now compared to the beginning 
of the programme was the best way to measure the effectiveness of the intervention. In 
the PR group, one participant felt that just asking their opinion would be the best way, 
another felt just seeing how far they could walk, while others felt the monitors or the 
walking test were the best way and were interested in their step count. 
 
“Ultimately for me it is probably getting the spirometry test to see, look has there 
been an improvement in capacity.” (M63 PAI) 
 
“Well the walking test…..the monitor is quite good, because at the end of the day it 
lets you know, and you know what you have done before.” (F67 PR) 
 
“Yeah I think the belt one was very good.  But I didn’t wait to see the number of 
steps I was doing……..…..I would be interesting to see the results.  My results from 
beforehand to after.  I would say there might be similar steps……” (F60 PR) 
 
 4.3.5 Views about continuing exercise/PA 
Participants were followed up three months post intervention (visit 4). We explored 
with participants their views about continuing to exercise or to be physically active. 
There were two subthemes common to each group: plans for continuing exercise/PA 
and motivation and confidence to continue exercise/PA. 
 
 4.3.5.1 Plans for continuing exercise/ PA 
A high number of participants in both groups planned to continue to be physically active 
and engage in exercise. Some had specific plans as to how they were going to achieve 
this.  In the PAI group, some participants planned to engage in other activities while 
continuing with the programme on their own was a popular plan for others. In the PR 
group, participants planned on continuing the exercises at home, making a more 
conscious effort to be physically active, purchasing a pedometer and another participant 
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was keen to return to PR in the coming months to help him to maintain his exercise 
capacity. 
 “You know I will keep it up…..No I think this goal setting for the week, I mean I 
am up to now 45,500 steps per week. And over the next three months you would 
hope to get that up to, particularly coming into the summer months you would hope 
to get that up to 10,000 over the next three months, 10,000 per day.” (M63 PAI) 
 
“I think it is sort of reinforcing how.  Exercise is so accessible……..………you know 
in the home.  As I said to one of the doctors… I said everybody has got a wall at 
home so you have no excuse not to do your ups and downs the wall.  I have access 
to a lot of different classes outside and swimming and I am just realising there is a 
lot of stuff out there that is accessible to your level of fitness.” (F60 PR) 
 
 4.3.5.2 Motivation and confidence to continue exercise/PA  
The benefits they achieved as a result of the PAI/PR provided the motivation and 
confidence to continue to engage with exercise and PA. Furthermore, most patients in 
both groups were confident they would continue; there was one participant in the PR 
group who had not adhered to the intervention who was not confident they would continue 
or perhaps even start to be physically active. 
“Well if I let it drop I am going to end up back where I was at the start. And I don’t 
want that back at the start I wouldn’t have moved. Just sitting there.  The only time 
I would move would be in to the kitchen to get a cup of tea.” (M55 PAI) 
 “So I knew that definitely the exercising must have been the thing that was doing 
me good because I wasn’t doing anything else.  I was on the same inhalers, the 
same…….….stuff, you know that I felt more able to do things so I put it down to the 
exercising.” (F74 PR) 
 
 “On a scale of one to ten….probably a 9.5… confidence, I would put it at a ten but 
there might be deteriorations in my……for other reasons…” (M67 PAI) 
 
“Oh, at this moment in time I am very confident, I hope I don’t fall by the wayside 
but I definitely do intend keep at it.”  (F67 PR) 
 
“Not very confident.  I know that’s bad.” (M72 PR) 
 
 4.4 Discussion  
The aim of this study was to explore the participants’ views and experience relating to 
satisfaction and benefits of a PAI and of PR.  This qualitative research was a key 
component of assessing the feasibility of the LIVELY COPD trial. Participants’ views 
and satisfaction of both the PAI and PR were explored, this provided key information on 
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the acceptability of the PAI and PR, which was not have available from the quantitative 
data. The barriers to participation and reasons for dropout were further explored. Patients’ 
views on the outcome measures used and their plans for continuing PA/exercise helped 
to explain and verify some of the quantitative findings. The results of this qualitative 
research can be used to help inform a future study as well as future research in the COPD 
population. This is also the first study in COPD to explore patients’ views of a PAI. 
 
Participants in both the PAI and PR experienced a range of benefits and were generally 
satisfied with their respective programmes. Satisfaction and acceptability of the PAI is a 
core component of assessing the feasibility of a study (Bowen et al. 2009) and if the 
quantitative results showed a favourable effect but participants were dissatisfied, the 
feasibility of the future intervention would be questionable. Patients’ views of PR in 
particular also reinforced the underpinning rationale that PR may not be suitable for all 
individuals, some participants in the PR group did not feel that all of the educational items 
were relevant to them or felt that they could have done more in terms of the exercises 
provided. Additionally, some of the PR participants did not feel that the programme was 
tailored to them; conversely the PAI group felt they were fully involved in shaping their 
intervention. Current National Health Service (NHS) policy on personalising medicine 
recognises that individuals with the same condition do not all have the same needs and 
advocates tailoring of treatment to the individual (NHS England 2016). Personalising 
healthcare can increase costs. Delivering the PAI on a one-one basis is more costly than 
delivering PR, based on the time taken to deliver each intervention, which is double that 
of the time taken to deliver the PR (Chapter 3). However this qualitative research has 
helped us consider areas where the cost could be reduced for a future study for example 
some participants in the PAI felt they could have transitioned to telephone contact earlier 
than at six weeks, so facilitating this earlier transition in a future trial or indeed in clinical 
practice would help reduce the cost of delivery. There were also higher rates of adherence 
and lower rates of drop outs in the PAI compared to PR (Chapter 3), which has the 
potential for cost saving in the long term. The high rate of dropout and nonattendance at 
PR results in an inefficient use of staff time and resources (Fischer et al. 2009). Finally, 
with the established benefits of higher levels of PA in COPD in terms of reduced 
hospitalisations (Moy et al. 2013), it is reasonable to hypothesise that personalising PA 




   
High rates of drop out were observed in the LIVELY COPD project (Chapter 3). This 
qualitative research provides important information on adherence to the PAI and to PR. 
Adherence was explored with all participants in terms of barriers and facilitators. There 
were common barriers to participation in both groups including health, the 
weather/environmental factors, lack of social support and time/other commitments which 
have been reported elsewhere (Thorpe et al. 2014, Arnold et al. 2006, Keating et al. 2011). 
Interestingly the group based delivery of PR was considered both a barrier and facilitator 
by different participants in this group, previous research has reported the group setting as 
a barrier to the uptake of PR (Harris et al. 2008), while de Sousa Pinto 2013 identified the 
group setting as a positive aspect of PR. This further supports the current evidence that 
PR is suitable for some but not all individuals with COPD and reinforces the need for 
increased choice for individuals with COPD to increase their exercise/PA levels. A future 
trial could consider a preference RCT to allow participants to choose or express their 
preference for which group they feel would best facilitate their needs and lifestyle. A 
recent feasibility study by Chaplin et al. 2017 compared a web based PR programme to 
conventional PR, the authors explored participants’ preference prior to randomisation but 
did not allocate patients according to preference. The authors found that those who were 
younger and less disabled would have preferred the web based trial and older patients had 
a preference for the class. This is line with current literature; patients with coronary heart 
disease who are still working prefer a home based class (Grace et al. 2005). Therefore 
exploring patient preference and randomising accordingly could help overcome barriers 
and reduce dropout.  
 
Patient views on outcome measures were mixed. There were no clear views on outcome 
measures which could help inform a future trial.  However the qualitative exploration 
indicates that the outcome measures used may not have been optimal, in helping detect 
change.  Quality of life in the current study was assessed with CAT and EQ5D5L and 
other questionnaires, including IPAQ (long form), stages of change, Marcus self-efficacy 
questionnaire and the global rating of change were also completed. Some participants 
found the questionnaires complicated and lacking repeatability, stating that every time 
you complete them you might answer them differently. A future study should consider 
reducing the number of questionnaires, taking into account the objective findings, the 
removal of the IPAQ, Stages of change, Marcus self-efficacy and stages of change would 
be advised. The stages of changes and self efficacy questionnaires could be incorporated 
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into the intervention as tools to help shape the intervention.  Furthmore some patients 
found wearing the activity monitor belt (with the ActiGraph and pedometer) 
uncomfortable which may have impacted on the wear time. The use of one activity 
monitor is recommended for a future trial.  
 
Nearly all participants expressed a desire and will to continue to engage in PA and 
exercise irrespective of group. The three month follow up (visit 4) quantitative data 
showed an increase in step count for both groups from baseline (visit 1 and vist 2) (Figure 
2, Chapter 3). As part of the BCS employed in the LIVELY PAI, in the final consultation, 
providers discussed with patients their plans for maintenance; this may have aided their 
adherence to PA in the follow up period. Nonetheless this increase in step count was 
observed in both groups. The findings of this qualitative study in relation patients 
continuing to be physically active or engage in exercise can be mapped to elements of the 
Theory of Planned Behaviour (Azjen 1991), which has the potential to explain this 
increase in step count at three month follow up (visit 4). Patients intended to continue to 
be active, they expressed positive attitudes towards continuing to be active, the main 
reason for wanting to continue was due to the benefits experienced. In terms of the 
perceived behavioural control; a high number of participants expressed plans to continue 
to exercise in which they referred to the resources available to them, for example some 
participants planned to continue to use their pedometer or others planned on visiting the 
local health centre.  Current research indicates that the benefits of PR start to diminish at 
6-12 months (O’Neill et al. 2008, American Thoracic Society/European Respiratory 
2006), participants in the current study were not followed up at this period but the follow 
up data at 3 months is encouraging (Chapter 3), demonstrating an improvement in step 
count from baseline.  Both the BTS and ATS/ERS guidelines for PR recommend using 
cognitive behaviour therapy for behaviour change in COPD (Bolton et al. 2013, Spruit et 
al. 2013) and Mantanoi et al. (2016) recognise PA coaching as an effective method for 
increasing PA in people with COPD. Future studies should consider using the Theory of 
Planned Behaviour to help promote maintenance of PA and exercise in the COPD 
population. This theory has been previously shown to be a useful model to determine and 
predict exercise maintenance in other populations (Hasnan Ahmed et al. 2014).  
 
There were some challenges in analysing the results of this reserach. The phrasing of 
some of the questions in the semi strucutred interview script allowed for, a yes/no 
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response from participants, which limited the interpretation of the data. This is important 
learning and a future trial should endeavour to phrase questions in an semi structured 
interview such that they do not elicit a yes/no response and allow the participant to express 
their views more easily. 
 
 4.5 Conclusion 
In conclusion this is a novel study. Participants in the LIVELY COPD project experienced 
a range of benefits and were in general satisfied with their programme regardless of group 
allocation. This qualitative research was key in determining the feasibility of the LIVELY 
COPD project and helped verify and complement the quantitative results as well as 














































Agreement of a priori themes (Appendix 17,  A priori themes for qualitative 
component of the LIVELY COPD project) 
 
Analysis of 25% of transcripts: The Initial Template was formulated  (Appendix 
18,  Initial template for qualitative component of the LIVELY COPD project) 
 
Analysis of the remaining transcripts: Amendment of the Initial Template 
(Appendix 19,  Amended of initial template for qualitative component of the 




The Final Template was formulated (Appendix 20,  Final template for the 
qualitative component of the LIVELY COPD project) 
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N=50 patients recruited 
N=26 randomised to PR N=24 randomised to PAI 
N=0 did not receive allocation N=1 did not receive 
allocation 
N=27 PR N=23 PAI 
N=16 interviews conducted PAI 
N=1 paper based 
only outcome 
measures completed 
N=5 dropped out 
(withdrew from 
study) 





N=1 paper based 
only outcome 
measures completed 
N=2 did not start 
intervention 
N=5 dropped out 
(withdrew from 
study) 
N=1 unable to travel 





N=16 interviews conducted PR 
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Table 4-2 Outline of the LIVELY COPD project qualitative semi structured schedule 
Interview Schedule Questions  
How do you feel the physical activity intervention / pulmonary rehabilitation 
programme has affected your health?  
Do you think your relatives/carers/friends see a difference in you? 
Do you think you have a good understanding of the benefits of exercise/PA for 
someone with COPD? 
How satisfied were you with the: 
a. face-to-face physical activity intervention? 
b. pulmonary rehabilitation programme? 
What suggestions if any, would you give to improve the physical activity 
intervention / pulmonary rehabilitation programme? 
How involved did you feel in shaping the physical activity intervention / 
pulmonary rehabilitation programme, do you feel your level of fitness/ability 
was considered? 
How easy did you find it to adhere to the physical activity intervention / 
pulmonary rehabilitation programme? 
Have you ever done pulmonary rehab before? 
This research wanted to test how the physical activity/pulmonary rehabilitation 
programme affected your health.  
During the information collecting sessions with the researcher you wore two 
activity monitors for seven days at home, did a number of questionnaires and 
completed a walk test. How did you find these? 
How confident are you that you could continue to exercise or do physical activity 
on your own now that the programme has finished? 
Would you recommend the physical activity intervention / pulmonary 
rehabilitation programme to anyone else who has COPD? (optional question) 
Is there anything else that you would like to add regarding your experiences of 














   
 Table 4-3 Characteristics of participants completing the qualitative component of the 
LIVELY COPD project by group (n=32) 
 Physical activity 
intervention n=16  
Pulmonary 
rehabilitation n=16 
Age  61.5 (8.5) 67.6 (7.8) 
Gender  10M: 6F 7M:9F 



















Interviews conducted at visit 3 16 15 
Interviews conducted at visit 4 0 1* 
Others present at SSI 0 1** 
Previous experience with PR N=3 N=5 
*missed visit 3 outcome measure assessment due to holidays ** participant’s wife 


















   
Table 4-4 Themes and subthemes for patients’ views and perceptions of a PAI/PR in the 
LIVELY COPD project 
Theme Subthemes 
1. Perceived benefit  and 




1.3Social activity and social support 
1.4Enjoyment 
2. Views of and satisfaction 
with PAI/PR 
 
2.1Tailoring of the content of the PAI/PR to the 
individual  
2.2Frequency, duration and mode of contact 
with provider or PR staff 
2.3Education and education materials 
2.4Suggestions for improvement 
3. Adherence to the PAI/PR 3.1 Facilitators for 
adherence to the PAI/PR 
3.2Barriers to 
adherence to the 
PAI/PR 






3.1.4Pedometer and action 














 3.2.7 Motivation 
to do programme 
independently 
(PR specific) 
4. Views about outcome 
measures 
4.1 Activity monitors (two worn on belt) 
4.2 ISWT 
4.3 Questionnaires  
4.4 Recommendations for the best method to 
test the effectiveness of the programme 
 
5. Views about continuing 
exercise/PA 
5.1Plans for continuing exercise/PA 
 





   
Chapter 5 - Fidelity review: a scoping review of the methods 
used to evaluate treatment fidelity in behavioural change 
interventions 
 5.0 Chapter overview 
This review was undertaken to examine the most commonly used methods to assess 
treatment fidelity in the current literature to explore how treatment fidelity could be 
assessed in the LIVELY COPD project. This review was undertaken in collaboration with 
a Masters student (RMcC). The researchers involved in conducting this review and their 
roles are outlined in Table 5.1. The specific papers included in this review are referenced 
with “s” in this chapter, as the full results table is included in the appendices with this 
specific reference list attached (Appendix 21, Characteristics and reference list of 
included papers in the Fidelity review: a scoping review of the methods used to evaluate 
treatment fidelity in behavioural change interventions). This review has been published, 
please see dissemination of findings page xiv. 
 
Table 5-1 Role of members on the study team 
Personnel Role  
Orlagh O’Shea -Development of protocol 
-Conducted search of databases 
-Screened of title and abstracts 
-Assessed of articles for inclusion/exclusion 
-Data extraction 
-Synthesised results 
-Write up of chapter 
Rosemary McCormick -Development of protocol 
-Conducted search of databases 
-Screened of title and abstracts 
-Assessed of articles for inclusion/exclusion 
-Data extraction 
-Synthesised results 
Dr Brenda O’Neill -Development of protocol 
-Intellectual contribution to write up of paper/chapter 
Prof Judy M. Bradley -Development of protocol 





   
 5.1 Introduction  
The concept of treatment fidelity has evolved over time (Bellg et al. 2004); and there does 
not appear to be one single agreed definition. Treatment fidelity can refer to all the 
mechanisms that ensure an intervention tests its hypothesis and that all the components 
of the intervention are implemented as outlined in the protocol. There does however 
appear to be an agreement in the literature on the importance of assessing and monitoring 
treatment fidelity.  Firstly treatment fidelity increases the internal validity of a trial such 
that the results of the trial are directly attributable to the intervention (Moncher and Prinz 
1991). Good treatment fidelity also increases the reproducibility of the trial by enhancing 
external validity; this increases the extent to which the results can be generalised to the 
clinical setting (Bellg et al. 2004, Moncher and Prinz 1991, Resnick et al. 2005a). 
Additionally optimisation of fidelity can also increase the statistical power of an 
intervention as the varability in delivery has been minimised (Bellg et al. 2004, Resnick 
et al. 2005a, Spillane et al. 2007). If the results of an intervention are found to be non-
significant and fidelity has not been monitored, it would be unclear if the results were due 
to an ineffective intervention or whether key elements of the intervention were not 
implemented as planned. Conversely lack of attention to treatment fidelity could find an 
intervention to be effective due to extra treatment factors, potentially resulting in an 
ineffective intervention being found to be significant in an intervention and subsequently 
implemented in clinical practice (Moncher and Prinz 1991, Resnick et al. 2005a, 
Hengeller et al. 1997). Finally, fidelity monitoring can aid researchers in moving forward 
and refining interventions as it provides information on what components of the 
intervention were effective. 2S 
 
Treatment fidelity is of particular relevance to behavioural change interventions due to 
the complexity involved in targeting specific health behaviours, for example PA (Bellg 
et al. 2004, Michie et al. 2015, Radziewicz et al. 2009). Due to the inherent nature of 
these complex interventions, there is greater capacity for variation especially when 
different research sites and treatment providers are involved. 3S A review of behavioural 
change interventions between 1990-2000 found that 54% of studies did not report on 
intervention fidelity (Borrelli et al. 2005). In an effort to rectify this Bellg et al. (2004) as 
part of the NIH BCC identified five comprehensive domains under which treatment 
fidelity can be assessed and monitored or enhanced (Table 5.1): (1) design of study, (2) 
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training providers (3) delivery of treatment (4) reciept of treatment (5) enactment of 
treatment skills.  
 
In the last decade,  since the publication of NIH BCC recommendations on treatment 
fidelity, some studies have used these recommendations and it appears to be a useful 
model for monitoring and enhancing treatment fidelity (Robb et al. 2011, Radziewicz et 
al. 2009, Resnick et al. 2005b) .2S,15S,16S,27S,343,54S,65S 
 
Many aspects of physiotherapy include complex interventions (behavioural change, PAIs 
and exercise interventions). In order to ensure optimal translation of research findings 
into physiotherapy practice, knowledge of the fidelity of the trials that provide the 
underpinning evidence is important.  
 
 5.1.1 Aim 
Therefore, the aim of this chapter was to identify how fidelity is defined in the literature, 
and to explore the extent to which reported fidelity is assessed/monitored in the published 
evidence on behaviour change, physiotherapy, physical activity interventions and 
exercise therapy and how the methods employed in this literature map to the five domains 
of the NIH BCC.  
 
 5.1.2 Objectives  
(i) To summarise the definitions of fidelity used in the literature; 
(ii) To explore the strategies for assessing and monitoring treatment fidelity and 
to map how these match the domains of fidelity as described by the NIH BCC 
(Bellg et al. 2004).  
 
 5.2 Methods 
The methods involved a scoping review and included a six step framework: (1) 
identifying the research question; (2) searching for relevant studies; (3) selecting studies; 
(4) charting the data; (5) collating and summarising our result; (6) Consulting with key 
stakeholders (not applicable to this study) (Levac et al. 2010, Arksey and O’Malley 2005).  
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5.2.1 Identifying the research question: The research question which informed this 
review was “what methods are reported (in literature relating to behaviour change 
interventions, physical activity, exercise, physiotherapy) to assess/monitor treatment 
fidelity?” 
5.2.2 Searching for relevant studies: A specialised search strategy was developed in 
consultation with the librarian for the School of Health Sciences, Ulster University. Two 
reviewers (OO’S, RMcC) independently and systematically searched three key databases 
(Scopus, Medline (Ovid), and CINAHL). Search words included “fidelity” OR “treatment 
fidelity” AND “behavio* change;” AND “physiotherapy” OR “physical therapy;” AND 
“exercise therapy;” AND “physical activity interventions.” Searches were restricted to 
those conducted in humans and published in the English language. The literature was 
probed in preparation for this review and as a large volume of literature was available it 
was decided in advance of the search to limit the inclusion criteria to studies published 
from 2012-2015.  
5.2.3 Selecting studies: Titles and abstracts were screened independently to identify 
relevant studies where “fidelity” was used in the context of our review aims. Search 
results were combined and duplicates removed. Only studies that included a clear method 
of assessing fidelity were included for data extraction. Review articles, case studies and 
commentaries were excluded, but held for discussion purposes. Full paper copies were 
retrieved and divided between the two reviewers; for training and standardisation, five 
articles selected at random were exchanged between reviewers and reviewed to assess 
agreement about whether studies met the inclusion criteria.   
5.2.4 Charting the data: The research team met regularly to agree and refine the data 
extraction table. Ultimately the aims and objectives of the papers, a definition or summary 
of fidelity (if present) and the methods used to assess/measure fidelity were extracted and 
tabulated by each reviewer. The characteristics (design, population and number of 
participants) of the studies were also charted. 
5.2.5 Collating and summarising our results: The extracted methods used to 
assess/measure fidelity were summarised and then mapped to the five domains as set out 
by NIH BCC framework: design of study, training providers, delivery of intervention, 
receipt of the intervention and enactment of intervention skills (Bellg et al. 2004). At the 





   
 5.3 Results 
5.3.1 Literature search results  
There were 65 papers included in this scoping review. The search results are available in 
Figure 5.1.  One hundred and thirty seven full text articles were retrieved; 65 of these 
were included and the remaining 72 papers were excluded for the following reasons: 31 
did not report a clear method of how fidelity was monitored or assessed and therefore did 
not meet the inclusion criteria. A further n=34 were review papers, 5 were 
editorial/commentaries, 1 was an opinion piece and the remaining 1 was a cross sectional 
questionnaire study. 
 
The results of the data extraction are summarised in Table 5.3. Further details of the 
characteristics of the included papers, the definitions of fidelity and methods used to 
assess/monitor fidelity can be found in the Appendices (Appendix 21, Characteristics and  
references for included papers in the fidelity review: a scoping review of the methods 
used to evaluate treatment fidelity in behavioural change interventions). From the large 
number of studies included in this a review, a broad range of interventions were tested in 
diverse populations: N= 8 involved healthcare practitioners clinicians and care 
givers6S,8S,20S,26S,27S,30S,32S,65S,, n=7 involved children and adolescents 
1S,28S,31S,36S,41S,45S,65S, n=6 invovled patients at risk and with diabetes15S,17S,22S,37S,38S,54S, 
n=5 condcuted interventions involving families 7S,23S,33S,55S,60S, n=4 conducted an 
intervention with adults with intellectual disabilities29S,35S47S,49S, n=4 patients with 
musculoskeletal disorders13S,19S,40S,48S, n=3 children with autism spectrum 
disorder4S,44S,51S, n=3 stroke patients3S,25S,43S, n=3 alcohol and drug abuse53S,59S,64S, n=3 
smokers24S,39S,58S, n=2 cancer patients and cancer survivors16S,28S, n=2 specific 
occupations (school teachers and office workers)9S,12S, n=2 patients with sleep 
disorders21S,62S, n=2 people at risk of developing an illness50S,56S, n=2 patients with 
chronic conditions 14S,34S and n=9 other; including Australian football players 5S, shops 
that serve latino customers18S, post menopausal women46S, people with glaucoma52S, 
community dwelling older adults10S, patients without established cardiovascular disease 
taking antihypertensive or lipid lowering therapy11S, obese pregnant women42S, older 




   
 5.3.2 Fidelity definition  
Thirty four of the 65 (52.3%) papers gave a definition/short summary of fidelity and of 
these 23 indicated a reference source for their definition, 21 different authors were 
referenced for definitions. The definition proposed by Bellg et al. (2004) was the most 
commonly cited definition of fidelity, cited by 9 of the included papers. Most of the 
definitions centered around delivering the intervention as planned; 20 6S,8S-9S,12S,17S-19S,21S-
22S,24S,27S-28,S30S,36S,38S-39S,47S,56S,59S,60S explicity used “delivery” in their definition while a 
further eight used similar language for example “followed as planned,”implemented as 
planned” “provided as intended.”5S,16S,23S,31S,35S,42S,57S,65S  Other definitions stated that 
fidelity is an important component of “verifying a cause-effect relationship within 
complex interventions,”7S and Hildebrand et al. (2012) included treatment differentiation 
in their definition.57S 
 5.3.3 Strategies for assessing/monitoring treatment fidelity mapped to the 
NIH BCC domains 
Of the 65 papers included in this review only 2/65 (3%) included an assessment of all five 
domains; 39/65 (60%) papers assessed fidelity under one domain, 12/65 (18.5%) included 
two domains, 9/65 (13.9%) papers assessed fidelity under three of the NIH BCC domains, 
and 3/65 (4.6%) addressed four of the five domains.   
 
 5.3.3.1 Study Design 
Nine studies considered study design in their assessment/monitoring of fidelity (Table 
5.3). Four of these studies reported on the underpinning theory.2S,3S,54S,65S Seven papers 
included a prior information on the dose to be delivered, ensuring it was the same between 
conditions.11S,15S-16S,30S,34S54S,61S Two of the included studies trained more than one 
provider as a strategy to allow for any setbacks.2S,15S Beck et al. used a specifc study 
design to minimise contamination and all providers in this study remained blind to the 
intervention content during the control period. 2S Further strategies used to enhance 
fidelity relating to the domain of study design were incorporated by Winnet et al. (2015), 





   
 5.3.3.2 Training of providers 
Twenty two papers reported on the training of intervention providers in their assessment 
of fidelity (Table 5.3). Strategies reported to enhance provider training included 
standardisation of training so as all providers received a similar number of sessions or 
were given standard training manuals. 2S,15S,22S,34S,46S,61S,65S  Role play or practice 
delivering the intervention was part of the training in nine studies2S,14S,22S,44S,46S,52S,54S,64S-
65S; provider competence and adherence to the intervention components were usually 
assessed during these sessions. In efforts to minimise drift, refresher training was 
provided by Winnett et al. (2015) and others supervised or reviewed audio/video of 
sessions throughout the intervention and gave the providers feedback based on this; 15S in 
one case the sessions were evaluated and if provders scored below a certain level of 
fidelity they were given additional training. 44S Other strategies used included: seeking 
feedback on the training from the providers, 15S using the results of the assessment of 
delivery to inform future training 17S and the trainer reported if they had delivered the 
training as intended. 33S 
  
 5.3.3.3 Delivery of treatment 
Fifty nine papers reviewed included an assessment of delivery (Table 5.3). Thirty nine 
studies assessed delivery of the intervention either by direct observation or through an 
evaluation of an audio or visual recording1S-2S,6S-8S,10S,13S,17S,19S,20S,22S,-28S,32S-36S,39S-41S,44S-
47S,51S,55S-58S,61S-65S The number of actual treatment sessions assessed ranged from 10-
100%.  The criteria used to evaluate treatment delivery varied and included both objective 
checklists and subjective measures to evaluate the delivery of the intervention. For 
example in one study the raters reported on their “overall impression” of how the 
intervention was delivered40S another report evaluated the provider’s engagement with the 
participants and whether the session was delivered in “a constructive and empowering 
manor.”56S Other strategies used in the assessment of delivery included an effort to 
assess/measure the dose delivered (n=8).8S,12S,23S,25S,31S,38S,42S,59S The use of materials such 






   
 5.3.3.4 Receipt of treatment 
Thirteen of the papers included in this review reported an assessment of receipt (Table 
5.3). Strategies use to assess receipt varied between authors and included ensuring that 
participants had an understanding of the intervention15S, 11S,21S,60S.  Two authors made 
resources available to the participant so as they could perform the intervention activities. 
Other strategies included using online tracking codes to assess if participants accessed 
and received the material; 60S one protocol reported that receipt would be assessed through 
brief questionnaires 27S and Robbins et al. reported that receipt was assessed via providers’ 
logs and assessment of audio recordings. 65S  
 
 5.3.3.5 Enactment of treatment skills 
An assessment of enactment of treatment skills was included by 10 of the studies (Table 
5.3). The performance of the intervention skills was observed in the real life setting by 
one study5S; similarly two other reports used direct observation to examine the degree to 
which interventional changes took place. 18S,53S  Faulkner et al. (2012) used an objective 
measurement to assess if the treatment was being enacted in real life settings. 54S  Follow 
up contact to assess the enactment of the treatment skills was reported by two studies.  
21S,30S   
 
 5.4 Discussion  
This review identified the definitions used for treatment fidelity and explored the extent 
to which the five domains of treatment fidelity are reported in the literature, and detailed 
the strategies used to capture these five domains. The definition by Bellg et al. (2004) 
was the most commonly cited definition for treatment fidelity. Most of the definitions 
provided centred around delivery of the intervention. The overall reporting of treatment 
fidelity is poor; only 40% reported on more than two of the five components. Treatment 
delivery was the most frequently reported domain which is consistent with previous 
research (Borrelli 2011). Study design was the most under reported domain of fidelity 
with only nine studies including this domain in their analysis. There was a wide variation 




   
The definition by Bellg et al. (2004) was the most commonly cited definition of treatment 
fidelity in the reviewed articles. This definition centres mainly around reliability and 
validity, referring to both the strategies used to monitor and enhance these and the 
practices to ensure that the research reliably and validly tests the intervention. All of the 
reasons outlining the importance of measuring treatment fidelity as detailed in the 
introduction are directly realated to reliablity and validity (both internal and external) and 
it is likely that this definition provided by Bellg et al. (2004) was developed bearing in 
mind the benefits of ensuring good treatment fidelity. Borrelli et al. (2005) also draws on 
upon this definition and was cited by two reviewed studies.2S,6S  However many of the 
papers in this review simply deduced fidelity down to the delivery; ensuring an 
intervention was delivered as intended. This simplified definition and concept of 
treatment fidelity may have influenced the methods used to assess treatment fidelity. This 
is evidenced through the results as treatment delivery was the most frequently assessed 
domain. The definition developed by Bellg et al. (2004)  was developed by an expert 
group and we would encourage the use of this definition to aid in the standardisation of 
the assessment of treatment fidelity. 
 
As treatment delivery was the most frequently reported domain it appears that authors 
have a good awareness of the importance of this. However all five components of fidelity 
are mutually exclusive; lack of consideration to any one category could potentially 
compromise the validity of the study (Borrelli et al. 2005).  For example if an intervention 
is found to be ineffective and the only domain of fidelity assessed was delivery which 
was high, it is possible that neglect of other domains may have caused  the insignificant 
results; the providers may not have been adequately trained or the study design may not 
have tested the hypothesis. There is some debate around the importance and relevance of 
all five domains. This review found enactment to be comparatively less well reported than 
the other four domains. Gearing et al. (2011) have conceptualised a treatment fidelity 
framework that does not include enactment as a core component of fidelity.  Gearing et 
al. (2011) also argue that enactment is a component of treatment efficacy rather than 
treatment fidelity; participants in a study may remain unwilling or unable to apply the 
treatment skills in real life settings despite the provider delivering the intervention as per 
protocol.  This is of particular importance to behavioural change interventions. The 
ultimate goal of behavioural change interventions is to change the participant’s behaviour 
to enable them to engage with or carry out the treatment skills; if the participant remains 
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unwilling to do so despite full consideration to the other four domains, perhaps this could 
then indicate that the treatment was ineffective. 2S However, further work is required to 
wholly explore and agree this issue and come to a definitive conclusion on the relative 
importance of each of these five domains.  
 
Study design was the most under reported component of fidelity and may have been over 
looked as an element of fidelity. Study design is an integral part of any intervention and 
impacts greatly on the ability of the intervention to evaluate the hypothesis (Bellg et 
al.2004).  Only a small number of the studies in this review included a measure or 
assessment of study design when reporting fidelity. Bellg et al. (2004) outline specific 
criteria around study design so that the study can adequately test its hypothesis in relation 
to its underlying theory. The theory which underpins interventions for behaviour change 
is important when designing an intervention, as it can provide a more in depth 
understanding of the processes of how the intervention might work (Davis et al. 2014),  
yet only four papers referred to a theoretical framework when reporting their fidelity 
assessment.  Other reviews in various populations have found the reporting of the use of 
theories to underpin interventions ranged from 12-72% (Keogh et al. 2015, Painter et al. 
2008, Davies et al. 2010, Prestwich et al. 2013, French et al. 2014, Richardson et al. 2014),  
The aim of this review was to summarise reported methods used to assess and monitor 
treatment fidelity; the evaluation of the study design was beyond the scope of this review 
and it is possible that papers reviewed included components of study design elsewhere.   
 
This review focused on reports published since 2012. In 2011 Borrelli, a member of the 
research group that published the NIH BCC framework in 2004, published a checklist 
which further developed the NIH BCC framework into a 39 item checklist which was 
designed to assess the treatment fidelity of a study across all these five domains.  Despite 
the publication of the checklist preceding the publication of all the papers included in this 
review, it was only used by two of the studies 2S,15S reviewed to help inform their 
assessment of treatment fidelity. Both these papers reported a comprehensive fidelity 
assessment; Beck et al. (2015) 2S included four out of the five domains and Winnett et al. 
(2015) 15S included all five domains. The lack of reporting of treatment fidelity in this 
review demonstrates the need for the use of a standard process or checklist to be used by 
authors so that none of the five components are overlooked. This checklist provides 
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authors with a structured framework for which to monitor and assess all elements and 
components of treatment fidelity 
 
Established reporting guidelines exist for the reporting and publication of clinical trials 
(CONSORT and Transparent Reporting of Evaluations with Nonrandomized Designs 
(TREND)) (Schulz et al. 2010, Des Jarlais et al. 2004) and protocols (Standard Protocol 
Items: Recommendations for Interventional Trials (SPIRIT 2013)).  None of these 
guidelines provide any specific guidance for the assessment and reporting of treatment 
fidelity. However, some of the components on these checklists do overlap with the NIH 
BCC guidelines, for example intervention content and dose. More recently Hoffman et 
al. 2014 published the TIDieR checklist with the aim to improve the completeness of 
reporting and replicability of interventions. This 12-item checklist contains two items of 
treatment fidelity (11 and 12). These items are ambiguous and limited in their description 
stating that only if intervention fidelity was assessed it should be described and if assessed 
the extent to which it was delivered as planned should be reported. It is however 
encouraging that fidelity is being included in these new guidelines. The monitoring, 
assessment and reporting of treatment fidelity would greatly benefit from the 
development of more explicit and compulsory reporting guidelines in line with the NIH 
BCC guidelines.  
 
The inattention to treatment fidelity reported in this review may be due in part to the 
additional resources required to assess treatment fidelity. Assessing and monitoring 
fidelity requires increased time, equipment and personnel. This increased burden may 
concern researchers and funding agencies; Bellg et al. (2004) argue that not devoting these 
resources to treatment fidelity may be more costly in the longer term. Including a plan to 
assess and monitor treatment fidelity in a study can enhance the translation into clinical 
settings and reduce the likelihood of ambiguous results. Lawton et al.9S provide an 
example of the importance of monitoring treatment fidelity for reliable and valid results; 
the authors found that a worksite physical activity intervention delivered across five sites 
was only found to significantly increase physical activity levels in one site where it was 




   
 5.4.1 Limitations 
The actual documentation and reporting of fidelity within published papers was a central 
limitation to this review.  This may be due in part to restrictions on word count for journal 
publication. One way to overcome this issue is to provide online supplements so that the 
scientific community can access any additional information about the methods for 
assessing and monitoring treatment fidelity. 
 
Finally the mapping of the reported methods of fidelity to the domains of fidelity as set 
out by the NIH BCC was based on reviewers’ judgement. This may have led to some 
misclassification of methods; however attempts were made to reduce this as 
classifications were agreed by the two reviewers and regular meetings were held with a 
more experienced researcher throughout the process who was consulted when any 
disparity arouse. 
 
 5.5 Conclusion  
In this scoping review we identified that there remains an inconsistency and paucity 
across the literature for the defining and reporting of methods for treatment fidelity 
assessment and monitoring in complex interventions. We recommned that future 
researchers should use the definition proposed by Bellg et al. (2004)  A fidelity framework 
such as that published by Borrelli (2011) will support the comprehensive consideration 
and reporting of treatment fidelity in future research activities. The use of this checklist 
to embed fidelity into clinical trials will ultimately enhance the translation of research 







































   
Tables 
















Design of study: Treatment fidelity practices related to study design ensure that a 
study adequately tests its hypotheses in relation to its underlying theoretical and 
clinical processes.  
Training providers: Treatment fidelity involves assessing and improving the 
training of treatment providers to ensure that they have been satisfactorily trained 
to deliver the intervention to study participants. 
Delivery of treatment: Treatment fidelity processes that monitor and improve 
delivery of the intervention so that it is delivered as intended 
Receipt of treatment: Receipt of treatment involves processes that monitor and 
improve the ability of patients to understand and perform treatment-related 
behavioural skills and cognitive strategies during treatment delivery.  
Enactment of treatment skills: Enactment of treatment skills consists of processes 
to monitor and improve the ability of patients to perform treatment-related 
behavioural skills and cognitive strategies in relevant real-life settings.  
Definition: Treatment fidelity refers to the methodological strategies used to 
monitor and enhance the reliability and validity of behavioural interventions. It 
also refers to the methodological practices used to ensure that a research study 
reliably and validly tests a clinical intervention. 
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Table 5-3 Summary of results from scoping review 
 
Reference* Definition 1 2 3 4 5 Number of 
components 
Bailey et al. 
20151S 
No definition      1/5 
Beck et al. 
20152S 
Yes (Borrelli et al. 
2005) 
     4/5 
Casey et al. 
20153S 
No  definition      1/5 
Chesworth 
et al. 20154S 
Yes (Bellg et al. 2004)      1/5:  
Fortington 
et al. 20145S 
Yes ( Hansen 2013,  
Allen et al. 2012) 
     1/5  
French et al. 
20156S 
Yes (Bellg et al. 2004,  
Borrelli et al. 2005) 
     1/5  
Fulkerson et 
al. 20157S 
No  definition      1/5  
Hanbury et 
al. 20158S 
Yes (no reference)      1/5  
Lawton et 
al. 20159S 
Yes (Bellg et al. 2004,  
Oakley et al. 2006, 
Craig et al. 2008) 
     3/5  
Martin et al. 
201510S 




Yes (Craig et al. 
2008) 
     3/5  
Pawar et al. 
201512S 
No  definition      1/5  
Pincus  et 
al. 201513S 
No  definition      1/5  
Williams et 
al. 201514S 
No  definition      1/5  
Winnett et 
al. 201515S 
No  definition      5/5  
Wyatt et al. 
201516S 
Yes (Radziewicz et al. 
2009,  Calsyn  2000,  
Wyatt 2010) 
     4/5  
Avery et al. 
201417S 
Yes (Resnick et al. 
2005a) 
     2/5  
Baquero et 
al. 201418S 
Yes (no reference)      3/5   
Bryant et al. 
201419S 
Yes (Bellg et al. 2004)      2/5  
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Dewing et 
al. 201420S 
No definition      1/5  
Dyas et al. 
201421S 
Yes (Bruckenthal and 
Broderick 2009) 




Yes (Bellg et al. 2004)      2/5  
Kulwa et al. 
201423S 








No  definition      1/5  
Neilson et 
al. 201426S 
No  definition      2/5  
Presseau et 
al. 201427S 
Yes (no reference)      3/5  
Robbins et 
al. 201428S 
Yes (Linnan and 
Steckler 2002) 
     1/5  
Van 
Schijindel- 
Speet et al. 
201429S 
Yes (Baranowski et 
al. 2000,  Saunders et 
al. 2005, Glasgow 
2006) 




Yes (Glasgow et al. 
1999) 
     3/5  
Almas et al. 
201331S 
Yes (no reference)      1/5  
Bach et al. 
201332S 
No  definition      1/5  
Barber et al. 
201333S 
No  definition      2/5  
Benzo et al. 
201334S 




Yes (Fraser 2009)      1/5  
Branscum et 
al. 201336S 
Yes (no reference).      1/5  
Gabbay et 
al. 201337S 
No  definition      2/5   
Goode et al. 
201338S 




Yes (Bellg et al. 2004, 
Borrelli 2011) 
     1/5  
Mars et al. 
201340S 
Yes ( Bellg et al. 
2004) 
     1/5  
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Pfeiffer et 
al. 201341S 
No  definition      1/5  
Poston et al. 
201342S 
Yes (no reference)      1/5  
Scobbie et 
al.  201343S 
No  definition/      1/5  
Sears et al. 
201344S 
No  definition      2/5  
Seo et al. 
201345S 
No  definition      1/5  
Sternfield et 
al. 201346S 
No  definition      2/5  
Wilner et al. 
201347S 
Yes (Moncher and 
Prinz 1991) 
     1/4  
Zheng et al. 
201348S 
No  definition      1/5  
Bodde et al. 
201249S 
No  definition      1/5  
Broekhuize
n et al. 
201250S 
No definition      1/5  
Brookman-
Frazee et al. 
201251S 
No  definition      1/5  
Cate et al. 
201252S 




No  definition      1/5  
Faulkner et 
al. 201254S 
Yes (Bellg et al. 2004)      5/5  
Gallanter et 
al. 201255S 








Yes (Perepletchikova  
and Kazdin 2005,  
Sharpless and Barber 
2009) 
     1/5  
Hollands et 
al. 201258S 
No  definition      1/5  
Irvine et al. 
201259S 




Yes (no reference)      1/5  
Llewellyn et 
al. 201261S 
Yes (no reference).      3/5  
McCurry et 
al. 201262S 
No definition      3/5  
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*Reference list included in Appendix 20 
1=Study design 
2= Training of providers 
3=Delivery of treatment 
4= Receipt of treatment 

















Moore et al. 
201263S 
No definition      2/5  
Morganstrer
n et Al. 
201264S 
No definition      2/5  
Robbins et 
al. 201265S 
Yes (Bellg et al. 2004)      4/5  
97 
 
   
Chapter 6 - Assessment of the Fidelity of the LIVELY PAI 
 6.0 Chapter overview 
This chapter describes the methods used to assess the treatment fidelity and the results of 
the assessment of treatment fidelity of the LIVELY PAI (Chapter 3), utilising the Borrelii 
2011 checklist as a framework. The researchers who were involved in conducting this 
research and their roles are detailed in Table 6.1.  
 
Table 6-1 Role of members of study team 
Person  Role 
Orlagh O’Shea -Development of fidelity assessment 
protocol 
-Mapping of Borrelli (2011) checklist 
to the LIVELY intervention 
-Development of LIVELY specific 
checklists 
- Assessment of  practicality and 
acceptability of LIVELY specific 
checklists                                                             
-Fidelity assessment (primary rater) 
-Analysis and write up 
Dr Brenda O’Neill -Training of providers 
-Development of fidelity assessment 
protocol                                                  
-Mapping of Borrelli (2011) checklist 
to the LIVELY intervention 
-Development of checklists  LIVELY 
specific 
-Assessment of practicality and 
acceptability of  LIVELY specific 
checklists   
-Fidelity assessment (secondary rater)  
- Intellectual contribution to 
interpretation of results and write up of 
chapter  
Professor Judy Bradley -Training of providers 
-Development of fidelity assessment 
protocol      
-Provided mentorship to the providers 
throughout the intervention 
-Mapping of Borrelli (2011) checklist 
to the LIVELY intervention 
- Development of  LIVELY specific 
checklists  
-Assessment of practicality and 
acceptability of  LIVELY specific 
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checklists                                                                          
-Fidelity assessment (secondary rater)  
- Intellectual contribution to 
interpretation of results and write up of 
chapter  
Professor Suzanne McDonough -Training of providers 
-Development of fidelity assessment 
protocol      
-Provided mentorship to the providers 
throughout the intervention 
-Assessment of practicality and 
acceptability of  LIVELY specific 
checklists                                                                          
-Fidelity assessment (secondary rater)  
- Intellectual contribution to 
interpretation of results and write up of 
chapter 
Professor Madelynne Arden -Development of fidelity assessment 
protocol     
-Assessment of practicality and 
acceptability of  LIVELY specific 
checklists  
-Fidelity assessment (main secondary 
rater). 
- Intellectual contribution to 
interpretation of results 
 
6.1 Introduction 
There is no agreed definition for treatment fidelity (O’Shea et al. 2016). However 
treatment fidelity is frequently defined as the methodological strategies used to monitor 
and enhance the reliability and validity of behavioural interventions; it also includes the 
methodological practices used to ensure that a research study reliably and validly tests a 
clinical intervention (Bellg et al. 2004). The assessment and monitoring of treatment 
fidelity has been identified as an important and valuable process in research to ensure that 
an intervention is delivered as intended. Knowledge of how the intervention was 
delivered can also help to refine an intervention, and may aid the translation of 
interventions into clinical practice (Bellg et al 2004). Additionally the MRC guidelines 
have recommended evaluating treatment fidelity in complex interventions (Craig et al. 
2008).  The LIVELY COPD PAI is a complex behaviour change intervention with the 
potential to be delivered in clinical practice.  Furthermore the LIVELY PAI is part of the 
randomised controlled feasibility study in this thesis and has the capacity to be further 
tested in a future larger RCT.  Assessing the treatment fidelity of the LIVELY PAI was 
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therefore identified as key aim of the LIVELY COPD project. If fidelity is not monitored 
the results cannot be fully supported as it is possible that additional unplanned 
components were delivered without the researchers knowledge (Moncher and Prinz 
1991).   In addition to this the implementation of an intervention across multiple sites by 
multiple providers can increase the capacity for variation; the LIVELY PAI was delivered 
across six different sites by three different intervention providers. 
 
Treatment fidelity is a concept that often is neglected in the literature in general (Borrelli 
et al 2005, Dusenbury 2003, O’Shea et al. 2016) and in physiotherapy interventions 
specifically (Huijg et al. 2015, Toomey et al. 2014). Methods to assess and monitor the 
treatment fidelity of a complex intervention are also limited (O’Donnell 2008). For 
guidance on how the treatment fidelity of a PAI in the COPD population could be assessed 
we explored the literature on PAIs in COPD. Twenty papers that had been included in a 
recent review on PAIs in COPD by Wilson et al. 2014, were assessed using the TIDieR 
checklist. The TIDieR checklist is a 12 item checklist that was designed to “improve the 
completeness of reporting and ultimately the replicability of interventions.” This 
checklist contains two items (11 and 12) that specifically relate to the reporting of the 
fidelity of an intervention, (item 11: If intervention adherence of fidelity was assessed 
describe how and by whom, and if any strategies were used to maintain or improve 
fidelity describe them and item 12: If intervention adherence or fidelity was assessed, 
describe the extent to which it was delivered as planned).   Few studies in this review 
(n=3/20) met these criteria (Berry et al. 2010, Berry et al. 2003 and Tabak et al. 2014) 
(Appendix 22, summary table of results of assessment of studies included in a systematic 
review by Wilson et al. 2014 with the TIDieR checklist). These three papers only reported 
the following information in relation to fidelity; Berry et al. 2003 and Berry et al 2010 
explored participant compliance (the number of session completed versus the number of 
planned sessions) and Tabak et al. (2014) reported on a telehealth intervention and 
assessed the number of sessions participants logged onto the web portal to complete.  
None of these papers provided a procedure or framework for the assessment of fidelity 
that could be replicated, or provided guidance on how treatment fidelity could be assessed 
within the LIVELY PAI. 
 
Therefore with no available guidance from the COPD literature, a review was undertaken 
to identify the most common methods used to monitor fidelity in the wider literature. A 
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detailed report and the results of this review can be found elsewhere (Chapter 5). The 
conclusion of this review was that the checklist published by Borrelli 2011 could be used 
to support the assessment and reporting of treatment fidelity in future research (Appendix 
23, Blank Borrelli 2011 checklist). The Borrelli (2011) checklist was based on the best 
practice guidelines and recommendations published by the NIH BCC (Bellg et al. 2004).  
These guidelines outline five key domains for treatment fidelity (Chapter 5, Table 5.2), 
which have been used to inform the assessment, monitoring and enhancement of fidelity 
in a number of trials (Beck et al. 2015, Winnet et al. 2015, Wyatt et al. 2015, Presseau et 
al. 2014, Benzo et al 2013, Faulkner et al. 2012. Robbins et al. 2012, Robb et al. 2011, 
Radziewicz et al. 2009, Resnick et al. 2005b). The Borrelli (2011) checklist has further 
been used to assess the reporting of treatment fidelity in physiotherapy interventions to 
promote self-management of osteoarthritis and chronic low back pain (Toomey et al. 
2014). To the best of our knowledge the Borrelli (2011) checklist has never been used as 
a framework to assess the fidelity of an intervention. 
  
 6.1.1 Aim 
The aim of this chapter therefore, was to assess the fidelity of the LIVELY PAI. 
  6.1.2 Objectives  
(i) To develop a protocol to assess the fidelity of the LIVELY PAI using the 
Borelli (2011) checklist as a framework. 
(ii) To test the acceptability and practicality of tools developed within the 
protocol to assess different domains of treatment fidelity in the LIVELY 
intervention. 
(iii) To complete the fidelity assessment across all five domains (Chapter 5, 
Table 5.2).  
  
 6.2 Methods 
The LIVELY intervention took place between April 2014 and January 2016. The fidelity 
assessment of the LIVELY intervention commenced in October 2014 and was completed 
in July 2016.  A flow diagram of the methods can be found in Figure 6.1.  
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 Step 1 Mapping the Borrelli (2011) checklist to the LIVELY intervention 
including developing assessment tools specific for the LIVELY 
intervention 
During this step each item on the Borrelli (2011) checklist was considered in the context 
of the LIVELY COPD project as well as how the assessment could be satisfied or 
achieved. Some specific assessment tools and checklists were developed.  
1. Study design: The LIVELY study documents were to be reviewed to assess if the 
6 items on the Borrelli checklist were satisfied or how they could be further 
satisfied in the context of the LIVELY COPD project. The LIVELY study 
documents refer to the full study protocol, the grant application, the PAI file and 
minutes of all study meetings.  A plan was also set out to assess the treatment dose 
of PR (the comparison condition) at each site (Appendix 24, Pulmonary 
Rehabilitation check form for all sites included in the LIVELY COPD project). 
The methods for mapping the study design items to the LIVELY project are 
available in Table 6.2.  
2. Training of providers: A specific training procedure and materials were 
designed for the LIVELY study. These training materials, in addition to the study 
documents were to be reviewed to assess if items on the Borrelli (2011) checklist 
were satisfied in the context of the LIVELY study. Where the protocol could not 
provide enough detail to fulfill the criteria for an item on the checklist, additional 
resources or tools were developed. For example a questionniare to assess whether 
the participants felt the training plan took into account their different education, 
experience and learning styles was developed (Appendix 25, Evaluation of 
training of providers for the delivery of the LIVELY PAI- provider feedback 
evaluation questionnaire); intervention providers were mentored throughout the 
programme as part of training and a report on how this mentorship took place was 
obtained from the mentors. The mapping of all items under training of providers 
for the LIVELY COPD project is included in Table 6.3. 
3. Delivery of treatment:  “The gold standard to ensure satisfactory delivery is to 
evaluate or code intervention sessions (observed in vivo or video- or audiotaped) 
according to a priori criteria (Bellg et al. 2004).” It was planned to audio record 
all consultations (i.e.1-12) with two participants from each of the 3 providers. The 
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a priori criteria were in accordance with the BCSs that were specifically 
considered in the LIVELY PAI (Appendix 26, List of original Behaviour Change 
Strategies for the LIVELY PAI, on CD-ROM) as well as the consultation schedule 
for each consultation. The BCSs were mapped specifically to the consultation they 
were planned to be delivered in and checklists were made for each consultation to 
record the assessment of delivery. The consultation schedule was found at the start 
of each consultation plan and this informed the layout of the template for providers 
to record their consultation notes. The delivery checklists contained check boxes 
to record if a component was delivered and space to document notes. The 
components to be delivered throughout consultation 3-11 (with the exception of 
consultation 5) were the same; a single checklist was created for these and 
additional delivery checklist created for consultations 1,2,5 and 12 (Appendix 27, 
Original delivery checklists developed specifically for the assessment of fidelity 
of the LIVELY PAI, on CD-ROM). The audio recordings and intervention 
provider notes of consultations were to be used to assess delivery. Table 6.4 
summarises the method for mapping of items under delivery treatment to the 
LIVELY PAI. 
4. Receipt of treatment: There are 5 distinct items in the Borrelli checklist on 
receipt. To assess how these items could be fulfilled the LIVELY study documents 
were reviewed (Table 6.5). Elements of the LIVELY study protocol that matched 
these criteria were mapped to the consultations they were planned to be received 
in by the participant, and a single checklist was developed (Appendix 28, Original 
receipt checklist developed specifically for the assessment of fidelity of the 
LIVLEY PAI, on CD-ROM) to enable the full assessment of receipt. To formally 
assess receipt; the audio recordings and intervention provider consultation notes 
were to be reviewed with the receipt checklist.  
5. Enactment of treatment: There are two items under enactment on the Borrelli 
(2011) checklist. The LIVELY study documents were reviewed to plan how 
enactment was to be assessed throughout the LIVELY PAI. An enactment 
checklist was developed to enable the full assessment of this domain (Appendix 
29, Original enactment checklist developed specifically for the assessment of 
fidelity of the LIVELY PAI, on CD-ROM) (Table 6.6). Enactment was to be 
assessed by reviewing the audio recordings and provider consultation notes 
against the checklist.  
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 Step 2: Testing the practicality and acceptability of the assessment tools 
for delivery, receipt and enactment with the research team 
In this part of our methods we explored the practicality and acceptability of the checklists 
developed in step 1 to assess delivery, receipt and enactment. Audio recordings and 
consultation notes for one patient (C124) were chosen randomly to assess the practicality 
and acceptability of the delivery, receipt and enactment checklists that had been 
developed specifically for the LIVLEY PAI. All members of the team were involved in 
this stage. All checklists were assessed by at least two researchers to assess consistency.  
The consultations were divided among the team pragmatically: SMcD: consultation 1 and 
2, BO’N: consultation 5 and 7, JB: consultations 6 and 12, and MA: consultations 5 and 
12; and the primary researcher OO’S assessed all consultations. Each member was given 
access to the audio recordings and provider notes (all of which were anonymised for this 
patient).  
 
The team met in January 2016 to discuss how the checklists developed during step 1 
worked in practice. A number of amendments were made to the checklists following 
recommendations from this meeting for example, changes to the layout and wording were 
made to promote clarity such as “action plan and barriers discussed,” was amended split 
into “Action and coping plan completed,” and “barriers discussed.”. The amended 
checklists were reviewed and finalised by the team. All updated checklists can be found 
in the Appendices 30-32 (Appendix 30, Amended delivery checklist developed 
specifically for the assessment of fidelity of the LIVELY PAI, Appendix 31, Amended 
Receipt checklist developed specifically for the assessment of fidelity of the LIVELY 
PAI, Appendix 32, Amended enactment checklist developed specifically for the 
assessment of fidelity of the LIVELY PAI).  
 
 Step 3: Completing the assessment of the LIVELY intervention  
1. Study design: The Borelli (2011) checklist was populated with information 
obtained from the LIVELY study documents and the self-check questionnaire was 
completed by all PR sites The PR self-check was conducted in February 2015.  
2. Training of providers: The Borelli (2011) checklist was populated with 
information obtained from the LIVELY study documents. The questionnaire to 
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assess if the providers felt the training took into account their individual training 
needs, education and learning styles was circulated in February 2015 prior to 
training day five.  The mentors (JB and SMcD) provided the report on mentorship 
in June 2016. 
3. Delivery of treatment: The Borelli (2011) checklist was populated with 
information obtained from the LIVELY study documents. Based on the 
availability of recordings we adopted a pragmatic approach and assessed delivery 
by each provider across the entire intervention to one participant (i.e. 
consultations 1-12 from each provider to a single participant). These were chosen 
based upon the most complete set of recordings by provider for a single patient. 
We therefore assessed 16.3% (n=36/221) of all consultations.  
 
Each consultation was assessed by two members of the team; OO’S as the primary 
rater and one other (secondary rater (MA)).  Details can be found in Table 6.7.  
The primary rater and secondary rater assessed the consultations separately and 
then met to discuss their findings. If any disparities arose the rater notes and audio 
recordings were revisited for supporting evidence. 
 
To summarise the findings of delivery, fidelity was defined as the number times 
a component was delivered by each provider compared to the planned protocol. 
These were then expressed as a percentage and a mean overall value for each 
component was obtained. There was a discussion among the research team of 
what percentage of components on the delivery checklists should be adhered to; 
an ”a priori specification of treatment fidelity.” It was decided that in line with 
current recommendations (Borrelli et al. 2005) providers should adhere to greater 
than 80% to be considered high treatment fidelity.   
4. Receipt of treatment: Receipt was assessed by the research team as outlined in 
Table 6.7. The findings of the assessment between the primary and secondary 
rater(s) were discussed and if any disparities arouse the audio recordings or 
provider notes were revisited for supporting evidence.  It was then recorded how 
many times a component was actually received versus how many times it was 
planned from each participant; these values were expressed as a percentage and 
mean overall value for each component was then obtained.  
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5. Enactment of treatment: For the assessment of enactment the consultations were 
assessed by the team as detailed in Table 6.7. The primary and secondary rater(s) 
then discussed their findings and any differences were further explored by 
reviewing the audio recordings or provider notes. The number of times a 
component enacted by each participant was recorded and expressed as a 
percentage of the number of times it was planned to be enacted. 
 6.3 Results  
 Results of testing acceptability and practicality of delivery, receipt and 
enactment checklists 
The checklists were amended as a result of testing the acceptability and practicality of the 
checklist. The list of BCSs was also amended under the guidance of health psychologist 
MA. For example; “Plan coping behaviour using action /coping plan,” was removed as it 
was felt this was already covered under “Plan behaviour using action and coping plan.” 
One item “Reviewing overall SMART goal,” was added to the list. The items “Reward 
self,” and “If goals are met increase and reward success,” were combined and changed to 
“Reward success or effort.” The updated list of BCSs can be found in (Appendix 6, 
Amended list of Behaviour Change Strategies included in the LIVELY PAI).  Changes 
to wording or grammar were also made to some checklists increase clarity in for example 
in checklist 3-11 “action plan and barriers discussed,” was changed to (i) “action and 
coping plan completed,” and (ii) “barriers discussed.”  
Members of the team also had queries regarding the receipt and enactment checklists. For 
example; “discuss benefits to PA” was an item on both the delivery and receipt checklists. 
It was clarified that in delivery the emphasis is on the provider, however in relation to 
receipt the focus is on the participant; to fulfill this criteria, the rater is assessing the 
patient’s involvement in this discussion. Changes were also made to the receipt checklist, 
for example; “stages of change and additional strategies” was removed as a strategy to 
improve participant performance of the intervention skills in settings during the 
intervention period as it was not deemed relevant. Furthermore there was some confusion 
regarding the differentiation between the two items under enactment on the Borrelli 
(2011) checklist. The author (Dr. Borrelli) was contacted to seek increased clarity around 
this. We were provided with three articles (Borrelli et al. 2005, Campbell et al. 2005 and 
106 
 
   
Borrelli 2011). Based on recommendations from these articles the enactment checklist 
was revised to better reflect the criteria of enactment. 
 
All the original checklist and amended checklists developed specifically for the 
assessment of fidelity of the LIVELY PAI can be found in the appendices demonstrating 
the full extent of changes (Original Checklists on CD-ROM: Appendix 27 Original 
delivery checklist, Appendix 28 Original receipt checklist, Appendix 29 Original 
enactment checklist; Amended Checklists: Appendix 30, Amended delivery checklist, 
Appendix 31 Amended receipt checklist, Appendix 32,  Amended enactment checklist). 
 
 Results of the assessment of the fidelity of the LIVELY PAI utilising the 
finalised assessment process and tools. 
 
1. Study design: The LIVELY COPD project fulfilled almost all items (5/6) on the 
Borrelli checklist under study design, as detailed in Table 6.8. As this was a 
feasibility study potential confounders (item 5) that may have limited our ability 
to make conclusions at the end of the trial were not identified so this criterion 
could not be fulfilled. The full results of the PR self-check can be found in the 
appendices (Appendix 33, Results of the pulmonary rehabilitation check of sites 
included in the LIVELY COPD project, on CD-ROM). 
 
2. Training of providers: The results of the training of providers as per the Borelli 
(2011) checklist can be found in Table 6.9. All 7 items under this domain were 
met in the LIVELY COPD project. A description of how the trainers were to be 
trained was set out from the outset. An examination of the described training plan 
(Appendix 5, PAI file, section, 9, Training, on CD-ROM) found some minor 
discrepancies between the planned and actual training of providers. The first 3 
sessions were conducted as planned. It was planned to have a training session 
every 6 months thereafter but the 4th session was conducted 4 months later and 
the 5th, 6 months thereafter. The final participant completed the study seven 
months following the training day 5 with no further formal training having been 
conducted in this period.  The actual training conducted reflected the recruitment 
rates to the LIVELY PAI.  
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Providers were mentored by experienced members of the LIVELY study team 
throughout the whole study. Each week there was contact between the mentor and 
provider before and after each consultation. They discussed the consultation plan 
prior to the consultation and after the consultation they discussed if any problems 
arose during the consultation. As a result of this contact process changes were 
made to the template for intervention provider notes to provide additional 
guidance for the providers and clarity in their notes.  As the intervention 
progressed this communication took place via email with the option of phone call 
discussions if necessary. In some cases the weekly contact was reduced due to 
annual leave. 
 
A feedback evaluation questionnaire to evaluate whether providers felt the 
training plan that took into account their different education and experience and 
learning styles was administered to the providers (n=3) prior to training day 4. 
The evaluation of training was very positive, with all respondents agreeing (n=2) 
or strongly agreeing (n=1) that the early training was adequate to prepare them to 
start the intervention and that the on-going training was regular enough. They also 
agreed (n=2) or strongly agreed (n=1) that the training accounted for their 
individual learning styles, experience and education. Feedback and suggestions 
regarding future training (for example the use of real case studies from the 
LIVELY PAI) was taken into consideration and incorporated into the later 
training sessions. 
 
3. Delivery of treatment: The results of the assessment of delivery of the LIVELY 
PAI with the Borrelli (2011) checklist can be found in Table 6.10. Eight of the 
nine items under this domain were met. In some instances the duration of the 
intervention was either shorter or longer than the planned 12 weeks; mean 
duration 12.7 (SD:2); range; 9.3-17 weeks. The following item under this domain 
was not met; “nonspecific treatment effects,” were not considered for the LIVELY 
PAI. However the remaining eight items were fulfilled, additional procedures had 
been put in place to fulfill these criteria through the audio taping of consultations 




   
The devised plan for audio recording consultations was revised during the study 
due to drop outs and refusal of consent by a participant. Therefore providers were 
subsequently instructed to record all remaining consultations to ensure there were 
a sufficient number of audio recordings available to assess delivery of the PAI. 
There were a total of 221 consultations conducted; 34% (n=75) of these were 
completed before the fidelity protocol was finalised, a further 16.3% (n=36) were 
not recorded due to changes to the fidelity protocol, one participant declined to be 
audio recorded therefore their twelve consultations (5.4%) were not recorded and 
8.1% (n=18) were not recorded due to errors (recorder, provider and researcher 
error). Therefore, 80 consultations (36.2%) were recorded. In total 36 
consultations were assessed (16.3%); 14% had an audio recording available to 
assess the delivery, receipt and enactment of the intervention; the further n=5 
(2.3%) consultations were assessed by reviewing the clinician notes only, as 
recordings were not available due to error. A summary report on all recordings is 
available in the appendices (Appendix 34, Summary of available recordings of 
LIVELY PAI consultations). 
 
Nine of the 20 BCSs were delivered 100% of the time. A further n=5 were 
delivered on >80% of intended occasions.  Of the remaining BCSs n=4 were 
delivered  between 50-80% of occasions and n=2 were delivered on <50% of 
planned occasions, (i.e. the clinician encouraging social support (walking with 
family or friends or walking to someone) and the certificate of achievement were 
delivered with the lowest level of fidelity 48.5% and 33.3% respectively). The 
results of the assessment of delivery of these BCSs are summarised below in Table 
6.11.  Provider 2 was the least consistent in delivering the BCSs per protocol; 
delivering eight components with sub optimal fidelity (<80% of the times) 
compared to four by the other providers. 
 
Nearly all of the components from the consultation schedule were delivered with 
>80% fidelity and only n=1 component was delivered with <80% fidelity, (i.e. the 
component “Remind patient of the goal of the programme” was only delivered on 
66.6% of planned occasions). These results are summarised in Table 6.12. The 




   
 
4. Receipt of treatment: Receipt is assessed under 5 separate items on the Borrelli 
(2011) checklist. The population of Borrelli (2011) checklist for the receipt of 
treatment is available in Table 6.13. The results of the assessment of receipt by 
item are detailed: 
(1) “There is an assessment of the degree to which participants understand 
the intervention”: The familiarisation week assessed the participants’ 
understanding of the intervention to some degree, whereby the 
participants were given an opportunity to practice recording their daily 
steps from the pedometer in the step diary. This was received by all 
participants. 
(2) “There are specification strategies that will be used to improve participant 
comprehension of the intervention”: There were nine strategies noted 
under this item. Seven of these strategies were received on 100% of 
occasions. The educational component was only received with 83.3% 
fidelity; one participant received 50% of the education. A recap on the 
benefits of PA was to be received by patients at consultations 3-11; this 
was received with 33.3% fidelity. Participant 1 and 2 received it on 22.2% 
of occasions and participant 3 on 55.5% of occasions.  
(3) “The participants’ ability to perform the intervention skills will be 
assessed during the intervention process”: All the components under this 
item were received with 100% fidelity. One method which was used to 
assess the participants’ ability to perform the skills was the use of the 
pedometer and step diary, the step diaries were not copied to the research 
team and this could therefore not be assessed. The pedometer was 
consistently used throughout the intervention and this component was 
deemed to be received with 100% fidelity. 
(4) “A strategy will be used to improve participant performance of 
intervention skills during the intervention period”: Six strategies were 
included in the LIVELY PAI under this item. All strategies except for one 
were received on 100% of occasions; Providers were to help the 
participants identify strategies from the previous week that enabled them 
to do more walking so as they can better perform the intervention skills in 
the coming weeks. This was only received on 90% of occasions for 
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participant 1 and 40% for participant 2; it was received 100% of occasions 
for the third participant. 
(5) “Multicultural factors considered in the development and delivery of the 
intervention”: This item was only relevant to participant 2. These factors 
were taken into consideration when planning the delivery of the 
intervention to this individual.  
These results are summarised in Table 6.14 
5. Enactment of treatment:  There are two items under enactment on the Borrelli 
checklist. A summary of how this checklist was populated is available in Table 
6.15. 
(1) Participant performance of the intervention skills will be assessed in 
settings in which the intervention might be applied. The first week of the 
intervention was a familiarisation week. Participants were given their 
pedometer and step diary, only to record their daily steps. There was some 
mismatch between the step diary and the seven day pedometer recall; this 
was only enacted on 50% occasions and due to unforeseen circumstances 
this could not be assessed for one participant as there were five weeks 
between their first and second consultation. Providers were required to 
review the extent to which the participant followed their action plan to 
assess enactment; this was completed on 70% of occasions. Provider 1 
assessed this on 90% of occasions and providers 2 and 3 assessed this on 
60% of occasions. 
(2) A strategy will be used to assess performance of the intervention skills in 
settings in which the intervention might be applied. All components under 
this item were enacted with 100% fidelity across the intervention.  
 
Results of the assessment of enactment from the audio and provider notes 
are available in Table 6.16. 
 
 6.4 Discussion 
This chapter describes a working example for assessing the fidelity of a PAI for people 
with COPD using the Borrelli checklist (2011).  The overall aim of this chapter was to 
assess the fidelity of the LIVELY PAI. This was achieved by firstly mapping the items 
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on the Borrelli (2011) checklists to the LIVELY PAI, and developing specific checklists 
and procedures to satisfy these items, secondly testing the acceptability and practicality 
of these checklists and finally by applying all processes to complete the assessment of 
fidelity of the LIVELY PAI.  The fidelity of the LIVELY PAI was high. However this is 
a novel piece of research and a number of key lessons were learned during process. 
Specifically, fidelity should be considered in the design phase of a study to ensure that all 
aspects can be fully assessed. 
 
The Borrelli (2011) checklist is user friendly, with detailed rationale provided for each 
item. Further guidance on how to fulfill each item can be found in Bellg et al. 2004. 
However, we did need to develop further checklists to allow us to determine whether we 
fully met criteria on the checklists. The assessment of training of providers, delivery, 
receipt and enactment were more challenging than the assessment of study design as most 
of the study design detail was included in the protocol. Finally we did require further 
clarification for the items under the domain of enactment from the author (Borrelli 2011). 
 
Study design is a domain in treatment fidelity that is frequently omitted from fidelity 
assessment (O’Shea et al. 2016). In the current trial all items under study design in the 
Borrelli (2011) checklist were examined except for one; “potential confounders that limit 
the ability to make conclusions at the end of the trial,” were not identified.  These were 
not identified as the LIVELY COPD project is a feasibility trial; we did not aim to make 
conclusions regarding the effectiveness of the intervention and instead aimed to report on 
the feasibility of this trail.  By definition a feasibility study is “a test of the methods and 
procedures to be used on a larger scale,” (Last 2001). Therefore it can be argued that the 
purpose of a feasibility trial is used to identify potential confounders before progressing 
to a larger scale trial and “identifying potential confounders that limit the ability to make 
conclusions at the end of the trial,” is not an applicable criterion for feasibility trials. 
 
Borrelli et al. 2005 stated that, inattention to any one of the categories of treatment fidelity 
could compromise the internal validity of the study despite adherence to the other 
categories. This is particularly relevant to the training of providers in the current fidelity 
assessment.  All items for the training of providers on the Borrelli (2011) checklist were 
met. One provider did not attend the first two training sessions due to unforeseen 
circumstances; while attempts were made to compensate for this through individual 
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training, the result of this missed training may have impacted on the delivery of the 
intervention. One provider delivered the BCSs with less fidelity compared to the other 
two providers; eight of the BCSs were delivered with <80% fidelity compared to four by 
providers 1 and 3. In addition, the items on the consultation plan were delivered with the 
lowest level of fidelity by this provider (n=4 delivered with <80% fidelity). Our 
assessment of delivery was limited to 16.3% of all consultations; stronger conclusions 
could be drawn regarding this should a greater number of consultations have been 
assessed.   
 
Overall the assessment of delivery conducted in the current study demonstrated nearly all 
components of the intervention were delivered with high fidelity (>80%). Components of 
the intervention comprised of BCSs and the components on the consultation schedule; 
70% (n=14/20) of BCSs were delivered with high fidelity and 96.7% (n=29/30) of 
components on the consultation schedule were delivered with high fidelity. Only two 
(10%) of the 20 prescribed BCSs were delivered with low fidelity (<50%) 
(Perepletchikova and Kazdin 2005) and four were delivered with moderate fidelity (50-
80%). Researchers have indicated that <50% is low fidelity (Perepletchikova and Kazdin 
2005) and >80% is considered high fidelity (Borrelli et al 2005); it is therefore reasonable 
to consider 50-80% as moderate fidelity. There is lack of consistency in the assessment 
and reporting of fidelity in the current literature (O’Shea et al. 2016) making it difficult 
to draw comparisons between our results and others. However French et al. 2015 explored 
the fidelity of an educational intervention to improve GP management of low back; they 
reported that only 57% (4/7) BCSs were delivered with high fidelity and no BCSs in this 
trial were delivered with low fidelity (<50%).  
 
In an attempt to understand why 10% (n=2/20) of BCSs in the LIVELY PAI were 
delivered with low fidelity, we reviewed the training materials of the LIVELY PAI. 
Providers in the LIVELY PAI were trained to deliver all BCSs with the exception of 
“certificate of achievement”. This was not included in the training and was only delivered 
with 33.3% fidelity. Additionally the BCS “Clinician encourages social support, walking 
with friends/family or walking to meet somebody etc.,” was also poorly delivered 
(48.5%). This BCS was to be delivered in consultations 2-12. Encouraging social support 
for all participants each week may not have been appropriate for all participants, for 
example, those who were more isolated or preferred to complete their PA alone. It is 
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possible the providers delivering the current PAI somewhat tailored the BCSs to each 
participants needs each week. A recent publication from Procter et al. (2014) reported 
that if an intervention is employing BCSs, a sufficient number of strategies should be 
included such that the BCSs in the intervention can be tailored to each participant’s needs. 
A future trial should consider increasing the number of BCSs included to allow for 
adaption to each individual and potentially increase the fidelity of the intervention.  
 
The domains of receipt and enactment shift the focus from the provider and to the 
participant. Measuring fidelity in these domains is of particular importance as patients are 
increasingly regarded as active participants in healthcare rather than passive (Newman et 
al. 2008), with a strong focus on self-efficacy in chronic conditions (Lorig et al. 2003). 
Despite this, these domains are not routinely assessed in the current literature (O’Shea et 
al. 2016). The LIVELY PAI had a strong emphasis on promoting self-efficacy and 
incorporated a number of strategies to allow for assessment of receipt and enactment 
including the use of and training to use a pedometer, an activity diary, goal setting, 
provision of feedback to participants and problem solving to develop strategies to 
overcome barriers (Bellg et al. 2004). In the assessment of receipt, only three components 
were not fully received; the educational component (83.3% (5/6)), a recap on benefits of 
physical activity (33.3% (n=9/27)) and identifying strategies from the previous week that 
worked do more walking (76.6% (n=23/30)). There are currently no thresholds to 
determine how to define receipt treatment; in the LIVELY PAI a number of key strategies 
were included to enhance receipt and in our assessment nearly all of these were received. 
Future research should aim to develop a tool to assess and define the receipt of a PAI. In 
our assessment of enactment we attempted to address each item on the Borrelli (2011) 
checklist. The items to assess enactment in the Borrelli (2011) checklist were difficult to 
define in the context of the LIVELY PAI.  It can be argued that the use of a pedometer 
satisfies the assessment of enactment as it allows for the assessment of a specific 
behavioural skill and motivational state (reaching step goals) in an appropriate setting 
(the participants own environment) (Bellg et al. 2004). This demonstrates the need for a 
more specific fidelity checklist for PAIs. 
 
 6.4.1 Limitations 
Although executed systematically, this research is not without its limitations. Firstly the 
LIVELY PAI had already commenced prior to the development of the fidelity assessment 
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protocol. This limited our assessment of fidelity under some of the domains.  For example 
the domain training of providers recommends that all providers are certified to deliver the 
intervention; this can be done through observing the provider delivering the intervention 
(either directly or with a video/audiotape) with a pilot patient and scoring them against 
pre-set criteria, providers must reach a minimum score before they are certified to deliver 
the intervention. Following certification between 20-50% of consultations should be 
reviewed and if the provider falls below a certain level of competency then additional 
training and feedback are required (Borrelli 2011). This certification was not done in the 
current study, planning for the assessment of fidelity prior to starting the intervention 
would ensure that such procedures are included. Previous authors have implemented these 
procedures, for example providers in a study conducted by Sears et al. 2013 had to reach 
90% fidelity before they could implement the intervention and if they fell below 80% 
during the intervention they received additional training. Although the regular mentorship 
of providers in the LIVELY PAI, may have helped prevent any drift in skills. Future 
studies should include these strategies. Checklists to certify and monitor providers can be 
developed specific to the intervention or existing standardised checklists are available 
which can be used if applicable to the intervention for example the motivational 
interviewing skills code (Miller and Mont 2001) and the Behaviour Change Counselling 
Index (Lane et al. 2005). 
 
The delay between commencing the intervention and the implementation of the fidelity 
assessment protocol also limited the number of audio recordings available for assessment. 
One third (n=75/221) of the consultations were conducted before the protocol for fidelity 
was implemented; the consultations that were recorded and used to assess fidelity were 
delivered in the latter part of the study. Assessing consultations that occurred earlier in 
the intervention would have allowed us to determine whether the providers were 
becoming more skilled in delivering the intervention over time or whether there was any 
drift in their skills and whether this had an impact on the participants receipt and 
enactment of treatment skills.  
 
 6.4.2 Lessons learned 
The assessment of fidelity of the LIVELY PAI was novel and a number of key areas have 
been identified that should be addressed in a future study (Table 6.17). Some of the 
consultation recordings were lost due to recorder error, provider error and researcher 
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error; a future study should include processes that require the providers to check the 
recorder operating prior to the delivering the consultation, for example that it is charged 
and ready for use and all audio recordings should be sent to the research team within 24 
hours of delivering the consultation. Additionally, using a yes/no tick box to assess 
delivery of the items did not reflect the quality of the delivery. A Likert scale rating the 
quality of the delivery could offer a stronger measure of how well the intervention was 
delivered per protocol. Borrelli (2011) considered this, but felt that the use of such a scale 
would introduce an element of subjectivity, making it difficult to suggest a valid 
conclusion.  The use of two raters to assess delivery and clearly defining the criteria for 
each point on the scale would help eliminate any subjectivity. Previous authors have used 
a Likert scale to assess delivery; Bryant et al. (2014) assessed specific provider 
behaviours during their delivery and rated these on a 5 point like scale.  
 
Assessing treatment fidelity is a time consuming and resource intense process. Once it 
was decided to use the Borrelli (2011) checklist as a framework for assessing fidelity, a 
considerable amount of time was spent planning the methods for the assessment of fidelity 
in the LIVELY PAI. Furthermore, time was spent reviewing the LIVELY PAI documents 
and mapping these to the specific consultations for the delivery, receipt and enactment 
checklists; these checklists were also assessed for practicality and acceptability before 
they were used in the rest of the study. Finally, conducting the assessment of fidelity 
required further time; the mean (SD) length of time for face to face consultations was 
49.8(8.9) and 19.5 (2.8) minutes. In total 19 face to face audio recordings and 12 
telephone audio recordings of consultations were assessed independently by two raters, 
and additionally paper based records for 5 consultations were reviewed (the recordings 
for these consultations were not obtained).  This was a considerably time consuming 
process. The results were then synthesised and reported. Despite this lengthy and time 
consuming process, the assessment of fidelity was an invaluable process and future 
research should allocate appropriate time and funding to the assessment of fidelity.   
 
Finally our fidelity assessment revealed that the components that were listed on the 
consultation schedule were delivered with higher fidelity than the BCSs; 96.7% (n=30/31) 
components on the consultation schedule compared to 70% (n=14/20) of BCTs were 
delivered with >80% fidelity. It is likely that the components on the consultation schedule 
were delivered with higher fidelity as the list of these was located at the beginning of each 
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consultation in the layout of the template so that providers could record their consultation 
notes. This structure also informed the layout and flow of the consulutation. The inclusion 
of the list of BCSs in the consultation schedule should be considered in a future trial to 
enhance the delivery of these. 
 
 6.5 Conclusion 
Overall the fidelity of the LIVELY PAI was high. The assessment of fidelity is 
challenging with limited guidance on the specific procedures to use. This novel piece of 
research provides a working example using the Borrelli (2011) checklist for the 
assessment of fidelity. There were some limitations of our assessment of treatment 
fidelity and a number of key lessons have been learned regarding the process for assessing 













































































Step 1: Mapping the Borrelli (2011) checklist to 
the LIVELY intervention; including developing 
assessment tools specific for the LIVELY 
intervention (Objective 1). 
Step 2:  Testing the acceptability and practicality of 
the assessment tools for delivery, receipt and 
enactment with the research team (Objective 2). 
Step 3:  Completing the fidelity assessment of the 
LIVELY intervention (Objective 3). 
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Tables 
 
Table 6-2 Proposed methods for mapping Borelli (2011) study design items to the 
LIVELY project 
Borrelli (2011) checklist item How this item is going to be achieved in 
the LIVELY project 
 
1. Provider information about treatment dose in the intervention condition 
A. Length of contact (minutes) Review of study documents*. 
B. Number of contacts Review of study documents. 
C. Content of treatment Review of study documents. 
D. Duration of contact over time Review of study documents. 
2. Provide information about treatment dose in the comparison condition 
A. Length of contact (minutes) Check of PR sites; self-reported. 
B. Number of contacts Check of PR sites; self-reported. 
C. Content of treatment Check of PR sites. self-reported. 
D. Duration of contact over time Check of PR sites. self-reported. 
E. Method to ensure dose equivalent 
between conditions 
Review of study protocol and self-
reported check of PR sites. 
F. Method to ensure dose is 
equivalent for participants within 
conditions 
Review of study protocol and audit of 
PR sites. 
3. Specification of provider credentials that are needed 
Exploration of study protocol.  
4. Theoretical model upon which the intervention is based is clearly 
articulated 
 
A. The active ingredient are specified 
and incorporated in the intervention 
Review of study documents. 
B. Use of experts or protocol review 
group to determine whether the 
intervention protocol reflects the 
underlying theoretical model or 
clinical guidelines 
 Review of team. 
C. Plan to ensure that the measures 
reflect the hypothesise theoretical 
constructs/mechanisms of action 
Review of study documents. 
5. Potential confounders that limit the ability to make conclusions at the end 
of the trial are identified.   
Consensus among research team. 
6. Plan to address possible setbacks in implementation (i.e. back-up systems 
or providers)  






* study documents refers to the full study protocol, the grant application, the 




   
Table 6-3 Proposed methods for mapping Borrelli (2011) training of providers items to 
the LIVELY project 
Borrelli (2011) checklist item How this item is going to be achieved 
in the LIVELY project 
1. Description of how providers will 
be trained (manual of training 
procedures)   
Review of the training materials. 
2. Standardisation of provider 
training (especially if multiple 
waves of training are needed for 
multiple groups of  providers) 
Review of the training materials. 
3. Assessment of provider skill 
acquisition 
Review of the training materials and 
of mentorship telephone calls.  
4. Assessment and monitoring of 
provider skill maintenance over 
time 
Review of the training materials and 
weekly mentorship telephone calls. 
5. Characteristics being sought in a 
treatment provider are articulated 
a priori. Characteristics that 
should be avoided in a treatment 
provider are articulated a priori 
Review of study documents. * 
6. At the hiring stage, assessment of 
whether or not there is a good fit 
between the provider and the 
intervention (e.g. ensure that 
providers find the intervention 
acceptable, credible and 
potentially efficacious) 
Discussion among study team. 
7. There is a training plan that takes 
into account trainees different 
education and experience and 
learning styles 
Review training materials and a 
questionnaire to assess if the providers 
felt the training plan took into account 
their different education and learning 
styles was developed (Appendix 25, 
Evaluation of training of providers for 
the delivery of the LIVELY PAI- 
Provider feedback evaluation 
questionnaire,).  
   * study documents refers to the full study protocol, the grant application, the 
PAI  and minutes of all study meetings 
Table 6-4 Proposed methods for mapping Borrelli (2011) delivery of treatment items to 
the LIVELY project 
Borrelli (2011) checklist item How this item is going to be achieved in 
the LIVELY project 
1.Method ensure that the content of 
the intervention is delivered as 
specified 
Review of study documents*, assessment 
of audio recordings of consultations and 
provider notes with specifically 
developed checklists for LIVELY and 
mentorship programme.  
2. Method to ensure the dose of the 
intervention is delivered as specified 




   
3. Mechanism to assess if the 
provider actually adhere to the 
intervention plan  
Plan for audio recording and provider 
notes with LIVELY specifically 
developed checklists for assessment of 
delivery created from review of study 
materials.  
4. Assessment of nonspecific 
treatment affects 
Discussion with research team. 
5. Use of treatment manual Review of study documents.  
6.There is a plan for the assessment 
whether or not the active ingredient 
was delivered 
Plan for audio recording and a LIVELY 
specific checklist for assessment of 
delivery created.  
7.There is a plan for the  assessment 
of whether or not the proscribed 
components were delivered (e.g. 
components that are unnecessary or 
unhelpful) 
Discussion with research team. 
8.There is a plan for how 
contamination between conditions 
will be prevented 
Review of study documents.  
9.There is a priori specification of 
treatment fidelity (e.g. providers 
adhere to >80% of components) 
Discussion with research team. 
* study documents refers to the full study protocol, the grant application and minutes of 
all study meetings 
Table 6-5 Proposed methods for mapping Borrelli receipt (2011) of treatment items to 
the LIVELY project 
Borrelli (2011) checklist item How this item is going to be achieved in 
the LIVELY project 
1. There is an assessment of the 
degree to which participants 
understand the intervention. 
The study documents* were reviewed 
and a LIVELY specific checklist created.   
2. There are specification strategies 
that will be used to improve 
participant comprehension of the 
intervention. 
The study documents were reviewed and 
a LIVELY specific checklist created.  
3. The participants’ ability to perform 
the intervention skills will be assessed 
during the intervention process. 
The study documents were reviewed and 
a LIVELY specific checklist created.  
4.A strategy will be used to improve 
participants performance of 
intervention skills during the 
intervention period 
The study documents were reviewed and 
a LIVELY specific checklist created.  
5.multicultural factors are considered 
in the development and delivery of 
the intervention   
The study protocol was reviewed.  
* study documents refers to the full study protocol, the grant application, the PAI file 





   
Table 6-6 Proposed methods for mapping Borrelli enactment (2011) of treatment items 
to the LIVELY project 
Borrelli (2011) checklist item How this item is going to be achieved in 
the LIVELY project 
1. Participant performance of the 
intervention skills will be assessed in 
settings in which the intervention might 
be applied. 
The study documents* were reviewed 
and a LIVELY specific checklist 
developed. 
2. A strategy will be used to assess 
performance of the intervention skills in 
settings in which the intervention might 
be applied. 
The study documents were reviewed and 
a LIVELY specific checklist developed. 
* study documents refers to the full study protocol, the grant application, the PAI file  




Table 6-7 Assessment of delivery, receipt and enactment, by provider and primary and 
secondary raters for each set of consultations 
Provider  Provider 1  Provider 2 Provider 3 
Participant  C224  C124 C113 
Primary rater OO’S OO’S OO’S 
Secondary rater (s) MA SMcD: C1 and C2, BO’N: 
C3, C4, C7 and C8, JB: C6, 
C9, C10, C11 MA: C5 and 
C12) 
MA 
              *C= Consultation 




Results of the LIVELY COPD project 
 
1. Provider information about treatment dose in the intervention 
condition 
a. Length of 
contact 
(minutes) 
PAI to be <1hour for face to face consultations, 
consultation 1 may last longer (1.5 hours) with 
telephone calls to be of shorter duration e.g. 10-20 
minutes (Appendix 5, PAI file Sections 2, Consultation 
instructions page 4, on CD-ROM) 
b. Number of 
contacts 
12 (6 face to face and 6 telephone) (Appendix 5, PAI 
file, Section 2, LIVELY PAI principles and overview, 
page 1, on CD-ROM) 
c. Content of 
treatment 
The content of the treatment is detailed in the PAI file 




   
d. Duration of 
contact over 
time 
Twelve weeks (Appendix 5, PAI file, Section 2, 
LIVELY PAI principles and overview, page 1, on CD-
ROM) 
2. Provide information about treatment dose in the comparison 
condition 
a. Length of 
contact 
(minutes) 
Results of PR self-check (Appendix 33, Results of the 
pulmonary rehabilitation check of sites included in the 
LIVELY COPD project on CD-ROM). 
b. Number of 
contacts 
 Results of PR self-check (Appendix 33, Results of the 
pulmonary rehabilitation check of sites included in the 
LIVELY COPD project on CD-ROM). 
c. Content of 
treatment 
Results of PR self-check (Appendix 33, Results of the 
pulmonary rehabilitation check of sites included in the 
LIVELY COPD project on CD-ROM). 
d. Duration of 
contact over 
time 
Results of PR self-check (Appendix 33, Results of the 
pulmonary rehabilitation check of sites included in the 
LIVELY COPD project on CD-ROM). 





Both groups received 12 contacts over the course of the 
PAI or PR. (LIVELY protocol: https://clinicaltrials.gov) 
f. Method to 





PR site self-reported at start and middle of intervention 
that 12 contacts are still being provided to participants 
(Appendix 33, Results of the pulmonary rehabilitation 
check of sites included in the LIVELY COPD project 
on CD-ROM). 
3. Specification of provider credentials that are needed 
This was restricted to personnel working in the Northern Irish Clinical Research 
Network (NICRN).  Either respiratory nurses or physiotherapists with experience 
in PR were sought. 
 
4. Theoretical model upon which the intervention is based is clearly 
articulated 
 





The LIVELY PAI combined recommendations from the 
PA guidelines, influences from the stages of change and 
key behaviour change strategies were identified in 
advance which mapped to the theoretical model i.e. the 
COM-B model (Appendix 6, Amended list of BCS 
included in the LIVELY PAI) (BASES 2011, Marcus 
and Forsyth 2009, Michie et al. 2014). 
b. Use of experts 
or protocol 






An expert team designed the programme. There was 
consultation between physiotherapists, health 















anisms of action 
The outcome measures were chosen to actively assess 
the hypothesis and mechanisms of action (Appendix 2, 
LIVELY CRF, on CD-ROM). 
5. Potential confounders that limit the ability to make conclusions at the 
end of the trial are identified.   
The LIVELY intervention was a feasibility study.  Therefore the small sample 
size in addition to drop outs limited the ability to make conclusions about the 
effectiveness of the intervention. 
6. Plan to address possible setbacks in implementation (i.e. back-up 
systems or providers)  
Three providers were trained to deliver the intervention, to allow for cover for 
annual leave or unexpected absences. Providers were also supported by a mentor, 





 Table 6-9 Results of assessment of training of providers in the LIVELY PAI with the 
Borrelli 2011 checklist 
Borrelli (2011) Item Results of the LIVELY COPD project 
1. Description of how 
providers will be 
trained (manual of 
training procedures)   
A plan for how the providers were to be trained 
was set out from the beginning (Appendix 5, PAI 
file, Section 9, Training, on CD ROM) 
2. Standardisation of 
provider training 
(especially if 
multiple waves of 
training are needed 
for multiple groups 
of  providers) 
All providers were to attend the same training 
days delivered by the research team. Due to 
unforeseen circumstances one provider did not 
attend one of the sessions. However through the 
weekly mentorship programme it was thought that 
the impact of the missed training sessions could 
be minimised (Appendix 5, PAI file, Section 9, 
Training, on CD-ROM) 
3. Assessment of 
provider skill 
acquisition 
Provider skill acquisition was assessed through 
formative assessment and feedback during 
training by using mock case scenarios initially and 
then real study data (Appendix 5, PAI file, Section 
9, Training, on CD-ROM). 
4. Assessment and 
monitoring of 
provider skill 
Assessment and monitoring of provider skill 
maintenance was carried out through regular 
training days throughout the study and the weekly 
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maintenance over 
time 
mentoring phone calls Appendix 5, PAI file, 
Section 9, Training on CD-ROM). 
5. Characteristics being 
sought in a treatment 
provider are 
articulated a priori. 
Characteristics that 
should be avoided in 
a treatment provider 
are articulated a 
priori 
Physiotherapists or respiratory nurse or working 
in the NICRN respiratory health network were 
sought. Characteristics to be avoided were not 
articulated (Appendix 35, Minutes of team 
meeting 12/12/12, on CD-ROM). 
6. At the hiring stage, 
assessment of 
whether or not there 
is a good fit between 
the provider and the 
intervention (e.g. 
ensure that providers 




This was not applicable to our assessment as the 
research team was limited to those already 
working in the NICRN. 
7. There is a training 
plan that takes into 
account trainees 
different education 
and experience and 
learning styles 
The training planned to include theory, practical 
components, case scenarios, group work, and 
workshop style delivery to help support different 
training needs.  There was also a mentorship plan 
in place; providers had weekly phone calls with an 
experienced colleague. A feedback evaluation 
questionnaire was completed by the providers at 
one time point to assess if they felt the training 
met these criteria. 
 
Table 6-10 Results of assessment of delivery of treatment of the LIVELY PAI with the 
Borrelli 2011 checklist 
Borrelli (2011) Item Results of the LIVELY COPD project 
1.Method ensure that the content of the 
intervention is delivered as specified 
The mentorship programme helped to 
ensure that the content is delivered as 
specified. Pre consultation checklists 
and templates for documentation also 
helped to ensure that the content is 
delivered as specified. 
2. Method to ensure the dose of the 
intervention is delivered as specified 
Weekly contact with the mentor 
helped ensure that the dose of the 
intervention is delivered as specified.  
The provider notes were reviewed at 
the end of the intervention to assess 
the mean duration of the intervention 




   
3. Mechanism to assess if the provider 
actually adhere to the intervention plan  
A sample of consultations were audio 
recording and with accompanying 
provider notes were assessed the 
delivery checklists. (Appendix 30, 
Amended delivery checklists, 
developed specifically for the 
assessment of fidelity of the LIVELY 
PAI) 
 
4. Assessment of nonspecific treatment 
affects 
Nonspecific treatment effects were not 
considered for the LIVELY 
intervention  
5. Use of treatment manual A treatment manual was specifically 
designed for and used in the LIVELY 
intervention (Appendix 5, LIVELY 
PAI file, on CD-ROM). 
6.There is a plan for the assessment 
whether or not the active ingredient was 
delivered 
A sample of consultations were 
assessed with the delivery checklists 
to see if these “active ingredients” 
were delivered (Appendix 30 
Amended delivery checklists, 
developed specifically for the 
assessment of fidelity of the LIVELY 
PAI). 
7.There is a plan for the  assessment of 
whether or not the proscribed 
components were delivered (e.g. 
components that are unnecessary or 
unhelpful) 
There was no plan for the assessment 
of proscribed components in the 
delivery; however during the 
assessment of audio recordings 
additional items that were not planned 
as part of the programme were noted, 
e.g. prescribing participants “rest 
days” from physical activity.  
8.There is a plan for how contamination 
between conditions will be prevented 
Participants did not meet each other 
during the intervention and each 
condition was delivered by separate 
providers.  
9.There is a priori specification of 
treatment fidelity (e.g. providers adhere 
to >80% of components) 
A set of key BCSs were identified for 
the LIVELY PAI, along with 
additional items on the consultation 
checklist. It was planned that 
providers would adhere to 80% of 
these components (Appendix 30 
Amended delivery checklists, 
developed specifically for the 







   
Table 6-11 Results of the assessment of delivery of Behaviour Change Strategies by 
provider to a participant in the LIVELY PAI 
 
LIVELY PAI BCS  Delivery by provider                                  
Mean 
Setting an overall walking (or 
functional) goal e.g. walking to 
sisters house or walking into 
town every day as a results of 













Provide information on the 
consequences of behaviour in 
general and for the individual 
and (pro/cons) of being more 
active (any risks of not being 












Disease specific education. 
























Training to use pedometer 
(including 20 step test) and 













(a)Use pedometer steps in self-













(b) Use 7 day pedometer steps 












Build self-efficacy focusing the 
patient’s attention on where 
they have been able to do well 














walking pace during self-












Plan behaviour using action 














   













Review planned and actual 
walking behaviour each week 
with clinician by reviewing 
diary and pedometer daily step 













Review if goal met, not met or 





































Clinician encourages social 
support, walking with 
friends/family or walking to 













 Week 12 refer back, also 
review past success and also in 
























Materials manual i.e. LIVELY 
patient manual (includes diary) 


























Table 6-12 Results of the assessment of delivery of the components on the consultation 
schedule by provider to a participant in the LIVELY PAI 
LIVELY PAI Consultation Plan Delivery by provider                                                      Mean
1.Report on patients health 
status and record any adverse 











2.Explain the goal of the 













   
3.Mention general benefits of 




























































8.Remind patient of goal of the 



































11.Note any problems with 




































































































19.New goal set and inserted in 























   
(2/2) (1/12) (2/2) 












22.Summary of 12 week steps 











23.Review progress from week 











24.Benefits of walking re-























26Summary of barriers and 












27.Other relapse prevention 











28.Relapse prevention due to 
COPD exacerbation advice 
























29.Resources for additional 












30.Complete physical activity 
intervention patient progress 













Table 6-13 Results of assessment of treatment receipt of the LIVELY PAI with Borrelli 
2011 checklist 
Borrelli (2011) Item Results of the LIVELY COPD project 
1. There is an assessment of the 
degree to which participants 
understand the intervention. 
The LIVELY PAI file was explored to 
determine how this was being met, 
checklists were developed and the audio  
recordings  and provider notes reviewed to 
assess receipt (Appendix 5 LIVELY PAI 
file, on CD-ROM) 
2. There are specification strategies 
that will be used to improve 
participant comprehension of the 
intervention. 
The LIVELY PAI file was explored to 
determine how this was being met, 
checklists were developed and the audio  
recordings  and provider notes reviewed to 
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Table 6-14 Results of the assessment of receipt of the LIVELY PAI by three 
participants 






pedometer and the 7 











Item 2:There is a specification of the strategies that will be used to improve 
participant comprehension of the intervention 



























(iii) Reaffirm physical 













(iv) Recap on benefits 

























assess receipt (Appendix 5 LIVELY PAI 
file, on CD-ROM) 
3. The participants’ ability to perform 
the intervention skills will be assessed 
during the intervention process. 
The LIVELY PAI file was explored to 
determine how this was being met, 
checklists were developed and the audio  
recordings  and provider notes reviewed to 
assess receipt (Appendix 5, LIVELY PAI 
file, on CD-ROM) 
4.A strategy will be used to improve 
subject performance of intervention 
skills during the intervention period 
The LIVELY PAI file was explored to 
determine how this was being met, 
checklists were developed and the audio  
recordings  and provider notes reviewed to 
assess receipt (Appendix 5 LIVELY PAI 
file, on CD-ROM ) 
5.multicultural factors considered in 
the development and delivery of the 
intervention   
The study excluded anybody who could not 
read or speak English. The programme was 
individualised so as factors outside of this 
could be incorporated (LIVELY protocol 
https://clinicaltrials.gov/ ).  
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(ix) Goal setting for step 















Item 3:The participants’ ability to perform the intervention skills will be assessed 
during the intervention process 
(i) Review progress 
assessing whether 
the step targets 














(ii) Use of tools: 
pedometer and step 













Item 4:A strategy will be used to improve participant performance of the intervention 
skills during the intervention 












(ii) Complete action 












































   
(v) Revisit step target 














(vi) Identify strategies 
from the previous 
week that worked 














Item 5:Multicultural factors considered in the development of the delivery 
(Throughout the intervention) 
No; but the intervention was very much individualised and could be easily tailored to 
incorporate any of these factors. For example C124 was involved in marching and 
this was incorporated in the programme.  
*P=participant 
 
Table 6-15 Assessment of treatment enactment of the LIVELY project with the Borrelli 
(2011) checklist 
Borrelli (2011) Item Results of the LIVELY COPD project 
1. Participant performance of the 
intervention skills will be 
assessed in settings in which the 
intervention might be applied. 
The LIVELY PAI file was examined to explore 
how this was being met, checklists were made 
and the audio recordings and providers notes 
examined to assess enactment (Appendix 5, 
LIVELY PAI file, Sections 1-7, on CD-ROM) 
2. A strategy will be used to 
assess performance of the 
intervention skills in settings in 
which the intervention might be 
applied. 
The LIVELY PAI file was examined to explore 
how this was being met, checklists were made 
and the audio recordings and providers notes 
examined to assess enactment (Appendix 5, 















   
 
Table 6-16 Results of the assessment of enactment of treatment skills of the LIVELY 
PAI by participants 
Item 1: Participant performance of the intervention skills will be assessed in 
settings in which the intervention might be applied 
(i) Does the step diary match the 7 










(iia) A review and report of the participants 












(iib) A review and report of whether the 












(iic) A review of the extent to which the 













Item 2: A strategy will be used to assess performance of the intervention skills in 
settings in which the intervention might be applied 
(i)A step diary and pedometer are provided 
for one week to allow the participant to 


























Table 6-17 Summary of key lessons learned that should be considered in future research 
for the assessment of treatment fidelity of an intervention 
 
(i) allocate adequate funds for the assessment of fidelity within proposals;  
(ii) include a detailed fidelity protocol within the trial protocol;  
(iii) train providers on the purpose of and the importance of assessing treatment 
fidelity; 
(iv) test any checklists developed specific to the intervention for practicality and 
acceptability;  









   
 
 
Chapter 7 - Discussion 
 7.1 Introduction  
The focus of this PhD was on PA in people with COPD. Higher levels of PA are 
associated with improved health outcomes in this population (Garcia-Ayermich et al. 
2009). There is strong evidence to demonstrate that people with COPD engage in lower 
levels of COPD compared to their healthy counterparts (Park et al. 2013, Troosters et al. 
2010a, Hernandes et al. 2009, Pitta et al. 2005). PR, the mainstay treatment for PA in 
people with COPD, does not always result in increased levels of PA (Troosters et al. 
2010b, Bolton et al. 2013, Spruit et al. 2013). In more recent years there has been an 
increased focus in exploring interventions to enhance PA in people with COPD (Wilson 
et al. 2014). Therefore the LIVELY COPD project aimed to investigate the feasibility of 
conducting a clinician facilitated pedometer driven walking intervention versus PR (usual 
care) in improving PA in people with COPD. This PhD was fully embedded within this 
project. There were two key aims in this PhD (1) to assess the feasibility of conducting a 
trial to explore the effectiveness of a pedometer driven clinician facilitated PAI versus 
PR in improving PA in COPD patients referred to PR (the LIVELY COPD project); and 
(2) to assess the treatment fidelity of the LIVELY PAI. 
 
There were three key findings of this research. Firstly, conducting a mixed methods 
feasibility trial was a valuable process. A number of important lessons were learned from 
conducting this feasibility study that need to be considered before progressing to a future 
large scale trial. For example in the LIVELY COPD project, we experienced a high rate 
of drop outs; although there were less dropouts in the PAI group compared to the PR 
group, we need to consider the reasons for this to help reduce dropouts in both groups in 
future. The primary outcome measure in the LIVELY COPD project was step count from 
the ActiGraph, which presented challenges in terms of the resource intense analysis and 
some data loss and we would therefore need to explore the best method for the assessment 
of PA. Secondly the LIVELY PAI was feasible and may provide a viable option for 
COPD patients in the NHS in addition to PR.  The third key finding of this PhD was that 
the assessment of fidelity was beneficial. The assessment of treatment fidelity of the 
LIVELY COPD project was a challenging and resource intensive, yet important, process; 
assessing and monitoring treatment fidelity should be considered central to all future 
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studies assessing a complex intervention. There were other findings that were also 
important for clinical practice and which should be taken into account when planning a 
future trial for PA in COPD.  
 
This chapter will discuss these findings and outline the implications for future research. 
It will also discuss the implications for clinical practice. 
 
 7.2.1 Main finding 1 and implications for future research  
The use of a mixed methods feasibility design was a valuable process: A mixed methods 
feasibility study design was chosen for the LIVELY COPD project as recommended by 
the MRC, the NIHR and other key publications (Craig et al. 2006, Thabane et al. 2010, 
Lancaster 2015, NIHR 2012). The NIHR criteria were utilised to report the success of 
this study; the results of the LIVELY COPD project indicated it was feasible to move 
forward to a full RCT. However important lessons need to be taken into consideration. 
 
Firstly, recruitment and randomisation were deemed to feasible in the current trial; we 
planned to recruit over a period of 14 months and achieved target at 16 months. In the 
LIVELY COPD project, 651 patients were screened, and 50 of these consented and were 
randomised. Other trials reporting on PAIs in COPD have reported more variable 
recruitment rates, for example Berry et al. 2003 screened 775 patients for eligibility and 
recruited 140 of these and elsewhere Varga et al. 2007 reported screening 79 patients for 
eligibility and recruited 71 of these patients. The numbers patients who were screened 
was carefully documented and reported in the LIVELY COPD project as part of the 
feasibility criteria (NIHR 2012). The reporting of screening is not part of the CONSORT 
checklist (2010) (Schulz et al. 2010) for reporting RCTs, however information on this has 
been proposed as an extension of the CONSORT checklist for a reporting of feasibility 
and pilot studies (Thabane et al. 2016). More recently Chaplin et al. 2017 reported 
screening 2646 for eligibility and 103 of these were recruited to a randomised controlled 
feasibility trial for an interactive web based PR programme versus conventional PR for 
people with COPD. Screening and recruitment rates should be more transparently 
reported not only in feasibility studies but also in RCTs to allow for better comparison 
between different recruitment procedures and populations. In terms of randomisation, the 
qualitative analysis revealed that almost all patients were happy with their allocation and 
enjoyed their respective programme (Chapter 4). The qualitative component of this mixed 
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methods trial was therefore important in determining the feasibility of the LIVELY 
COPD project.  
 
Secondly, there were high levels of dropouts in the LIVELY COPD project. There were 
fewer dropouts in the PAI group compared to the PR group. Dropouts from the PR group 
(52%) were a lot higher than those reported in a recent audit from England and Wales 
(29%) (Steiner et al 2016).  The reasons for this are unclear, and as stated in Chapter 3, 
this study was not developed to specifically explore the reasons for dropouts. The FEV%1 
predicted of the PR group in the LIVELY COPD project is similar to that reported in the 
audit (53% versus 54%) (Steiner et al. 2016) and it is possible that the patients in the 
current study had a higher rate of comorbidities; there were no patients in the current 
study without comorbidities compared with 14% of patients in the audit conducted by 
Steiner et al. (2016). Differences such as the presence of comorbidities might go some 
way to explaining the difference in these dropout rates. In addition to this, the NI COPD 
population has the lowest levels of PA among various other COPD populations, including 
the Republic of Ireland, Belgium and the United States (O’Shea et al. 2015). There is no 
published data of the PA levels in people with COPD for the rest of the UK. These high 
rates of dropouts from PR coupled with the low PA levels indicate that the COPD 
population of NI in this study may have had some different characteristics to other 
populations. For example NI is recognised as an area of low socieconomic status (EU 
Inequality Briefing 43, 2014), and lower socieoconomic status is associated with higher 
rates of drop out from PR (Steiner et al. 2017). However further research is warranted to 
investigate this. Finally the qualitative analysis provided some insight into the reasons for 
dropout for example some patients did not like the group setting (Chapter 4). The 
qualitative analysis did not capture the views of all those who dropped out and was limited 
only to those who were willing to return for outcome measure assessment. Future research 
should focus on developing strategies to optimise retention and reduce dropouts. 
 
Thirdly, important information on the outcome measures was obtained. PA was measured 
objectively using two different devices: a sealed pedometer and the ActiGraph worn on a 
belt around the waist. As discussed in Chapter 3, the ActiGraph is a more precise measure 
of PA (O’Neill et al. 2017a). The available data from the ActiGraph was reduced due to 
participants not meeting the wear time criteria. There are some aspects of objective PA 
measurement that could be explored to maximise this data. The wear time rules used for 
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the COPD population could be less stringent. In the LIVELY COPD project, we followed 
the rules for wear time from Byron and Rowe (2016), who recommend using five days of 
ten hours wear time for PA data in COPD. This review also found that wear time criteria 
is not routinely reported in the literature and there are also other reports and guidelines 
advising that less days and hours are acceptable to measure free living PA; as little as 
eight hours over 4 days has been recommended in both healthy people (Hagstromer and 
Sjostrom 2010) and the COPD population (Demeyer et al. 2014). Demeyer et al. 2014 
have also suggested that daylight hours should be considered as a covariate in the analysis. 
There is a need for greater consistency in the reporting of wear time and the publication 
of guidelines for wear time criteria for activity monitors in people with COPD, as their 
daily habits may differ from healthy individuals. The wear time algorithm in ActiLife 
(Choi et al. 2011) was developed for the healthy adult population; it is possible periods 
of prolonged sedentary behaviour may be classified as non-wear time in people with 
COPD. Finally, the use of a monitor worn on a different part of the body, such as the 
wrist, could increase wear time in the COPD population. The qualitative data in the 
current study revealed that a small number of participants did not enjoy wearing the 
device around their waist. There are a range of validated monitors available for assessing 
PA in people with COPD that could be considered in a future study, for example the 
ActiGraph can be worn on the waist, the DynapPort worn on the lower back, the 
SenseWear worn on the upper arm and the Fitbit worn on the wrist (Voojis et al. 2014). 
Future research should consider exploring where people with COPD find it most 
acceptable to wear an activity monitor. 
 
Furthermore objective PA data was reduced as some participants were unwilling to travel 
for re assessment and only completed the paper based outcome measures. There was 
therefore more available data for IPAQ compared to the ActigGraph. The IPAQ is a paper 
based outcome measure and participants who did not wish to return could complete this 
outcome measure by post. The IPAQ is a valid and reliable method of assessing PA (Craig 
et al. 2003), and had previously been used in people with COPD (Parada et al 2011, Ianal-
Ince et al. 2014).  However, the results of the LIVELY COPD project indicate that the 
IPAQ may not produce results comparable to that of the objective measurement; 18% 
(n=9/50) of participants were classified as highly active by the IPAQ at baseline, n=3/41 
(7%) of  participants were classified as somewhat active by the ActiGraph step count at 
baseline. Additionally, recent evidence in patients with bronchiectasis has indicated that 
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the IPAQ is not an accurate method of assessing PA in people with bronchiectasis 
(O’Neill et al. 2017a).  Furthermore a recent report has found that self-reported PA is not 
reliable for measuring time spent in moderate PA in people with COPD (Sievi et al. 2017). 
There is therefore considerable evidence that PA in people with COPD should not be 
assessed by self-report questionnaires in a research setting. When exploring patients 
views on the outcome measures in the LIVELY COPD project some patients felt the 
questionnaires were complicated.   Future research assessing PA in COPD patients should 
only consider objective measurements of PA. 
 
 7.2.2 Main Finding 2 and implications for future research 
The PAI appeared to be feasible in terms of the ability to train clinicians to deliver the 
intervention (providers), the successful delivery of the intervention (i.e. participants could 
achieved their weekly step goals) and acceptability of the intervention.  
 
Three providers were trained to deliver the intervention and this was feasible. Training 
was conducted before the intervention commenced and throughout the intervention as 
planned. The providers were also mentored in delivery of the intervention throughout. 
The training of providers was explored in further detail in Chapter 6.   
 
In Chapter 3, we explored the feasibility of the intervention in terms of whether 
participants could achieve their weekly step goals and the overall improvement. The mean 
change in step count is in line with the MCID for this population; however given the 
feasibility nature of this trial we cannot draw any conclusions regarding the effectiveness 
of the LIVELY PAI. This adds to the current research that PAIs can increase PA in people 
with COPD (Wilson et al. 2014). However as these PAIs have not been translated into 
clinical practice, PR remains the only form of exercise treatment for people with COPD 
in the NHS. Recently, Mantaoni et al. (2016) identified the components of a PAI that are 
effective in increasing PA levels in people with COPD, including BCS and a self-
monitoring device such as a pedometer; these were included in the LIVELY PAI.  The 
research challenge now is developing a PAI with the successful components that can be 
easily translated into clinical practice in a cost effective manner. The LIVELY PAI is 
estimated to take approximately double the length of time to deliver as the PR, which 
would place considerable strain on the NHS resources. The LIVELY PAI has already 
been adapted for people with bronchiectasis and delivered in the health service as a six 
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week intervention, with encouraging results, with both the HCPs and patients providing 
positive feedback (O’Neill et al. 2017b). The implementation of the LIVELY COPD PAI 
in clinical practice is therefore possible.  Cost reducing modifications to the intervention, 
for example increased telephone contact, and would require assessment in a research 
setting prior to implementation in routine clinical practice. Further methods that could 
reduce the time of delivering the PAI have been discussed in Chapter 3.   
 
The results of the qualitative exploration of the participants’ views of the PAI provide 
further confirmation of the feasibility of the PAI in terms of the acceptability (Chapter 4). 
These results revealed that nearly all participants enjoyed the intervention, which is an 
important measure of acceptability. In addition to this we explored participants’ views 
and satisfaction of the content and delivery of the programme; the combination of phone 
and telephone contact was well received with some participants expressing a preference 
for one mode over the other or felt they could have transitioned to the telephone contact 
earlier.  The participant materials for the PAI were viewed positively; participants found 
the pedometer motivational and the LIVELY patient manual useful. COPD patients’ 
views of a PAI have not yet been explored; in the LIVELY COPD project this qualitative 
data was important in making pragmatic decisions regarding the feasibility of the 
intervention.  
 
 7.2.3 Main finding 3 and implications for future research 
The assessment and monitoring of treatment fidelity is an essential component when 
developing and implementing an intervention. This should be included in both a 
feasibility study and a full RCT.  The review conducted within this PhD concluded that 
treatment fidelity is inconsistently defined and reported in the literature and 
recommended that a checklist, for example like that published by Borrelli 2011, could be 
used in future research to allow for the complete consideration of treatment fidelity. The 
Borrelli (2011) checklist was therefore used to develop a framework to assess the 
treatment fidelity of the LIVELY PAI. Treatment fidelity had not previously been 
assessed in a PAI for patients with COPD.  
 
The Borrelli (2011) checklist provides a useful and practical framework for assessing 
fidelity. However this requires increased resources for assessing and monitoring 
treatment fidelity (Bellg et al. 2004). This increased requirement on time, equipment and 
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personnel has been proposed as a possible explanation for the paucity of the assessment 
of treatment fidelity in the literature (Bellg et al. 2004). As outlined in Chapter 6, a 
considerable amount of time was spent planning for and conducting the assessment of 
fidelity of the LIVELY PAI. However important lessons were learned regarding the 
methods for assessing fidelity of an intervention and regarding the content and delivery 
of the LIVELY PAI (Chapter 6).  Therefore the assessment of fidelity of the LIVELY 
PAI may not only inform a future trial, but the dissemination of the methods used and 
lessons learned by the study team may help promote learning in the wider research 
community regarding the assessment and reporting of treatment fidelity, ultimately 
enhancing the quality of research and the translation of research into clinical practice. 
 
 7.2.4 Other key findings 
(i) Not all participants who adhere to PR achieve clinical benefit (Garrod et al. 2006).  In the 
LIVELY COPD project the number of participants in the PR group achieving the MCID 
for the ISWT and CAT was below that observed in a recent audit of PR in England and 
Wales (Steiner et al. 2015) (Chapter 3). Although this was a feasibility study and the 
numbers who adhered to PR were low, this coupled with the high rate of dropout, should 
be considered when planning future research. Future research may need to consider 
quality assurance measures to optimise PR programmes and a process to monitor the 
fidelity of PR delivered within a trial to ensure that true comparisons can be made. 
Additionally the identification of phenotypes for patients at increased risk of dropout for 
example those from a lower socioeconomic status (Steiner et al. 2017) would allow for 
targeted strategies aimed at increased adherence in these at risk patients. Such strategies 
could include arranging transport for PR and reminder weekly phone calls about PR.  
 
(ii) A key finding of the qualitative component of the LIVELY COPD project was that 
patients had clear preferences for different aspects of the PAI and of PR, for example 
some participants enjoyed the group aspect of PR where as others did not. Most of the 
participants in the PAI found the pedometer motivating but a small number did not enjoy 
wearing it and found it to be too much pressure. There is therefore a need to explore what 
forms of PA people with COPD want to engage in or their preferred platform of delivery. 
Research in healthy individuals has demonstrated that even healthy individuals have a 
preference for what type of PA they wish to engage in, Booth et al. 1997 surveyed healthy 
adults in Australia to explore their preferred type of PA and support, for example whether 
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they would like to exercise in a group. The results of this study demonstrated that walking 
was the preferred type of activity and the type of support depended on age, with the 
younger groups expressing a desire to exercise as part of a group and older adults 
preferring to receive advice. There is a need for a similar type of research to be conducted 
in people with COPD as the single approach i.e. traditional PR is not meeting the needs 
of all patients with COPD, evidenced through the poor uptake and dropouts (Steiner et al. 
2015). Aside from patient preferences there are problems with accessibility with a PR 
programmes are not available to a large number of patients with COPD (Steiner et al. 
2016, Rochester et al. 2015) and some PR programmes do not accept patients until they 
are at a more severe stage of the disease (Steiner et al. 2015).  Clarenbach et al. 2017 have 
demonstrated the need for early PA intervention for people with COPD, as every year PA 
decreases by approximately 500 steps.  Alternative platforms for delivering PR have been 
explored; Chaplin et al. (2017) have explored a web based platform for delivering PR to 
people with COPD. The feasibility of delivering a web based PR programme in 
comparison to conventional PR was assessed. No statistical difference in the outcome 
between the two groups was found and it was recommended that future research 
investigate choice for people with COPD and allow for better stratification of patient care. 
Furthermore Demeyer et al. 2017, investigated the effectiveness of a 12 week semi-
automated telecoaching intervention compared with usual care (the usual care group 
received a standard leaflet explaining the importance of PA in COPD as well as 
information about PA recommendations). The intervention group received one face to 
face PA counseling consultation and step counter. All step counts were uploaded remotely 
and step goals updated remotely. The investigators only made telephone contact with 
participants in cases of noncompliance or failure to progress. This telecoaching 
intervention was found to be effective in improving PA in people with COPD. Those with 
less symptoms and higher exercise capacity at baseline had a more favourable response; 
this reinforces the need for stratification of patient care. Providing patients with increased 
choices for exercise/PA training, at an earlier stage in their disease trajectory is paramount 
to help COPD patients maintain optimum levels of PA and reduce the frequency of 
exacerbations, comorbidities, hospitalisations and mortality. The provision of choice and 
different platforms for delivering and modes of PA also fits in with the NHS strategy for 




   
 7.3 Implications for clinical practice  
The implementation of interventions that have been proven to be effective in research 
into clinical practice on a trial basis would help enhance choice for patients with COPD 
as well as potentially facilitating earlier intervention. Examples such as the LIVELY PAI 
(Chapter 3), web based PR and telecoaching (Chaplin et al. 2017, Demeyer et al. 2017); 
provide potentially feasible platforms for delivery in the clinical setting. Interventions 
that are delivered remotely do not require as much resources as traditional PR in terms of 
personnel and could also be potentially more cost effective. Furthermore these types of 
interventions may be more feasible to personalise or may be more practical for patients 
who have transport difficulties or are still in employment and unable to attend class at 
specific times.  Increasing choice and adding new models of PA/exercise training would 
require increased resources such as training clinicians to implement in clinical practice. 
 
There are at present no guidelines for the components of or how to deliver a PAI to 
people with COPD. The components of PAIs in the current literature are variable 
(Wilson et al. 2014) and may not be easily implemented in clinical practice. We plan to 
disseminate the materials for the LIVELY PAI, for COPD including the patient manual, 
chart and provider PAI file with instructions on how to deliver the intervention. 
Training will be made available to those who request it. This will provide clinicians 
with the opportunity to deliver a PAI to patients who PR may not be suitable for, they 
would also have the choice of attending the group based education.   
 
PR programmes in NI, may need to consider implementing quality assurance procedures 
to reduce drop outs and optimise patient outcome. Implementing procedures such as 
phoning patients to remind them about the class or phoning patients when they have 
missed a class may help reduce these dropouts. Furthermore, exploring reasons for 
dropout with patients may help PR programmes implement changes that would reduce 
dropouts, for example in the LIVELY COPD project one of the reasons that contributed 
to a patient dropping out from PR was that they did not like the music in the class. 
Allowing patients to have some input into the music, is a simple modification that may 
help reduce drop outs in the future. Some patients dropped out from PR in the LIVELY 
COPD project due to poor health, following these patients up and restarting them in PR 




   
The current BTS and American Thoracic Society/ European Respiratory Society 
(ATS/ERS) guidelines for PR recognise that PR does not always results in increased 
levels of PA (Bolton et al. 2013, Spruit et al. 2013). The BTS guidelines therefore advise 
encouraging regular PA, five times a week for 30 min each time (Bolton et al. 2013, Spruit 
et al. 2013). However the assessment of PA as an outcome measure of PR is not included 
in the BTS guidelines for PR (Bolton et al. 2013) and the ATS/ERS guidelines do include 
information on assessing PA (Spruit et al. 2013).  A recent audit of the PR services in 
England and Wales found 11% of programmes assess PA with an activity monitor. Step 
count is a simple metric of PA that is easily understood, and pedometers offer a cost 
effective method of assessing PA. Participants in the PR group were interested in their 
step count and seeing the change/improvement in step count from baseline to post 
intervention (Chapter 4).  Clinicians should consider using step count from a pedometer 
as an outcome measure for PR.  
 
 7.4 Conclusion 
 This programme of research explored the feasibility of conducting a trial to explore the 
effectiveness of a pedometer driven clinician facilitated PAI versus PR in improving PA 
in COPD patients referred to PR (the LIVELY COPD project). A mixed methods 
randomised controlled design was chosen and the fidelity of delivering this intervention 
was also assessed. The results of this research indicate that the LIVELY COPD project 
was feasible to progress towards an RTC and the intervention was delivered with good 
fidelity. The inclusion of the qualitative component provided added learning regarding 
the feasibility of the LIVELY COPD project and enriched the results.  There are a number 
of important considerations for future research, both for the LIVELY COPD project and 
for future research to enhance PA in the COPD population and for clinical practice.  
 
A future RCT will require strategies to increase recruitment. Strategies will also be 
required to reduce dropouts from both the PAI group and from PR. Treatment fidelity 
will need to be considered in the design phase of the trial using the Borrelli (2011) 
checklist, allowing for the allocation of adequate resources. Additionally future research 
will need to consider quality assurance and fidelity measures for PR to ensure it is being 
delivered as intended. Finally the research team will need to consider what is the optimal 
method for assessing PA, taking factors such as the positioning of the monitor and wear 
time rules into consideration.  
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Future research to promote PA in patients with COPD should focus on identifying 
phenotypes of patients to allow for stratification of patient care. Current research has 
identified some phenotypes that may result in better adherence to an intervention, for 
example Demeyer et al. 2017 reported that patients with a better exercise capacity and 
less symptoms were more responsive to a telecoaching intervention and Steiner et al. 2017 
reported that patients with a lower socioeconomic status are more likely dropout of PR. 
Furthermore the results of the LIVELY COPD project indicated that some patients had 
clear preferences for exercise for example the group setting was a reason dropping out of 
PR for some patients. In addition to this current research recommended that future 
research should investigate COPD patients’ preferences (Chaplin et al. 2017). The 
identification of phenotypes as well what preferences patients with COPD have for 
PA/exercise will help the better stratification of patients, provision of care and optimise 
outcomes.  
 
PR is currently the only method of PA/exercise training offered to people with COPD in 
the current health care structure. Future research should focus on the role of personalised 
exercise/PA interventions for COPD, how best to stratify patients and the translation of 
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1) All of the activity monitors should be worn for seven full days in a row during waking 
hours 
2) Please take off the activity monitors during night-time sleeping and put them on 
again each morning after you wake up.  You need to make sure each device is placed 
in the same position every time it is taken off (it may be useful to set the activity 
monitors beside your keys / wallet / phone so that you remember to attach them 
the next day). 
3) If you usually take a nap during the day, please keep the activity monitors on during 
this time. 
 
Please remove the activity monitors when you have a shower/bath because they are 
not waterproof. Put them on again straight away after your shower/bath. 
 
 
Using the ActiGraph 
 
1) You should wear the ActiGraph (Picture 1) which is attached to the 
ActiGraph belt on the hip area of the waist on your dominant side  
(i.e. _________ side) (Picture 2). 
 
2) The device must fit snugly against your body to prevent errors when 
recording data (Please note the device can be worn above or beneath clothing so 
does not have to be worn against the skin). 
 
 
Please make sure the monitor sits level on your waist as in Picture 2 and is not 
tilting forwards or to the side. 
 
 
3) The green light flashing on the ActiGraph is normal, and 
indicates that everything is working properly and that it is on 
standby. Note – do not worry if there is NO light flashing as 





   
4) If the red light on the ActiGraph flashes at any time or if the elastic belt becomes loose 
/ detaches from the ActiGraph, please call the research team. Their contact numbers 
are at the end of this instruction manual. 
Using the Pedometer 
Ah 
1) You should wear the pedometer (see Picture 3) to the inside of the ActiGraph 
on the ActiGraph belt on the hip area of the waist on your dominant side (i.e. 
_________ side) (see Picture 2) (Please note the device can be worn above or 
beneath clothing so does not have to be worn against the skin). 
 
2) Please make sure the monitor sits level on your waist and 





Using the Activity Monitor Diary 
 
1) Please start filling in the activity monitor diary after Visit 1. 
2) Please use the activity monitor diary to record when you put on the activity monitors 
each morning and also the time you took off the activity monitors each night. 
3) If you forget to wear any of the activity monitors, please write this down on the space 
provided on the activity monitor diary (Write down which activity monitor you 
didn’t wear, the times you didn’t wear it and the reason why you didn’t wear it). 
 
 







   
Activity Monitor Diary 
 
Activity monitors returned:   Date______ Time_____ 
*Please record the times to the nearest 5 minutes
 
DATE 
Time you put on 
the ActiGraph/ 
Pedometer 
Time you took off 
the ActiGraph/ 
Pedometer  
Amount of time and reason/s 
you didn’t wear the monitor/s 
during the day 
Example Sat 4th  Feb 10.15am 11.30pm 8.00-10.15am (Forgot to put 



























































When & time 













Your next scheduled appointment is: 
 




Rules for Reminder System 
 
 One reminder method can be selected 
 Remember to write which day the participant requests a reminder 
 Participants can receive one reminder over the seven full days 





DATA CHECKING AND WEAR TIME 
COMBINATIONS FOR ACTIGRAPH AND 
































Data checking and wear time combinations for ActiGraph 
and pedometer pre analysis 
 
The analysis of the ActiGraph is a complex process with several stages, additionally there 
is little guidance regarding the wear time rules for the inclusion of data. Therefore to 
ensure high quality ActiGraph data, the data was checked and different wear time 
combinations were explored prior to analysis. The data entry for the pedometer as also 
checked in this process. The aim of conducting data checking and exploring different 
wear time combinations is to ensure high quality data and valid results.  
 
Data checking was carried out by OO’S with JW. JW completed his PhD in Physical 
Activity in Patients with Bronchiectasis, and has experience in downloading and 
analysing ActiGraph data and managing pedometer data.  Therefore as new information 
came to light throughout the analysis of our data we revised our data analysis process to 
ensure the maximal use of our data.  
 
OO’S and JW met on two separate occasions in September and October 2015. On the first 
occasion, JW provided training to OO’S. OO’S processed 5 raw data baseline files and 
the corresponding 5 raw data post intervention files through the ActiLife 6.11.9 to ensure 
the process was accurate. On the second occasion JW observed OO’S processing 5 raw 
data follow up files (from the same participants) through the ActiLife software.  The wear 
time for each of these files was explored against the documented wear time in the 
participants’ diaries. For some participants there were large discrepancies between the 
diary and ActiLife output of wear time, it was decided to only include data that met the 
wear time criteria as reported in the ActiLife results. Wear time criteria at this time point 
was 5 days of ten hours of wear time (Gretebeck and Montoye 1992, Trost et al. 2005).  
 
After the training and standardisation process, OO’S proceeded to analyse the ActiGraph 
activity. It became clear that a number of participants were not meeting the wear time 
criteria of 5 days of ten hours and that we would need to explore some more lenient wear 
time options.  In January 2016, all data for the LIVELY COPD trial had been collected 
and OO’S attended an ActiGraph training course at Leicester-Loughborough Diet, 




facilitators of this course advised the wear time rules (days and weeks) should be flexible 
to allow available data to be maximised; advising that as little as one day and seven hours 
per day should be considered. Following this advice, the available pre-post data was 
considered a priority and a matrix determining the percentage of participants that had both 
pre and post data at each of the combinations of wear time was formulated (Table 2).  
There were 28 combinations from 7-10 hours and 1-7 days. Additionally in January 2016 
Byron and Rowe published a review identifying the methodology used in the use of 
accelerometers to measure free living activity in patients with COPD; the authors 
recommend using a minimum of 5 days and 10 hours of wear time to describe activity in 
the COPD population (Byron and Rowe 2016).  In March 2016, taking into account the 
results of the matrix and the recommendations by Byron and Rowe 2016, it was then 
decided to explore the ActiGraph data using three different combinations: 5 days of 7 
hours wear time, 6 days of 7 hours wear time (where 92.9% (n=13) of available data sets 
in both groups met these criteria) and 5 days of ten hours wear time (85.7% (n=12) of 
available data sets from PAI and 78.6% (n=11) from the PR group met these criteria).  
OO’S and JW met in April 2017, to apply the new parameters for analysis. The data was 
processed for the baseline, post intervention and follow up data across all of these 
parameters. The corresponding pedometer data was added to the ActiLife Excel outputs; 
only pedometer data that recorded 100-50,000 steps per day was included (Matthiessen 
et al. 2015). JW cleaned the PAI pre-post data of 5 days of 7 hours wear time; OO’S 
checked these were correct.  OO’S cleaned the remaining Excel files and JW checked 
these to make sure they were correct.  Cleaning here refers to the process of ensuring that 
only data that meets the criteria is included and removing any additional data.   All errors 
were rectified the data was copied into SPSS version 22.0 and analysed using descriptive 
statistics. The data (mean (standard deviation)) was tabulated for each combination of 
wear time, Table 2 Pre-post ActiGraph data across 4 days of 7 hours, 5 days of 7 hours 
and 5 days of 10 hours of wear time for the PAI group and Table 3 Pre-post ActiGraph 
data across 4 days of 7 hours, 5 days of 7 hours and 5 days of 10 hours of wear time for 
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Appendix 4.Table 1 Matrix of the percentage of available Actigraph data for participants 
who have both pre and post data at each combination of wear time ranging between 7-10 
hours s and 1-7 days for PAI group and the PR group 
 
PAI percentage of participants with pre-post ActiGraph data by days and hours 
(N=14 total) 
Days 7 6 5 4 3 2 1 
Hours 
10 35.7% 64.3% 85.7% 85.7% 85.7% 92.9% 100% 
9 50% 85.7% 85.7% 85.7% 85.7% 92.9% 100% 
8 57.1% 85.7% 92.9% 92.9% 92.9% 100% 100% 
7 78.5% 92.9% 92.9% 92.9% 92.9% 100% 100% 
PR percentage of participants with pre-post ActiGraph data by days and hours (N=14 
total) 
Days 7 6 5 4 3 2 1 
Hours 
10 64.3% 78.6% 78.6% 85.7% 85.7% 85.7% 92.9% 




8 78.6% 78.6% 85.7% 92.9% 92.9% 92.9% 92.9% 
7 78.6% 92.9% 92.9% 92.9% 92.9% 92.9% 92.9% 
 
 
Appendix 4, Table 2 Pre-post ActiGraph data across 4 days of 7 hours, 5 days of 7 
hours and 5 days of 10 hours of wear time for the PAI group 
PAI Group: 6 days of 7 







MVPA 10+ number of bouts .0.659(0.138) 0.495 (1.118) 
MVPA10+ time (mins/day) 1.066 (2.181) 9.503 (21.480) 
Total MVPA  17.014 (15.937) 22.982 (26.689) 
ActiGraph steps 3714.199 (1996.251) 4598.7637 
ActiGraph step category Sedentary N=11 
Low active N=1 
Somewhat active N=1 
Sedentary N=10 
Low active N=1 
Somewhat active N=1 
Active N=1 
Pedometer steps N=12 3604.492 (2037.442) 4974.206 (3638.158) 
Pedometer step category Sedentary N=9 
Low active N=3 
Sedentary N=9 
Low active N=1  
Active N=1 
Highly active N=1 
PAI Group: 5 days of 7 







MVPA 10+ number of bouts 0.209 (0.376) 0.495 (1.118) 
MVPA10+ time (mins/day) 1.253 (21.86) 9.503 (21.480) 
Total MVPA 18.464 (15.477) 22.932 (26.718) 
ActiGraph steps 3794.8040 (1986.284) 4657.764 (3080.644) 
ActiGraph step category Sedentary N=11 
Low active N=1 
Somewhat active N=1 
Sedentary N=10 
Low active N=1 
Somewhat active N=1 




Pedometer steps N=12 3564.026 (2038.213) 5137.694 (3537.681) 
Pedometer step category Sedentary N=9 
Low active N=3 
Sedentary N=8 
Low active N=2 
Somewhat active N=1 
Active N=1 
Highly active N=1 
PAI group 5 days of  10 







MVPA 10+ number of bouts 0.0762 (0.146) 0.536 (1.158) 
MVPA10+ time (mins/day) 1.348 (2.399) 10.295 (22.236 ) 
Total MVPA 17.519 (17.044) 24.171 (27.502) 
ActiGraph steps 3766.246 (2092.008) 4738.264 (3219.081) 
ActiGraph step category Sedentary N=9 
Low active N=2 
Somewhat active N=1 
 Sedentary N=9 
Low active N=1 
Somewhat active N=1 
Active N=1 
Pedometer steps N=10 3671.321 (2221.798) 5325.946 (3923.210) 
Pedometer step category  Sedentary N=7 
Low active N=3 
Sedentary N=6 
Low active N=2 
Highly active N=2 
 
Appendix 4, Table 3 Pre-post Actigraph data across 4 days of 7 hours, 5 days of 7 hours 
and 5 days of 10 hours of wear time for the PR group 
PR group 6 days of 7 hours 
wear time  N=13 
BASELINE 
Mean (standard deviation) 
POST INTERVENTION 
Mean (standard deviation) 
MVPA 10+ number of bouts 0.024 (0.083) 0.012 (0.412) 
MVPA10+ time (mins/day) 0.300 (1.041) 0.122 (0.423) 
Total MVPA 6.594 (5.995) 6.524 (4.366) 
ActiGraph steps 2620.845 (1620.363) 2595.542 (1379.456) 
ActiGraph category Sedentary N=11 
Low active N=1 
Sedentary N=12 




Pedomter step category Sedentary N=6 
Low active N=1 
Sedentary N=5 
Low active N=2 
PR group 5 days of 7 hours 
wear time N=13 
BASELINE 
Mean (standard deviation) 
POST INTERVENTION 
Mean (standard deviation) 
MVPA 10+ number of bouts 0.033 (0.0856) 0.011 (0.039) 
MVPA10+ time (mins/day) 0.459 (1.149) 0.113 (0.406) 
Total MVPA 10.823 (16.293) 11.951 (19.379) 
ActiGraph steps 3154.143 (2470.639) 3160.6187 (2424.307) 
ActiGraph step category Sedentary N=11 
Low active  N=1 
Somewhat active N=1 
Sedentary N=12 
Somewhat active N=1 
Pedometer steps N=8 3813.9464 (2047.429) 3756.694 (2385.475) 
Pedometer step category Sedentary N=6 
Low active  N=2 
Sedentary N=5 
Low active  N=2 
Somewhat active N=1 
PR group 5 days of 10 
hours wear time N=11 
BASELINE 
Mean (standard deviation) 
POST INTERVENTION 
Mean (standard deviation) 
MVPA 10+ number of bouts 0.039 (0.092) 0.013 (0.431) 
MVPA10+ time (mins/day) 0.542 (1.238) 0.133 (0.442) 
Total MVPA 12.552 (17.281) 13.408 (20.864) 
ActiGraph steps 3624.201 (2411.091) 3628.460 (2356.804) 
ActiGraph step category Sedentary N=9 
Low active N=1 
Somewhat active N=1 
Sedentary N=10 
Somewhat N=1 
Pedometer steps N=8 3824.241 (2032.852) 3733.439 (2384.497) 
Pedometer step category Sedentary N=6 
Low active N=2 
Sedentary N=6 
Low active N=1 




APPENDIX 6  
LIST OF BEHAVIOUR CHANGE STRATEGIES 
























Amended List of Behaviour Change Strategies included in the LIVELY PAI 
LIVELY PAI Component 
1. Setting an overall walking (or functional) goal e.g. walking to sisters house or walking 
into town every day as a results of the increased step counts/physical activity  
2. Provide information on the consequences of behaviour in general and for the individual 
and (pro/cons) of being more active (any risks of not being more active)  
3. Disease specific education. 
4. Discuss barriers to physical activity  
5. Training to use pedometer (including 20 step test) and completion of 7 day diary= 
skills/demonstration. 
6. (a) Use pedometer steps in self-efficacy  walk to set step goal 
(b) Use 7 day pedometer steps to set step goal 
7. Build self-efficacy focusing the patient’s attention on where they have been able to do 
well and focus on achievements. 
8. Demonstrate appropriate walking pace during self-efficacy walk and Borg rating 
9. Plan behaviour using action and coping plan 
10. Record daily steps with pedometer 
11. Review Smart goal  
12. Review planned and actual walking behaviour each week with clinician by reviewing 
diary and pedometer daily step count and provide feedback 
13. Review if goal met, not met or partially met 
14. Reward success/effort 
15. Certificate of achievement 
16. Clinician encourages social support, walking with friends/family or walking to meet 
somebody etc. 
17.  Week 12 refer back, also review past success and also in terms of successful strategies. 
18. Plan for relapse prevention 







TIDIER CHECKLIST RESULTS FOR THE 
CLINICIAN FACILITATED PHYSICAL ACTIVITY 
INTERVENTION VERSUS PULMONARY 
REHABILITATION IN IMPROVING PHYSICAL 




























TIDieR Checklist Reported 
1.Brief name: provide a name or a phrase that describes the intervention  
2.Why: Describe any rationale theory or goal of elements essential to the 
intervention 
 
3. What (materials): describe any physical or informational materials used 
in the intervention including those provided to participants or used in the 
intervention or in training of intervention providers. Provide information 
on where the materials can be accessed (materials can be accessed by 
contacting b.oneill@ulster.ac.uk) 
 
4. What (procedures): describe each of the procedures, activities and or 
processes used in the intervention including any enabling or support 
activities. 
 
5. Who provided: for each category of intervention provider, describe their 
expertise background and specific training given. 
 
6. How: Describe the modes of delivery such as face to face or by some 
other mechanism, such as internet/telephone) of the intervention and 
whether it was provided individually or in a group. 
 
7. Where: Describe the type(s) of location(s) where the intervention 
occurred including any necessary infrastructure or relevant features 
 
8. When and how much: Describe the number of times the intervention was 
delivered and over what period of time including the number of sessions, 
their schedule and their duration, intensity and dose 
 
9. Tailoring: If the intervention was planned to be personalised, titrated or 
adapted then describe what, why when and how 
  
10. Modifications: If the intervention was modified during the course of the 
study describe the changes (What, why, when and how) 
N/A 
11. How well (planned): if the intervention adherence or fidelity was 
assessed, describe how and by whom and if any strategies were used to 
maintain or improve fidelity describe them. 
 
12. How well (actual): If the intervention adherence or fidelity was 
assessed, describe  the extent to which the intervention was delivered as 
planned 
 
Appendix 8: TIDieR Checklist Results for the Clinician facilitated physical activity 
intervention versus pulmonary rehabilitation in improving physical activity in 
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ADDITIONAL BASELINE CHARACTERISITCS OF 








































Appendix 12, Table 1 Additional baseline characteristics for participants in the LIVELY 
COPD project 
SOC –Stages of Change 
 Regularly physically active relates to: Exercise e.g. weight training, aerobics for 20 minutes 3 times 
per week, OR Sport e.g. golf, hockey, netball, athletics, swimming for 20 minutes 3 times per week,  
OR General e.g. walking, cutting the grass, vacuuming, washing the car accumulating to at least 30  
minutes 5 times per week.  
SOC Questionnaire: Stage 1 - I am not regularly PA and do not intend to be so in the next 6 










Previous PR attendance 
















SOC Questionnaire  
(frequency) 
Stage 1  
Stage 2  
Stage 3  
Stage 4  































-Increased activity/ be 
more active 
-Improved general 







Downsides of PA 
-Breathlessness  
-Fatigue 








































































































months; Stage 3-I do some PA but not enough to meet the description of regularly PA given above; 
Stage 4 -I am    regularly PA but only began in the last 6 months; Stage 5 -I am regularly PA and 
have been for longer than 6 months. 
*other refers to: improved self-discipline to control pace of walking; sleep pattern; enjoyment; to 


























Baseline, post intervention and follow up outcome 
























Appendix 13, Table 1 Baseline, post intervention and follow up outcome measure data for 





















































































































































N=1 N=2 N=2 
 









































































































































































20.5 (9.3)  
 
 

































































MVPA- Moderate to Vigorous Physical Activity 
IPAQ- International Physical Activity Questionnaire  
GROC- Global Rating of Change 
ISWT- Incremental Shuttle Walk Test 
CAT-COPD Assessment Test 
*Not meeting criteria (ActiGraph: 5 days of ten hours wear time, pedometer: 100-50,000 steps 
recorded) Ʃ patient non-compliant with wearing device ® researcher download error.π: paper based 
outcomes only completed. β ActiGraph error, α: unable/unwilling to complete, # outcome measure 
added to CRF post visit Ω Outcome measure not available in CRF, α: unable to complete as unwell 






STANDARD OPERATING PROCEDURE FOR 
































Appendix 14: Standard operating procedure for initialising, downloading and analysing Actigraph 
 
Complete this table for each participant in the study 
Study title: _______________________________________ 
Participant number: _________ 
Visit number: ______                Date of visit: ______ 
 
 
Activity  Date Completed by 












Collect Actigraph from patient  ___/___/_________ 
 
 





Analyse Actigraph data ___/___/_________ 
 
 
Analysis of Actigraph data, checked 










Patient meeting wear time criteria 
(5 days of 10 hours per day) 
  







QUALITATIVE RESEARCH TEAM: CREDENTIALS, 























Appendix 16 Table 1: Qualitative analysis research team: credentials, training and/or 
experience  
 Credentials  Training/experience 
Orlagh O’Shea -BSc Physiotherapy           -
MSc Exercise Physiology                        
-PhD student: ‘Physical 
Activity in people with 
COPD.’ 
-Essentials of Qualitative Research (Prof 
Brian Taylor, 19/11/14)                                   
-Practical Qualitative Research Skills 
Workshop (Dr Iseult Wilson, 15/06/15) at 
Ulster University.                                            
-Fundamentals of Qualitative Data 
Analysis (Dr Jane Forman 05/05/15)                              
-Writing with Qualitative Data (Prof 
Jennifer Mason 06/05/15) at Dublin City 
University Qualitative Summer School.  
Professor Judy 
Bradley  
-BSc Physiotherapy,            
-PhD ‘The assessment of 
disability and handicap in 
adult Cystic Fibrosis’  
-Experience with pharmacological and non-
pharmacological qualitative and 
quantitative trials. 
Dr Brenda O’Neill  -BSc Physiotherapy,            
-PhD ‘The efficacy and use of 
ambulatory and short burst 
oxygen therapy in Chronic 
Obstructive Pulmonary 
Disease’ 
-Experience with rehabilitation trials, both 
qualitative and quantitative in the COPD 
and other respiratory populations. 
Dr Adele Boyd -BSc Biomedical Science                           
-PhD  
-Training with LIVELY COPD project 
team to conduct semi structured interviews. 
Professor 
Madelynne Arden 
-BSc Psychology                 
-PhD 
-Experience in behaviour change research 
for different health behaviours and in the 
conduct of qualitative and quantitative 
trials. 
Natasha Green -BSc Sport Science                              
-MSc Sport and Exercise 
Science and 
Medicine                             - 
PhD student: ‘Physical 
function and activity in 
survivors of critical illness 
following discharge from 
the intensive care unit'                               
-Informal training with King’s Template 
Anlaysis; A method of analysing interview 
transcripts in qualitative research from JB 
and OO’S 
Alanna Rogan -BSc Physiotherapy              
- PhD student: ‘Physical 
function and activity in 
survivors of critical illness 
following discharge from 
the intensive care unit' 
-Informal training with King’s Template 
analysis; A method of analysing interview 







 A PRIORI THEMES FOR QUALITATIVE 































A priori themes for qualitative component    
1. Benefit  and impact of PAI/PR on health 
1.1 Physical health 
1.2 Mental health 
1.3 Social aspect 
1.4 Family noticing a difference in health/functional ability 
 
2. Views and satisfaction with PAI/PR 
2.1 Content (how was this tailored to the individual’s needs) 
2.2 Frequency of contact 
2.3 Information provided (education) 
2.4 Materials: LWWCOPD booklet (common); pedometer and step diary (PAI 
specific); Home exercise programme (HEP) (PR specific) 
2.5 Suggestions for improvement 
2.6 PAI specific: goal setting; reward; mode of contact 
 
3. Adherence to the PAI/PR 
3.1 Facilitators for adherence to the PAI/PR 
3.2 Barriers to adherence to the PAI/PR 
 
4. Views about the outcome measures 
4.1 Recommendations for the best method to test the effectiveness of the 
programme 
4.2 Questionnaires  
4.3  Activity monitors (two worn on belt) 
4.4 ISWT 
 
5. Views about continuing exercise 
5.1 Plans for continuing exercise 
5.2 Facilitators to help participants to continue 








APPENDIX 18 INITIAL TEMPLATE FOR 

























Initial template for qualitative component following analysis of 25% of transcripts from 
each group 
1. Benefit  and impact of PAI/PR on health 
1.1 Overall health 
1.2 Social activity and social support 
1.3 Enjoyment 
2. Views and satisfaction with PAI/PR 
2.1 Content (how was this tailored to the individual’s needs) 
2.2 Duration and frequency and mode of contact 
2.3 Information provided (education) 
2.4 Materials: LWWCOPD booklet (common); pedometer and step diary (PAI 
specific); Home exercise programme (HEP) (PR specific) 
2.5 Suggestions for improvement 
2.6 PAI specific: goal setting; reward 
3. Adherence to the PAI/PR 
3.1 Facilitators for adherence to the PAI/PR 
3.1.1 Motivation 
3.1.2 Staff/providers 
3.1.3 Social support 
3.1.4 Pedometer 
3.1.5 Action and coping planning 
3.1.6 Individual strategies to increase PA 
3.1.7 Group setting 
3.2 Barriers to adherence to the PAI/PR 
3.2.1 Overall health 
3.2.2 Weather/environmental 
3.2.3 Social support 
3.2.4 Time/other commitments 
3.2.5 Group setting  
3.2.6 Motivation  
4. Views about the outcome measures 
4.1 Recommendations for the best method to test the effectiveness of the 
programme 
4.2 Questionnaires  
4.3 Activity monitors (two worn on belt) 
4.4 ISWT 
5. Views about continuing exercise 
5.1 Plans for continuing exercise 
5.2 Motivation to continue 





AMENDED INITIAL TEMPLATE FOR 
























Amended initial template for qualitative component following analysis of 25% of 
transcripts from each group 
1. Benefit  and impact of PAI/PR on health 
1.1 Overall health 
1.2 Social activity and social support 
1.3 Enjoyment 
2. Views and satisfaction with PAI/PR 
2.1 Tailoring of content to the PAI/PR to the individual 
2.2 Frequency, duration and mode  of contact with interventionist or provider 
2.3 Education and educational materials 
2.4 Suggestions for improvement 
3. Adherence to the PAI/PR 
3.1 Facilitators for adherence to the PAI/PR 
3.1.1 Motivation 
3.1.2 Staff/providers 
3.1.3 Social support 
3.1.4 Pedometer 
3.1.5 Action and coping planning 
3.1.6 Individual strategies to increase PA 
3.1.7 Group setting 
3.2 Barriers to adherence to the PAI/PR 
3.2.1 Overall health 
3.2.2 Weather/environmental factors 
3.2.3 Social support 
3.2.4 Time/other commitments 
3.2.5 Group setting  
3.2.6 Motivation to do programme independently 
4. Views about the outcome measures 
4.1 Recommendations for the best method to test the effectiveness of the 
programme 
4.2 Questionnaires  
4.3 Activity monitors (two worn on belt) 
4.4 ISWT 
5. Views about continuing exercise 
5.1 Plans for continuing exercise 
5.2 Motivation to continue 







FINAL TEMPLATE FOR QUALITATIVE 
























Final Template for Qualitative Component (following verification by colleagues) 
1. Perceived benefit  and impact of PAI/PR  
1.1 Physical health 
1.2 Mental health 
1.3 Social activity and social support 
1.4 Enjoyment 
2. Views of and satisfaction with PAI/PR 
2.1 Tailoring of the content of the PAI/PR to the individual  
2.2 Frequency, duration and mode of contact with interventionist or PR staff 
2.3 Education and education materials 
2.4 Suggestions for improvement 
3. Adherence to the PAI/PR 
3.1 Facilitators for adherence to the PAI/PR 
3.1.1 Intrinsic motivation 
3.1.2 Staff/interventionists 
3.1.3 Social support 
3.1.4 Pedometer and action and coping planning (PAI specific) 
3.1.5 Individual strategies to increase PA (PAI specific) 
3.1.6 Group setting (PR specific) 
3.2 Barriers to adherence to the PAI/PR 
3.2.1 Physical health 
3.2.2 Mental health 
3.2.3 Weather/environmental factors 
3.2.4 Lack of social support 
3.2.5 Time/other commitments 
3.2.6 Group setting (PR specific) 
3.2.7 Motivation to do programme independently (PR specific) 
4. Views about the outcome measures 
4.1 Activity monitors (two worn on belt) 
4.2 ISWT 
4.3 Questionnaires  
4.4 Recommendations for the best method to test the effectiveness of the 
programme 
5. Views about continuing exercise/PA 
5.1 Plans for continuing exercise/PA 







CHARACTERISTICS AND REFERENCES FOR 
INCLUDED PAPERS IN THE FIDELITY REVIEW: A 
SCOPING REVIEW OF THE METHODSUSED TO 
EVALUATE TREATMENT FIDELITY IN 

















Appendix 21 Table 1 characteristics and references for included papers in the fidelity review: a scoping review of the       
methodsused to evaluate treatment fidelity in behavioural change interventions 
Author and 
study design 































No definition. All sessions were audio recorded. 
Implementation fidelity was assessed using a 
specific checklist; which focused on the 
number of steps which were correctly 
implemented. 



















fidelity in The 















strategies designed to 
monitor and enhance 




et al. 2005a).  
Study design:  Stated the underpinning 
theories and how these impacted the active 
components and the overall design of the study. 
The exact dose could not be set out given the 
flexibility of the designed intervention; 
providers completed a log and audio recorded 
sessions to verify this. Strategies were used to 
minimise contamination between groups 
(keeping providers blind to the intervention 
content during the control period and told not to 
discuss details of their intervention beyond their 
site, any apparent contamination will be 
analysed from audio recordings), the study team 
also provided for possible setbacks by training 
more providers than necessary and tailoring the 
training content and schedule to suit the 
providers. 









Provider training: training was standardised 
for all providers as it was conducted by the 
same trainers using the same powerpoints, role 
play and discussions were used to ensure that 
the training was suited to the individual needs. 
Skill acquisition was assessed by self report 
assessments done before and after training, role 
plays were also videoed to assess skill 
acquisition. Ongoing supervision and feedback 
was provided to measure competence in 
delivering the intervention. Any concerns 
regarding clinician delivery of the intervention 
are discussed with the research team and raised 
with the clinician. This on-going supervision 
helped minimise drift in provider skills in 
addition to summarising key concepts on 
supplementary resources to prompt integration 
of training concepts into clinical practice. 
Booster training sessions were also completed. 
Delivery: Supervision was used to monitor 
delivery. All sessions were audio recorded and 
assessed using an intervention specific checklist 
and standardised checklists to assess delviery. 
20% of audio recorded were randomly seleted 
for assessment by trainined raters Providers had 
to score a minimum level on these checklists, if 
there were any concerns regarding delivery they 
were raised with the study team.  
Questionniares were used to collect information 
about the proviers previous training and clincal 
experience to account for any difference in 
providers; other questionnaires were used to 









therapeutic alliance and the providers 
interpersonal skills were also measured.  
Receipt: The authors felt that it was difficult 
to adopt the concept of receipt for this particular 
intervention and their interpretation of receipt 
for this was to focus on the degree to which the 
intervention was delivered. 









To evaluate the 
















No definition Recorded attendance at specific time points. 
At a particular time point specific 
measurements were taken of the tasks to be 
completed in the two trials. 
Chesworth 




























strategies used to 
monitor and enhance 





practices used to 
ensure that a research 
study reliably and 
validly tests a clinical 
intervention” (Bellg 
et al. 2004) 
Clinical logs completed by the providers 
regarding the delivery of the intervention were 
reviewed. 















To measure the 

















adaptation is the 
extent to which a 
program is changed 
after implementation 
in a real world setting 
Hansen 2013, Allen et 
al. 2012). 
Players were observed carrying out the 
exercises by two raters using a specifically 
designed checklist. Only observations that the 
raters agreed on were used for analysis. 
 
 













To evaluate the 
fidelity of the 
IMPLEMENT 

















refers to both the 
methodological 
strategies used to 
monitor and enhance 
the reliability and 
validity of delivery of 
interventions, and the 
extent to which an 
intervention as 
delivered is faithful to 
the intervention as 
planned (Bellg et al. 
2004,  Borrelli et al. 
2005). 
All workshop sessions were audio recorded 
and transcribed. The audio recordings were 
coded according to the presence of behavioural 
change techniques (BCTs). To establish 
reliability one transcript was coded by two 
raters and an agreement of 80% for the presence 
of a BCT had to be reached.  One of these raters 
then coded the remaining transcripts 10% of 






control trial  
To describe 
weight-related 
outcomes of the 
Healthy Home 













No definition  Pre-selected sessions were observed and 
delivery assessed using a standardised checklist.  






















To summarise the 
fidelity 





































How well the delivery 
and receipt of the 
intervention mirrors 
the plans of those 
who have developed 
it – the intervention’s 
fidelity – is 
increasingly 
recognised as an 
important determinant 
of its effectiveness. 
(No reference) 
Sessions were observed and delivery assessed 
using a specified fidelity checklist, which rated 
the providers’ adherence to the protocol. The 
providers’ presentations were also examined for 
adherence and their presentation skills also 
rated. 
Participant feedback regarding the style of the 
providers’ delivery and the quality of the 
intervention was obtained. 
Exposure/dose was evaluated by examining 
the attendance records to assess the number of 
targeted health professionals attending and the 
number of practices with representation. 












To test whether 
the effectiveness 
of a worksite 
physical activity 
intervention 
delivered in five 
work 
organizations 























controlled trials, it is 
important to collect 
data about how the 
intervention is 
delivered in practice 
(fidelity) and whether 
this varies according 
to the 
 (1)Adherence: assessed the extent to which 
each of the facilitators had delivered each of the 
9 components. 
 (2) Quaility of delivery was assessed self-
report: facilitators were asked a number of 
questions regarding their perceptions of the 
quaility of the delivery and facilitators also 
reported on the number of hours they spent 
implementing the intervention.  
 (3) Exposure: participants had to indicate the 
extent to which they had received each of the 9 
components (yes/no) 
 (4) Responsiveness was measured by 










context (Bellg et al. 
2004, Oakley et al. 
2006, Craig et al 
2008). 
 
usefulness of each of the components of the 
intervention. 
 (5) Engagement: particpants were asked to 
indicate whether they had taken part in the team 
challenges. 
Scores across all 4 domains was used to 
evaluate fidelity. 










To develop a 
sustainable, skill-
based training 
program to assist 







N=198  No definition Academic research staff assisted with the 
development of a programme manual  
Academic research staff attended all initial 
sessions delivered at each site to assess fidelity 
to the programme and materials and provided. 
Feedback was also provided. 
McNamara 






























fidelity is an 
important component 




(Craig et al. 2008).  
 (1)Process indicators examined the 
appropriatess and suitability of the structure 
(taken from provider documentation); retention 
of participants and time taken to deliver the 
intervention. 
 (2)Prcoess indicators were used to determine 
the appropriatene targetting and delivery of the 
intervention; (i) recruitment of particpants with 
uncontrolled risk factors (baseline 
documentation). (ii) Recommendations of goals 
to address particpants risk factors (baseline 
documentation).  (iii) Patient agreement to 
pursue recommendations of strategies (taken 
from provider documentation). (iv) 
Development of strategies to address risk 










documentation). (v) Indentification of barriers 
and enablers to behaviour change inititaion and 
maintenance (taken from provider 
documentation). 
Providers also documetned their percieved 
success of behaviour strategies. 
Self assessed perceived competence by 
providers to deliver the intervention was 
documented. 
Providers perceived need for further patient 
support at completion of the intervention was 
documented.  






control trial  
















The extent to which 
intervention was 
delivered as planned 
(‘fidelity’). (No 
reference) 
Points were awarded if an intervention 
component was implemented, therefore the 
higher the score obtained the higher the fidelity.  
















to patients with 
high fear 
avoidance who 










No definition  The delivery of CBBT was assessed from 
audio recordigns using a structured coding 
format.  
The fidelity of the physiotherapists was 
established through (1) Exit interviews with a 
sample of particpants (2) observations of one 
sessions per site the research team (3) 
exploration of the physiotherapy self report of 
session rating forms which detailed the 
components covered in each session. 

















To investigate the 





































No definition  Providers were observed delivering the 
intervention before the trial commenced and 
were required to reach a minimum level of 
compentence before delivering the intervention 
in the trial. 
Winnett et. 















(RT) with the 




















to one of two 
conditions: 
No definition  Design: (i) The study design was based on a 
theory.(ii) The dose was set out before the 
intervention commenced.(iii) Specification of 
provider credentials. (iv)Ensured they had 
sufficient power to detect treatment effects. (v) 
Wave system of recruitment to match 
personnel.  
Training: (i) The certificates of providers 
were checked before training. (ii) All providers 
received standardised initial training. (iii) 
Providers were given manuals. (iv) On-going 
supervision and feedback. 
























Delivery: (i) The providers were given session 
scripts to follow prompts for which points in the 
session to emphasise.  (ii) Post session 
checklists were completed (iii) Sessions were 
randomly checked by the research team. (iv) 
Participants anonymously rated provider 
technical and interpersonal skills. (v) Sessions 
were supervised to maintain enthusiasm. (vi) 
Contamination was limited by using separate 
manuals for each condition and assigning any 
individuals with links to different groups. (vii) 
Participants reported on unsupervised sessions 
and were given feedback depending on group 
allocation. 
Receipt: (i) All participants received hands on 
training and feedback for 3 months during the 
intervention. (ii) All participants can perform 
each exercise with proper form, range of 
motion, and degree of effort at the end of the 
intervention period. (ii) All participants were 
provided with a manual and instructions for the 
maintenance phase. 
Enactment: (i) Participants completed 
transition sessions for unsupervised training; by 
the end of the transition participants were able 
to plan and report workouts. 







To examine the 
components of 
intervention 
fidelity, as put 






N=183 Fidelity consists of 
the measures taken to 
assure that an 
intervention is carried 
out as prescribed by 
the intervention 
protocol. (Radziewicz 
Dose parameters A clear description of the 
dose to be given was set out and described from 
the start. 
Training (i) Providers were trained to train 
participants in self-delivery by a certified 
acupuncturist. (ii) Demonstrations were 









Workgroup of the 
Behaviour 
Change 





within an ongoing 
acupressure study 





et al. 2009,  Calsyn  
2000,  Wyatt 2010) 
>/95% on the Acupressure Fidelity Form. (iii) 
Providers also received refresher training at a 
predefined point. (iv) Participant training: The 
correct technique was demonstrated to the 
participants. (vi) Participants then carried out 
the acupuncture with feedback and had to reach 
>/95% on the on the Acupuncture Fidelity Form 
before completing training. (v) Participants 
were also given an instruction manual and 
DVD. 
Self-delivery: (i) Participants had a 3 week 
follow up session after the initial training to 
evaluate their technique. (ii) Feedback was 
provided to the participants and participants 
were required again to meet >/95% on the 
Acupressure Fidelity Form. (iii) The 
participants logged their sessions throughout the 
intervention and are given contact information 
in case questions arise during the intervention 
period. 
Intervention receipt: (i) Participant logs were 
examined to evaluate receipt. (ii) Attrition rates 
were also used to examine the number of 
participants who completed the entire protocol. 
Enactment: (i) This is on-going and not 
reported.  





an open pilot 
study and 
To conduct an 
open pilot study 
to establish the 
acceptability, 
feasibility and 














With so few primary 
studies explicitly 
utilising treatment 
fidelity strategies to 
monitor and improve 
training for care 
providers (where 
Consultations were videotaped (20-40%) and 
review appointments to assess adherence to and 
appropriate use of components of the 
intervention using a specifically developed 
checklist. Efforts will be made to record an 
equal number of consultations at each 















medicine for type 




of 2 years. 
training is offered), or 
to monitor the 
delivery of 
interventions to 
patients in practice, it 
is difficult to establish 
whether the 
interventions are 
being delivered as 
intended. Therefore it 
becomes impossible 
to decipher whether 
reported outcomes are 
a function of the 
intervention or ‘non-
intervention’ factors 
(Resnick et al. 
2005a). 
The results of assessment of the delivery will 










To describe a 
comprehensive 
process 

























Fidelity was defined 
as the extent to which 
each of the 
intervention activities 
were delivered as 
intended, including 
the integrity and 




Process evaluation approach: Feedback was 
received from the employees and managers 
regarding the training. 
Measured the amount of time managers and 
employees spent in training. 
There was an assessment of how the funding 
for structural changes was allocated and which 
structural changes took place. 
Assessed the degree to which the marketing 
campaign took place/was implemented; food 
demonstrations took place as planned and print 
materials were distributed as planned 
Bryant et. al 
201419S 
 









Treatment fidelity, a 
term that refers to the 
consistent and reliable 
The quality of delivery of the intervention was 
assessed against previously standardised criteria 
















treatment and (2) 
















interventions (Bellg et 
al. 2004). 
 
selected 10% of recordings from both groups). 
Three measures of session’s quality were used: 
(1) Adherence to each specific element (2) 
Physical therapist competence (3) Evaluated for 







to follow up 
(12 months) 














N=39 No definition. Audio recordings were taken from two time 
points (1) recording per provider at time point 1 
and up to 3 at time point (2) and rated with a 
specifically developed coding sheet as to 
whether they adhered to the protocol and 
according to (a) the clarity with which the 
counsellor explained the scale to the patient and 
(b) whether the counsellor was specific about 
the behaviour that they were asking the patient 
to rate themselves on. 
Researchers also judged the quality of action 
plans agreed upon according to whether they 
appeared to have the potential to address the 
patient’s adherence barrier or not. 


































Treatment fidelity has 
been defined as the 






and Broderick 2009). 
Short telephone interviews were conducted 
with patients and practitioners who participated 
in the intervention to explore any breaches in 
fidelity. The conditions that they wanted to 
explore were set out a priori: (i) adherence to 
the intervention (ii) Patient receipt and 
understanding of the intervention (iii) Patient 
enactment.  
The interviews were analysed to identify 
















intervention fidelity and to understand why 
breaches in fidelity occurred.  
Hardeman 






































rarely include an 
assessment of the 
extent to which 
interventions are 
delivered and 
received as planned 
(fidelity), to what 
extent they are 
adapted, and what this 
means for long-term 
implementation and 
impact in routine 
clinical practice 
(Bellg et al. 2004). 
Training was standardised for all nurses 
delivering the intervention. 
The providers practiced intervention 
techniques during training. 
All consultations were audio recorded and 
assessed adherence to scripted protocol. 
Feedback was provided to nurses following 
listening to the audio recordings. 










To implement and 
evaluate  the 



















Assess whether the 
intervention activities 
are implemented as 
planned (i.e. fidelity).  
(No reference) 
Activity logs: A record will be kept of the 
amount of sessions conducted (with 
participants, health care workers, families and 
nutrition counsellors) and materials distributed. 
Supervisory reports: a review of the providers’ 
workbooks will be conducted to evaluate 
completeness, validity of documented 
information, referrals, appointments kept or 
missed. 
Registration forms will record the number of 
community based nutrition counsellors trained 











Pre-post test scores will be used to assess skill 
acquisition of providers was assessed before 
and after training.  
Evaluation forms: To evaluate the quality of 
the training sessions was evaluated 
Structured observations: Providers’ 
interpersonal skills during home visits, use of 
intervention material, problem solving and 
confidence will be assessed. 
Lorencatto 




























Fidelity refers to the 
extent to which core 
intervention 
components are 
delivered as intended 
distinguished from 
how components are 
delivered such as 
quality (Borrelli 
2011). 
Identified BCTs in the treatment manual. 
Audio recorded sessions (75) and assessed if 
the BCTs specified in the treatment manual 
were delivered in practice  
McKenzie 







To examine (1) 
operational 
feasibility of the 
programme; (2) 
participants’ 

















N=39 (n = 
20, control 
and n = 19 
intervention)
. 
No definition  Monitored sessions to assess if the delivery 
was consistent with the protocol in relation to 
time distribution within sessions, therapy 
materials, and appropriate inclusion of 
modelling, practice opportunities, feedback, 
reinforcement, verbal reward, review, response 
correction, encouragement, communication 
maximization strategies, and achievement of 










tongue and lip 



































No definition. Initial training was followed by additional 
formal mentoring and instruction, role playing, 
and performance feedback from a psychologist 
at each trial site over the course of 3 to 6 
months 
Audio recordings of training were reviewed by 
a psychologist to assess if the physical therapist 
was competent in delivering the intervention. 
Audio recordings of the PT- patient 
interaction were reviewed throughout the study 











To conduct a 
cluster 
randomised 
controlled trial to 
evaluate the 
effectiveness and 































the intervention was 
delivered as designed. 
(No reference) 
 
Delivery: (i) Provider’s will complete 
questionnaire-based facilitator report of delivery 
completed after each session. (ii) Consultations 
will be audio recorded and analysed using a 
checklist of the behavioural change technique 
(BCTs) to be delivered at each consultation and 
whether the duration of the BCT changes over 
the course of the delivery period and between 
facilitators. (iii) Post intervention feedback 
forms will be distributed post intervention. 
Receipt and enactment will be assessed 
through brief questionnaires delivered with the 










the provision of 
high-quality care 
for people with 














To evaluate the 
reach, dose and 
fidelity of Guys 
Only Activity for 






techniques for 6th 
and 7th grade 
boys.  
 













or the extent to which 
the intervention was 
implemented in the 
manner and spirit in 
which it was intended 
(Linnan and Steckler 
2002). 
Observed delivery of a physical activity 
intervention using a survey adapted from other 
studies to assess delivery of the use of strategies 
to motivate, encourage or support the boys to 
increase their moderate vigorous physical 
activity. This was scored on a 4 point likert 
scale. 
Motivational interviewing sessions were audio 
recorded. Two researchers were trained to 
evaluate these recordings and the Motivational 
Interviewing Code 3.1.1 was used to determine 
adherence to motivational interviewing. To 
further evaluate the delivery of the motivational 
interviewing the degree to which they assessed 
adherence to the underlying theory was assessed 
using a 4 point likert scale.  
Van 
Schijindel- 








Control trial  
 
To describe the 
results of the 
process 
evaluation of a 
physical activity 
(PA) programme 















implementation of the 
intervention 
(Baranowski et al. 
2000,  Saunders et al. 
2005, Glasgow 2006). 
PA instructors reported directly to the 
researcher if a PA programme session was 
cancelled. 


















To advance the 
discussion of 
treatment fidelity 




































The extent to which 
an intervention is 
delivered as intended 
(Glasgow et al. 1999). 
Study designed so as participants would 
receive a full dose of the intervention by 
attending all workshops. 
Reminders were sent for upcoming workshops 
to encourage attendance and attendance at each 
workshop was recorded. 
Participants were given a certificate of 
achievement upon completion and staff were 
given continuing education credits. 
All supplies were made available to 
participants to ensure they could successfully 
perform these activities. 
Follow up contact was made by the 
interventionist to see if a service plan had been 
created and if it was being followed as planned. 













aged 9–11 years 
to both study 


















was defined as the 
proportion of planned 
physical activity 
sessions actually held 
in the intervention 
group out of those 
planned. (No 
reference)  
Recorded the amount of sessions delivered and 




































No definition. A portion of consultations were audio recorded 
and scored with a predefined checklist. Fifty per 
cent were scored independently by two raters 
and the remainder were scored by a single rater.  










To describe the 
protocol for PIP 
Pre-schoolers in 









children aged 18 
months to 4 years; 
to assess the 
feasibility of 
conducting a full 











No definition. At the end of each session the trainer will 
record whether the training was delivered as 
intended. The providers being trained will also 
complete a short evaluation form at the end of 
each session to ensure skill acquisition. 
3 Sessions at each intervention site will be 
observed and scored with a standardised form.  
At the end of each session the provider will 
complete a form reporting whether the session 
was provided, the number attending and the 
activities provided. 
Benzo et. al 
201334S 
 






N=11 No definition. 
 
 
Study design (i) strategies were utilised to 
ensure the treatment dose was the same within 




















aspects of the 





that can have 












 different types of patients equally. (iii) All 
sessions recorded, with external monitoring. 
(iv) Interventionist self-monitoring of treatment 
delivery each session 
Training (i) Standardised training, both 
materials and personnel. (ii) Training used 
recorded session review and role-play to help 
account for patient differences and 
interventionist differences in implementation 
style. (iii) Interventionists were scored with 
pilot patients using session checklist. (iv) 
Interventionists used self-assessment with 
checklists. (v) Feedback was provided from 
recorded intervention session with 
interventionist. (vi) Interventionists asked to 
identify desired training topics to assist with 
intervention skill acquisition. (vii)  Regular 
booster training sessions were provided. (viii) 
Reviewed sessions where the interventionist or 
fidelity monitor identified the session deviated 
from protocol. (ix)  Regular debriefing meetings 
were held and training was centred according to 
needs, background, and clinical experience of 
the clinicians. 
Delivery: (i) Delivery was standardised as an 
intervention protocol was used to guide each 
session. (ii) Recorded sessions and assessed 
them with a behavioural checklist completed by 
the fidelity 
Monitor. (iii) Providers completed a self-
assessment checklist following each session. 
(iv) Case conferences were held in which 








providers discussed cases and trainer reviews 
skills and strategies. 
Bergstrom 













To investigate the 
























defined as the extent 
to which a 
programme adheres to 
its programme theory 
(Fraser 2009). 
Providers’ activity at network meetings was 
recorded and they were assigned points based 
on this. 
Measured number of sessions held for 
residents (participants) and assigned points as 
per same.  
Branscum et.  





of a Group 
randomized 
controlled 
design.   
To report the 
results of a 
comprehensive 
process 


















The extent to which 
the intervention was 






Intervention sessions were observed with a 
structured tally sheet (author has established the 
readability and validity before use); which 
included a list of major tasks the provider was 
to complete to assess if the intervention was 
delivered as intended the provider  also 
completed a separate checklist for self-check.  
Gabbay et. al 
2013 37S 
To determine if 





No definition. Sessions were audio recorded and evaluated 




















usual care would 
result in improved 
outcomes over 
two years in 
patients with type 
2 diabetes who 
are at high risk for 
cardiovascular 
complications. 
with type 2 
diabetes 
who were 







Change Counselling Index to evaluate the 
delivery of the motivational interviewing. 
Feedback was given regularly based on these 
evaluations but diminished as the providers 
became more proficient. 
The providers and two investigators met to 
review study progress biweekly or more 
frequently if needed. 









of a cluster 
randomised 
control trial 
To highlight what 
is optimally 
involved on the 
part of researchers 


















or the extent to which 
a program is delivered 
as intended, or 
adheres to essential 
elements of the 
original evidence-
based intervention     
(Fraser 2009). 
All providers were trained 
Developed manuals for the providers and 
participants 
Number of calls completed 
Duration of calls completed 
Participant use of program materials and 
satisfaction. 
Lorencatto 

















Fidelity of an 
intervention refers to 
the extent to which 
interventions are 
delivered as intended, 
with adherence to 
specifications in 
A proportion of consultations were obtained 
audio recorded. 
Treatment manuals were coded according to an 
established taxonomy of BCTs. 
Transcripts of the audio recordings were then 





























(Bellg et al. 2004, 
Borrelli 2011). 
treatment manual to assess delivery of the 
intervention. 


















integrity of a 
complex 
intervention for 









Intervention fidelity is 
defined as the use of 
methodological 
strategies to monitor 
and enhance the 
reliability and validity 
of behavioural 
programmes (Bellg et 
al. 2004). 
All courses were audio recordings and fidelity 
was assessed under 3 domains. (i) Adherence: a 
component specific measure was designed to 
assess the delivery of key elements as described 
in the intervention facilitator’s manual. (ii) 
Competence: A generic competence measure 
was designed to determine the extent to which 
the providers created an environment in which 
participants could share their experiences and 
learn new skills. (iii) Overall impression: 
Another measure was designed to reflect the 
extent to which the aims and objectives of the 
component were achieved and how the material 
was received in the group. 





To observe the 











No definition. Direct observations and ratings of PA 
opportunities provided by teachers and 
children’s PA during those opportunities 
(OSRAC-P, observational system for recording 





















expenditure in 3-5 
year-old children; 
identify factors 
that associate with 







Teachers’ self-reports of intervention 
completeness, fidelity measures; barriers to 
implementation and children’s responsiveness 
to the intervention were obtained.  
The site directors’ self-reports of practices 
related to physical activity with interviews were 
obtained. 





control trial  




women leads to 
anticipated 
changes in diet 
and physical 
activity 
















If each component of 
the complex 
intervention was 
provided as intended. 
(No reference) 
Health trainers (providers) completed audio 
diaries (130 recordings) reflecting on the 
fidelity and feasibility of the intervention 
delivery. 
Measured if the intervention package was 
delivered as intended i.e. all consultations. 




















of a goal planning 
and action 
planning 
framework in one 
community 
rehabilitation 
































No definition  Provider case notes for participants were 
reviewed to assess if the intervention was 
implemented as planned. 







To examine the 
feasibility and 
potential efficacy 
of adapting the 
prevent-teach-
reinforce model 
for use with two 







N=2 boys (4 
and 6 years 
old) and 
their families 
No definition   Implementation fidelity was calculated as 
percentage based on the total number of correct 
intervention steps implemented divided by the 
total number of steps that were applicable. 
Parents delivering the intervention were 
trained on a 1:1 basis. They practiced 
implementing the steps until they could 
implement them with 90% accuracy. If the 
implementation scores fell below 80% at any 
point then additional coaching sessions were 
given.  
The researchers reviewed video recordings 
with the parents and provided feedback.   


















No definition  Interviewed school wellness co-ordinators, 
principals and cafeteria managers (on two 
occasions). 
Observed the school environment assessing 9 













program based on 













were exposed to 
the program for 








Scores were awarded based on this observation 
to assess whether the intervention was being 









To describe the 
rationale for the 3 
by 2 study design, 











N=355 No definition Training was standardised and all providers 
were given a study manual.  
During training mock yoga classes were 
conducted and all yoga instructors were given 
training CDs, DVDs and handbooks. 
Exercise trainers were given detailed written 
instructions regarding prescription and 
progression of exercises. 
The importance of strict adherence to the 
intervention protocol was emphasised 















Fidelity of the yoga intervention was 
monitored through the completion of a form by 
an unblended staff member and the yoga 
instructors communicated weekly via email 
with the Seattle investigators to describe how 
classes were proceeding and if they had any 
questions or concerns. 
Fidelity of the exercise intervention was 
monitored whereby one session a week was 
observed to ensure fidelity to the protocol using 
a quality control checklist. The exercise trainers 
completed a log to ensure the prescribed dose 
was being achieved. Exercise trainers, 
supervisors and experts in exercise training had 
regular conference calls to resolve any issues. 
For both exercise and yoga, a list of 
“Frequently Asked Questions” was compiled 
and distributed monthly to ensure a 
standardized approach to any issues that arose 
that had not been specified in the protocol. In 
addition, site visits were conducted.  
Wilner et. al 
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To evaluate the 










with mild to 
  Therefore, treatment 
integrity or fidelity 
checks are needed, in 
order to be able to 
monitor the extent to 
which treatments are 
delivered 
appropriately 
(Moncher and Prinz 
1991) 
Fidelity was monitored by direct observation. 
A pair of observers attended selected sessions to 
monitor fidelity. 
An existing checklist (CTS-Psy66) was 
adapted to monitor the fidelity of the 
intervention. Additionally monitors made global 
ratings on a ten point’s scale of fidelity to the 
manual, group process, principles of CBT and a 
single overall rating. Observers then compared 
their results and discussed any differences to 















quality of life and 
costs of health 
and social care; 
factors that 
influence 
outcome; and the 
experience of 
service users, lay 
therapists and 
service managers. 






To design a 
system to support 




of qualitative and 
quantitative 


















Not reported No definition  On screen documentation and prompts guided 






















To conduct a 
formative and 
process 




















No definition. Providers were instructed to use an exact 
script. 
On four random occasions the provider’s 
adherence to the script was assessed. 
Broekhuizen 






To evaluate the 




















No definition. It was assessed whether face-to-face counselling 
sessions were implemented as planned 
according to motivational interviewing (MI) 
guidelines (i.e. MI fidelity) was assessed by two 
MI experts, following the Motivational 


























deliver a package 
of evidence-based 
practice strategies 

























No definition Three methods were used to measure fidelity:  
Treatment planning phase fidelity: treatment 
planning forms were reviewed by intervention 
developers to assess to adherence to key 
elements. 
The active treatment phase session fidelity 
treatment: treatment sessions were observed. 
This included ratings on 3 required within 
sessions therapist behaviours. Each therapist 
behaviour had associated therapist strategies 
which guided a rating on a 4 point Likert scale.  
 Therapists completed a web based survey 
after the training period. For each intervention, 
the step therapists rated the extent to which they 
completed each step. 





























No definition  The providers information provision was 
assessed in terms of adherence to the BCC 
template and consultation style assessed using 
Behavioural Change Counselling Index via a 
video recorded session with an actor patient. 
The video recorded role-play session were 
independently reviewed according to the BBCI 
criteria by the Motivational Interviewing (MI) 
coach and two experts in MI independent to the 
research study. 
Individualised written feedback was provided 




















To evaluate the 
implementation of 






intake and body 
composition, and 
to study the 
association if 
implementation 








N=107 No definition Food environment changes were assessed 
through direct observations of reviewed 
shopping lists, weekly menus and food 
inventories in each of the six facilities, and 
observed meals.  
Faulkner et. 






























s with type 
one or type 
2 diabetes.  
N=50 Intervention fidelity 
refers to the 
methodological 
strategies used to 
monitor and enhance 




et al. 2004). 
 
Study Design: The intervention was built on a 
strong theoretical foundation for exploring 
behaviour change with an evidence base to 
support it. Treatment dose and intervention 
length were set out from the start. 
Training of providers: (i) A detailed study 
manual was developed. (ii) Providers learnt the 
study protocol and proper clinical etiquette for 
recruitment and professional communication 
with participants.(iii) Role play was also done 
so research assistants (RAs) could become more 
familiar with recruitment scripts, use of 
equipment and conducting home visits and 












 Delivery: (i) Fidelity checklists were 
completed at each home visit. (ii) The study 
team met weekly to discuss home visits fidelity 
checks, accelerometer downloads and any 
questions from the RAs could also be 
addressed.  
Receipt: Feedback was obtained from the 
participants about refinement of the intervention 
to further enhance sustainability of exercises. 
Enactment: Accelerometer recordings over 








To further explore 
the effectiveness 
of in-home parent 
child interaction 
therapy with a 
diverse sample of 
parent–child 
dyads by using 















No definition  The supervisor monitored two sessions per 
year to ensure consistency with the protocol. 
Heideman 









To assess the 
fidelity, feasibility 
and acceptability 
of a prevention 
program for 
overweight first 
degree relatives of 









N=21 Asses the fidelity 
(where intervention 
modules delivered as 
intended). 
(No reference) 
All the sessions were observed and findings 
recorded on a specifically developed checklist 
based. Observers checked whether all modules 
were delivered and all objectives for 
participants were covered; observers reported 
on the engagement of participants by looking at 
interactions between trainer and participants and 
among participants; and observed whether the 































To describe the 
development of 
methods to train 
and supervise 
therapists to attain 
adequate 
treatment fidelity 




































comprises two key 
aspects: 1) treatment 
integrity, that is, 
demonstrating that 
therapists carry out 
the intervention with 
adequate levels of 
adherence and 
competence to the 
treatment model or 
protocol; and 2) 
treatment 
differentiation, that is, 
ensuring that the 
experimental 
intervention condition 
differs from a control 
condition (i.e., 
showing much higher 
adherence and 
competence to the 
treatment model 
(Perepletchikova  and 
Kazdin 2005,  
Sharpless and Barber 
2009) 
All sessions were videotaped and rated with a 
checklist specifically developed to rate 
treatment adherence and competence that 
quantified behaviours consistent with the 
intervention. Observations for fidelity ratings 
were done 12 months after therapists training 
























No definition  Reviewed a random selection of audiotapes to 





















risk of developing 
Crohn’s disease 
based on 
genotype and that 
stopping smoking 
can reduce this 
risk motivates 
behaviour change 



















To assesses the 




involving no face 



















The fidelity of 
delivery of the 
intervention (the 
extent to which the 
text messages were 
delivered as 
intended).  (No 
reference) 















To evaluate the 



















process evaluation is 
a specific type of 
process evaluation 
that examines fidelity 
of program delivery. 
Assessment of 
implementation 
allows the researchers 
to ensure the program 
was delivered to the 
Log-in codes and tracking data will be used to 
assess whether the website and subsequent 
module materials were accessed. The date and 
duration of activity will be logged to assess 
whether audio-visuals were viewed and 
adequate time was spent to complete each 
activity. 
Online, interactive worksheets and module 
quizzes will have forced-response validation to 




































participants in the 
prescribed fashion. 
Failure to evaluate 
program fidelity can 
make it difficult to 
confirm whether non-
significant program 














Reminder emails will be sent to assess 
promotion. 
At the completion of the intervention, 
respondents will be requested to complete an 
open-ended questionnaire regarding 
acceptability and perceived usefulness of the 
program. Additionally, data regarding 





















building, over and 
above usual care, 
on risky sexual 
















Assessing the fidelity 
of the treatment is an 
important component 




Study design has ensured there will be the 
same dose between conditions. 
Reduction of differences within treatments will 
be ensured by the use of one trained 
interventionist. 
Interventionist skill acquisition and minimising 
‘drift’ in interventionist skills will be minimised 
by the development and use of a treatment 
manual with the provision of feedback. 
Audiotape sessions and coded using a 
validated instrument to ensure delivery and 













A secondary aim 
of this research is 
to examine the 
impact of the 
intervention on 
adherence to PEP.  
Provider to complete a checklist after each 
session to remind him to include appropriate 
skills and content. 
An advisory board will be used to monitor 
whether treatment protocol has been adhered to 













sleep in an adult 
family home 
residents with 
dementia and the 
relative efficacy 
of SEP compared 
to usual care 




















 No definition Delivery: Providers were given a written 
manual with materials for each session. A 
checklist was completed after each session 
indicating which treatment topics had been 
covered. All sessions audiotaped and reviewed 
by investigator who provided feedback re 
adherence to treatment protocol. 
Receipt: Staff-caregiver attendance at the 
sessions and clinical impressions were rated by 
a trainer after each session. The trainer also 
recorded whether staff- caregivers were able to 
identify specific behaviours and develop plans 
based on these behaviours for the week. 
Enactment: The trainer reviewed homework 
at every session, rated homework compliance 
and assisted staff-caregivers in problem-
solving. 












No definition Recordings of consultations were assessed 





















with MI before 












Coders then estimated whether professionals 
spoke for more than half, about half or less than 
half of the consultation time. 
Pre training to fidelity MI was compared with 
post training fidelity.  
 
Morganstrer







To test the causal 























No definition Training: Videotapes of practice cases were 
reviewed to ensure fidelity to the protocol. 
Performance was then reviewed and therapists 
were required to meet a certain level of fidelity 
before treating participants. 
Delivery (i) 30% percentage of sessions were 
observed and assessed for fidelity to MI using 
the MI integrity code 3.0 to assess fidelity from 
the observer perspective. (ii) The modified 
version of the therapy session report was used 
to assess for fidelity from the client perspective. 










To describe the 
methodology and 







girls and a school 
nurse to help the 







evaluating a treatment 
fidelity plan is a time-
consuming, but 
important, process for 
researchers to ensure 
that an intervention 
has been implemented 
as intended and 
accurately tested 
(Bellg et al. 2004). 
Study design: The underlying theory is stated 
and how it was congruent with clinical process. 
Training: An additional provider was trained 
to allow for potential setbacks. Training was 
standardised and the providers were given an 
intervention manual. The providers did role 
play and were given feedback as part of the 
training.  
Delivery and receipt: The providers kept logs 
of the sessions. All sessions were audiotaped 
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SUMMARY TABLE OF RESULTS OF 
ASSESSMENT OF STUDIES INCLUDED IN 
SYSTEMATIC REVIEW BY WILSON ET AL. 2014 









Appendix 22 Summary table of results of assessment of studies included in systematic review by Wilson et al. 2014 with the TIDieR checklist 
Study Item 1  Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12  
Nguyen et al. 
2008 
Y Y Y Y Y Y Y Y Y N/A N N 9/11 
Moy et al. 2008 Y Y Y Y N Y Y Y Y N/A N N 8/11 
Tabaket al. 2014 Y Y N Y Y Y Y Y Y N/A Y Y 10/11 
Effing et al. 
2011 
Y Y Y Y Y Y Y Y Y N/A N N 9/11 
Varga et al. 
2007 
Y Y N Y N Y N Y Y N/A N N 6/11 
Berry et al. 
2003 
Y Y Y Y N Y Y Y Y N/A Y Y 10/11 
Hospes et al. 
2009 
Y Y Y Y Y N N Y N N/A N N 6/11 
Nguyen et al.   
2013 
Y Y N Y Y Y Y Y Y N/A N N 8/11 
Wewel et al. 
2008 
N Y Y Y N Y Y Y Y N/A N N 7/11 
Moy et al.  2012 Y Y Y Y N Y Y Y Y N/A N N 8/11 
Behnke et al. 
2005 
Y Y Y Y N N N Y Y N/A N N 6/11 
Steele et al. 
2007 









Nguyen et al. 
2009 
Y Y N Y Y Y N Y Y N/A N N 7/11 
Probst et al. 
2011 
Y Y Y Y Y Y Y Y Y N/A N N 9/11 
Pomidori et al.  
2012 
N Y Y Y Y Y Y Y Y N/A N N 8/11 
Plegysulos et al. 
2013 
Y Y Y Y N Y Y N Y N/A N N 7/11 
Nguyen et al. 
2005 
Y Y N Y Y Y Y Y Y N/A N N 8/11 
Breyer et al. 
2010 
Y Y Y Y Y Y Y Y Y N/A N N 9/11 
Berry et al. 
2010 
Y Y N Y N Y N Y Y N/A Y Y 8/11 
DeBlok et al.  
2006 
N Y N Y N N N Y Y N/A N N 4/11 









































1. Provider information about treatment dose in the intervention condition 
 
A.Length of contact (minutes)  
B.Number of contacts  
C.Content of treatment  
D.Duration of contact over time  
 
2. Provide information about treatment dose in the comparison condition 
 
A.Length of contact (minutes)  
B.Number of contacts  
C.Content of treatment  
D.Duration of contact over time  
E.Method to ensure dose equivalent between 
conditions 
 
F.Method to ensure dose is equivalent for 
participants within conditions 
 
 




4. Theoretical model upon which the intervention is based is clearly articulated 
 
A.The active ingredients are specified and 
incorporated in the intervention 
 
B.Use of experts or protocol review group to 
determine whether the intervention protocol 
reflects the underlying theoretical model or 
clinical guidelines 
 
C.Plan to ensure that the measures reflect the 





5. Potential confounders that limit the ability to make conclusions at the end of the 













1. Description of how providers will be 
trained (manual of training procedures)   
 
2. Standardisation of provider training 
(especially if multiple waves of 
training are needed for multiple groups 
of  providers) 
 
3. Assessment of provider skill 
acquisition 
 
4. Assessment and monitoring of 
provider skill maintenance over time 
 
5. Characteristics being sought in a 
treatment provider are articulated a 
priori. Characteristics that should be 
avoided in a treatment provider are 
articulated a priori 
 
6. At the hiring stage, assessment of 
whether or not there is a good fit 
between the provider and the 
intervention (e.g. ensure that providers 
find the intervention acceptable, 
credible and potentially efficacious) 
 
7. There is a training plan that takes into 
account trainees different education 





1. Method ensure that the content of 
the intervention is delivered as 
specified 
 
2. Method to ensure the dose of the 
intervention is delivered as 
specified 
 
3. Mechanism to assess if the provider 
actually adhere to the intervention 
plan  
 
4. Assessment of nonspecific 
treatment affects 
 
5. Use of treatment manual  
6. There is a plan for the assessment 
whether or not the active ingredient 
was delivered 
 
7. There is a plan for the  assessment 





components were delivered (e.g. 
components that are unnecessary or 
unhelpful) 
8. There is a plan for how 
contamination between conditions 
will be prevented 
 
9. There is a priori specification of 
treatment fidelity (e.g. providers 





1. There is an assessment of the degree 
to which participants understand the 
intervention. 
 
2. There are specification strategies 
that will be used to improve 
participant comprehension of the 
intervention. 
 
3. The participants’ ability to perform 
the intervention skills will be 
assessed during the intervention 
process. 
 
4. A strategy will be used to improve 
subject performance of intervention 
skills during the intervention period 
 
5. Multicultural factors considered in 
the development and delivery of the 




1. Participant performance of the 
intervention skills will be assessed 
in settings in which the intervention 
might be applied. 
 
2. A strategy will be used to assess 
performance of the intervention 
skills in settings in which the 












PULMONARY REHABILITATION CHECK 
FORM FOR ALL SITES INCLUDED IN THE 
























Pulmonary Rehabilitation check form for all sites included in the LIVELY 
COPD project 








Contact Details  
- Telephone 





No. of PR progress 
(number of programs 
running at any one time) 
 
















Exercise Class (days) 
 
Attendance record kept 
(please circle if a record 














Education  /  Exercise 
 
Usual education sessions 










EVALUATION OF TRAINING PROVIDED FOR 
DELIVERY OF PHYSICAL ACTIVITY 
























Evaluation of Training Provided for Delivery of Physical Activity Intervention 
(PAI) 
 
1. The training prior to delivering the intervention was adequate to prepare me to 
start delivering the physical activity intervention. 
 
Strongly disagree           Disagree            Neutral           Agree         Strongly Agree 
 
2. On-going training was regular enough to help me adhere to the agreed PAI 
protocol (this refers to both the training sessions and the weekly mentoring 
phone calls). 
 
    Strongly disagree          Disagree         Neutral         Agree          Strongly Agree  
 
3. The training accounted for my individual learning styles, experience and 
education. 
 
     Strongly disagree          Disagree          Neutral          Agree        Strongly Agree  
 
4. Any positive/negative comments or thoughts with regard to the training 







5. Do you have suggestions on how the training for delivering this intervention 















AMENDED DELIVERY CHECKLISTS 
DEVELOPED SPECIFICALLY FOR THE 












































Appendix 30- Amended delivery checklist 
 
Consultation 1                                             
 
Participant number:                                            
 
 
Introduction (defined as a general introduction i.e. provider introducing self) 
 
 Report on patient’s health state and record any AEs 
 
Explain goal of the programme 
 
Mention general benefits of PA  
 
Familiarise patient with pedometer 
 
Do 20 step test 
 
Explain step diary 
 















BCS checklist Consultation 1 
 
Participant number:                                            
 
Item Component Delivered 
(,X,?) 
Comments 
2 Provide information on consequences of behaviour 
in general and for the individual (pros & cons) of 












5 Training in use of pedometer (including 20 step 
test) and completion of 7 day diary 
  
20 Materials manual this relates to the LIVELY 











Consultation 2                                                                      
Participant number:                                            
 
Introduction defined as a general introduction between the practitioner and patient 
 
Assess if any AEs Report on patients health state and record any AEs 
 
Remind the patient of the goal of the programme 
 
Re-affirm PA levels  
 
Discuss the benefits of PA 
 
Set general goal (SMART) 
 
Note any problems with pedometer 
 
Record steps for the familiarisation week 
 
Do self-efficacy walk 
 
Set step goal for week 
 
Complete Action & Coping Plan 
Any Barriers discussed 
 
Assess patient confidence level 
 

















BCS checklist Consultation 2 
 
Participant number:                                            
 
Item Component Delivered 
(,X,?) 
Comments 
1 Setting an overall walking (or functional) goal e.g. walking 
to sisters house or walking into town every day as a result of 
increased step counts/physical activity 
  
2 Provide information on consequences of behaviour in 
general and for the individual (pros & cons) of being more 
active (any risks of not being active) 
Recap on the benefits of PA to this patient by referring to 
previous consultations and additional resources.  Think 
about benefits patient has obtained or consequences of 









4 Discuss the barriers to physical activity    
6 (a) Use of pedometer steps in self efficacy walk to set 
step goal  
(b) Use 7 day pedometer steps to set step goal 
  
7 Build self-efficacy focusing patients attention on where they 
have been able to do well and focus on any achievement 
  
8 Demonstrate appropriate walking pace during self-effiacy 
walk and BORG rating 
  
9 Plan behaviour using action/coping plan   
11 Record daily steps with pedometer   
17 clinician encourages social support-so walking with family 
friends or walking to meet somebody etc 
  
20 Materials manual LIVELY patient manual (including diary) 





Consultations 3-11                                        
Participant number:                                            
 
 

























































BCS checklist Consultations 3-11 
Participant number:                                            
Item Component  Delivered 
(,X,?) 
Comments 
1 REVIEW (CONSULTATION 6 ONLY) 
Setting an overall walking (or functional) 
goal e.g. walking to sisters house or 
walking into town every day as a result of 
increased step counts/physical activity 
  
2 Provide information on consequences of behaviour 
in general and for the individual (pros and cons) of 
being more active (any risks of not being active) 
 
Recap on the benefits of PA to this 
patient by referring to previous 
consultations and additional resources.  
Think about benefits patient has obtained 
or consequences of activity specific to this 
patient. 
  




6 (a) Use of pedometer steps in self-efficacy 
walk to set step goal  
(b) Use 7 day pedometer steps to set step goal 
  
7 Build self-efficacy  focusing the patients attention on 
where they have been able to do well and focus on 
any achievement 
  
9 Plan behaviour using action/coping plan   
11 Record steps with pedometer   
13 R/v planned and actual walking behaviour each 
week with clinician by reviewing diary and 
pedometer daily step count and provide feedback 
  
14  Review if goal met, not met or partially met   
15  Reward success or effort   
17 Clinician encourages social support-so walking with 
family or friends or walking to meet somebody 
etc… 
  
20 Materials manual i.e. LIVELY patient manual 








Consultation 5                               
 


















New goal set & inserted into diary 
 
 







































BCS checklist Consultation 5 
Participant number:                                            
 
Item Component  Delivered 
(,X,?) 
Comments 
2 Provide information on consequences of behaviour in 
general and for the individual (pros and cons) of being 
more active (any risks of not being active) 
 
Recap on the benefits of PA to this patient by 
referring to previous consultations and 
additional resources.  Think about benefits 
patient has obtained or consequences of activity 
specific to this patient. 
 
  
3 Disease specific education    







6 a. Use of pedometer steps in self-efficacy walk to 
set step goal 
b. Use 7 day pedometer steps to set step goal 
  
7 Build self-efficacy confidence  focusing patients attention 
on where they have been able to do well and on 
achievements 
  
9 Plan behaviour using action/coping plan   
11 Record steps with pedometer   
13 R/v planned and actual walking behaviour each week with 
clinician by reviewing diary and pedometer daily step 
count and provide feedback 
  
14   
Review if goal met, partially met or not met 
  
15  
Reward success or effort 
  
17 Clinician encourages social support-so walking with 
family or friends or walking to meet somebody etc… 
  
20 Materials manual i.e. LIVELY manual (includes diary) 







Consultation 12                                            
 Participant number:                                            
 
 
Introduction (defined as general introduction) 
 
 
Report on patient’s health state & record any AEs 
 
 
Patient progress reviewed 
 
 
Step count inserted into chart 
 
 
Summary of 12 week steps inserted 
 
 
Review Progress from week 1  
 
 
Benefits of walking reinforced 
 
 
Personal goal reviewed 
 
 
Discuss maintenance strategies 
 
 
Summary of barriers & successful strategies inserted 
 
 
Other relapse prevention discussed 
 
 
Relapse due to COPD Exacerbation advice given 
 
 
Plan for continuing maintenance discussed  
 
 























Item Component Delivered 
(,X,?) 
Comment 
1 REVIEW Setting an overall walking (or functional) goal e.g. 
walking to sisters house or walking into town every day as a 
result of increased step counts/physical activity 
  
2 Provide information of behaviour in general and for the 
individual (pros and cons) of being more active (any risks of not 
being active) 
  
4 Discuss barriers to PA    
7  Build self-efficacy focusing the patients attention on where they 
have been able to do well  and focus on achievement 
  
BCS checklist Consultation 12 







13 Review planned and actual walking behaviour each week with 
clinician by reviewing diary and pedometer daily step count 
  
14  Review if goal met, not met or partially met   
15  Reward success or effort   
16 Certificate of achievement   
17 Clinician encourages social support-so walking with family 
friends or walking to meet somebody etc. 
  
18 Week 12 refer back, also review past sucess and also in terms of 
successful strategies  
  
19 Plan for relapse prevention   
20 Materials manual i.e. LIVELY patient manual (includes diary)  










AMENDED RECEIPT CHECKLIST DEVELOPED 
SPECIFICALLY FOR THE ASSESSMENT OF 






















Participant number:                                            
Item 1:There is an assessment of the degree to which the patient understands the 
intervention 
Familirisation week: Demonstration of patient using pedometer and 7 day recall  
Item 2: There are specification strategies that will be used to improve participant 


















3-11 Recap on 
benefits of PA 







 2  

















3 4 5 6 7 8 9 10 11 
 
3-12 Goal setting 
for step count 
with the 
pedometer 
3 4 5 6 7 8 9 10 11 12 
 
 
Item 3: The participants’ ability to perform the intervention skills will be assessed during 
the intervention process 
 
 
Item 4: A strategy will be used to improve subject performance of intervention skills 
during the intervention period 
Appointment Focus Comment 
2 Set step goal   
Complete action 





Appointment Focus Received Comment 
3-12 R/v progress- 
assessing whether 
step targets were 
met 















3-11 Reset walking 
goal 
3 4 5 6 7 8 9 10 11 
 
3-12 Revisit step 
target as per 
previous week 





that worked to 
do more walking   
3 4 5 6 7 8 9 10 11 12 
 
3-11 Complete action 
and coping plan 




3 4 5 6 7 8 9 10 11 
 
 
Item 5: Multicultural factors considered in the development of delivery of the 















AMENDED ENACTMENT CHECKLIST 
DEVELOPED SPECIFICALLY FOR THE 























Assessment of Enactment  (Whether the participant applies the skills learned in 
treatment to his/her daily life between sessions)    
Participant number                                
 
1. Participant performance of the intervention skills will be assessed in settings in 
which the intervention might be applied In LIVELY this relates to step counts 
and whether the participants meet their goals and the extent to which they 






Criteria  Comment 
2 (i) Does the step diary match the 7 day 
pedometer recall  
 
3 (i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 




(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 
participant followed their action plan is 
completed 
 
5 (i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 




(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 




(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 




(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 









2. A strategy will be used to assess performance of the intervention skills in settings in 
which the intervention might be applied In LIVELY the strategy relates to a 
record of step counts from the pedometer each week 
 
9  
(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 




(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 




(i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 
participant followed their action plan is 
completed 
 
12 (i) A review and a report on the participants 
step count is completed 
(ii) A review and report of whether the 
participant has met their goal is completed 
(iii) A review on the extent to which the 








Cons Criteria Comment 
2 A step diary and pedometer have been provided for 
one  week to allow the participant to familiarise 
themselves with  
 
3 A step count is recorded and reported.  
4 A step count is recorded and reported. 
 
 
5 A step count is recorded and reported  
6 A step count is recorded and reported.  
7 A step count is recorded and reported. 
 
 
8 A step count is recorded and reported. 
 
 
9 A step count is recorded and reported. 
 
 
10 A step count is recorded and reported. 
 
 
11 A step count is recorded and reported. 
 
 








SUMMARY OF AVAILABLE AUDIO RECORDINGS 


























Table 1. Summary of available audio recordings per consultation from each provider 
consultation Number of recordings Provider 1 Provider 2 Provider 3 
1 7 3 2 2 
2 7 3 2 2 
3 4 2 2 0 
4 6 4 1 1 
5 7 5 1 1 
6 6 4 1 1 
7 8 5 2 1 
8 7 2 2 3 
9 7 3 1 3 
10 6  2  0 3 
11 8 4 2 2 
12 8 5 2 1 
  
 
Total consultations conducted: 221 
Consultations done pre fidelity protocol: N=75 (34%) 
Consultations not recorded due to participant declining: N=12 (5.4%) 
Consultations missed due changes in protocol: N=36 (6.3%) 
Consultations missing due to various recorder problems: N=18 (8.1%) 
Consultations with available recordings: N= 80 (36.2%) 
 
 
 
 
 
 
